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Abstract 
The generation of metal nanoparticles has raised tremendous interest in recent years. They offer a 
huge variety of possible applications, due to their unique properties which strongly depend on their 
morphology. The controlled formation of nanoparticles of desired, monodisperse sizes and shapes 
still remains a challenge.  
Herein we present the design and investigation of novel peptidic additives in the formation of 
different metal nanoparticles. Oligoprolines in different lengths were functionalized with guanidine, 
imidazole, primary amine, carboxylic acid, indole and pyrrolidinyl groups on the backbone. All of the 
peptides adopt the well-defined polyproline type II (PPII) helix which was not disturbed by the 
functionalization on the backbone. The formation reaction was carried out with and without an 
external reducing agent.  
The additives were first investigated in the formation reaction of silver nanoparticles (AgNPs). The 
peptides bearing guanidine and imidazole groups were able to stabilize monodisperse and spherical 
nanoparticles using an external reducing agent in different sizes. Applying the additives without 
external reducing agents led in the case of guanidine- and indole-functionalized peptides also to the 
formation of monodisperse and spherical AgNPs.  
In the presence of amine-functionalized peptides using ascorbic acid as external reducing agents non-
spherical shapes were obtained and with pyrrolidinyl-functionalized peptides rods formed, next to 
spherical nanoparticles. 
It was found that not only the functional group that was attached, but also the defined secondary 
structure was necessary for the peptides to act as additive in the formation reaction to stabilize 
nanoparticles in defined sizes and shapes. 
In the formation of gold nanoparticles (AuNPs), guanidine- and imidazole-functionalized peptides 
were able to act as additives resulting in monodisperse nanoparticles when an external reducing 
agent was used. In contrast to the investigations for the formation of AgNPs also with amine-
functionalized peptides monodisperse AuNPs were obtained. Without external reducing agent only 
polydisperse AuNPs were formed. 
In the attempt to test the variability of the designed additives, first tests, evaluating the imidazole-
functionalized peptides in the formation of platinum nanoparticles (PtNPs) was carried out. This 
resulted as well in monodisperse nanoparticles. 
 
 
 
Furthermore a novel additive was designed inspired by a tripeptide, indentified in studies earlier 
carried out in our group. Using this peptide bearing two different functional groups it was possible to 
use it as additive in the formation of AgNPs using weak and strong reducing agents as well as visible 
light.  
These results demonstrate the potential of these peptidic additives in the formation of metal 
nanoparticles in defined sizes and shapes. 
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1. Introduction 
1.1. Noble Metal Nanoparticles 
1.1.1. History 
The first documented usage of nanoparticles comes from the 4th century and the fabrication of the 
Lycurgus Cup. This cup possesses dichroic glass with gold and silver nanoparticles embedded into it. 
They make the glass look opaque green from the outside, but when the cup is held with its interior 
facing the light source, it appears translucent red (Figure 1).[1]  
 
Figure 1: Lycurgus Cup (Rome) from the 4th century AD; a) light shining from the outside results in a 
green coloration; b) light shining from the inside results in a red coloration.  
From the 9th to the 17th century nanoparticles were used by artisans to generate a metallic luster on 
ceramics.[2-3] This effect was due to the presence of silver, gold or copper nanoparticles in the glaze, 
which were introduced by a special technique. The pottery was heated up to 600°C which allowed 
the nanoparticles to form from the metal salts and to migrate into the glaze were they were 
stabilized and can be seen until today, if the ceramics survived the centuries.[2, 4-5] Starting from the 
6th to the 15th century gold and silver nanoparticles were also employed to stain glass windows in 
European cathedrals.[6] From the 13th to the 16th century, carbon nanotubes found their application 
in the manufacturing of Damascus sabre blades which are famous for their particular strength and 
resilience.[7-8] 
The first contribution to the laboratory-based research on this topic was made by Michael Faraday.[9] 
In his paper from 1857 he described the synthesis of gold nanoparticles and their interaction with 
light. However a more significant progress and development of this research area required for 
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particular, advanced analytical techniques to be developed first. Transmission electron microscopy 
(TEM) and scanning electron microscopy (SEM) made it possible to gain deeper understanding of this 
growing field. 
A significant milestone was the famous speech delivered by Richard Feynman in 1959 where he 
declared: “there is plenty of room at the bottom”.[10] This speech was often recognized as the birth 
point of nanotechnology, as it provided the scientific community with visionary ideas of what could 
be achieved and which challenges need to be tackled in the future.  
1.1.2. Properties 
IUPAC defines nanoparticles as particles of any shape with a size between 1 and 100 nm.[11] However 
tubes and fibers with only two dimensions in this size range are also referred as nanoparticles.[11]  
When considering nanoparticles, the relatively high percentage of atoms present on the surface 
becomes relevant as it results in a large surface to volume ratio. Therefore nanoparticles possess 
distinctively different properties compared to those of bulk materials. They also strongly depend on 
the size and shape of the particles.[12] The ability to influence the properties of such nanostructures 
by controlling their geometry made this field very attractive and was one of the main reasons why 
the number of research projects focused around this topic was dramatically increased within the last 
decades. Especially gold and silver nanoparticles have attracted much attention due to their possible 
applications in electronics,[13] catalysis,[14-15] imaging[16-18] and medicine.[19-21] 
All metal nanoparticles display surface plasmon resonance (SPR).[12, 22] The surface plasmon 
resonance originates from the interaction of light with the nanoparticles which are smaller in 
diameter than the wavelength of the radiation. At a certain wavelength the photons resonate with 
the free electrons on the metal particle surface which causes them to oscillate locally around the 
particle. This phenomenon is defined as the localized surface plasmon resonance (LSPR, Figure 2).[23]   
 
Figure 2: Schematic diagram of a localized surface plasmon resonance (LSPR). 
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The resonance conditions are depending on the dielectric constant of the metal and the surrounding 
material as well as the size and shape of the nanoparticles.[18]  
The SPR of nanoparticles can be observed in UV-Vis spectroscopy and for copper, silver and gold 
nanoparticles it appears in the visible region of the spectrum (Figure 3). These nanoparticles are 
therefore colored which qualifies them for application in imaging. 
 
Figure 3: Representative visible absorption spectra of spherical copper, silver and gold nanoparticles 
in solutions.[24] 
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1.2. Silver Nanoparticles (AgNPs) 
AgNPs are among the most researched noble metal nanoparticles. As already mentioned above, they 
offer many possibilities for applications in imaging, catalysis, as antimicrobial agents and in 
electronics. Some examples are highlighted in the following chapter 1.2.1. In the course of the 
research carried out in the field, many different ways of generating AgNPs were found. Different 
approaches are presented in chapter 1.2.2.  
1.2.1. Applications of AgNPs 
1.2.1.1. AgNPs Used in Imaging 
Immobilization of biomolecules on nanoparticle surface was shown to be an efficient new approach 
towards biosensors, taking advantage of different properties like localized surface plasmon 
resonance (LSPR), surface enhanced Raman spectroscopy (SERS) and surface enhanced fluorescence 
(SEF) for sensitive detection.[25] The group of Van Duyne developed an optical biosensor using 
triangular AgNPs.[26] The system was tested for the binding of the antigen ADDL, a putative 
Alzheimer’s disease pathogen and anti-ADDL antibodies. Anti-ADDL antibodies were covalently 
bound to the nanoparticle surface via a sulfur bond and the antigen ADDL was incubated using 
different concentrations. The next step was incubation with a fixed concentration of free anti-ADDL 
antibody that was binding to the previously attached antigen ADDL (Figure 4). This was monitored 
using transmission UV-Vis spectroscopy, where a shift in the absorbance was observed upon binding. 
The assay format provided quantitative binding information about the antigen and the second 
antibody detection. This allowed to obtain the concentration, the binding constants and investigate 
the aggregation mechanisms under physiologically relevant concentrations, offering a new 
perspective for the understanding and potential diagnosis of Alzheimer’s disease.[26]  
 
Figure 4: Experimental setup for the LSPR biosensor for the ADDL detection and surface chemistry.[26] 
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The group of Wang used AgNPs for sensing in an enzymatic assay.[27] The enzymatic activity of calf 
intestine alkaline phosphatase (CIAP), dephosphorylating adenosine triphosphate (ATP) and of 
protein kinase A (PKA), phosphorylating a peptide, was investigated. In the conditions applied ATP 
prevented AgNPs from aggregating. However it was also consumed in both studied reactions. 
Therefore as soon as the reaction took place, the AgNPs started to aggregate, which resulted in an 
absorbance shift and with this, a visible change in color (Figure 5). Using this method, not only the 
activity of enzymes but also of added inhibitors could be determined. On top of that detection of the 
activity in complex biological fluids was achieved.[27] 
 
Figure 5: UV-Vis spectra of AgNPs used in the study of Wang et al.[27] in presence of 0.5 mM ATP 
without (black line) and with (red line) 0.1 unit/ µL CIAP. 
1.2.1.2. AgNPs Used for Catalysis 
Application of nanoparticles in catalysis is a rapidly growing field of research.[28] AgNPs are employed 
in many different reactions like C-C bond formation,[29-30] reduction of nitroarenes [31-32] and Diels-
Alder cycloadditions.[14, 33]  
An example of catalysis with AgNPs is the work of Chattopadhyay et al.[30] They used chitosan- 
supported AgNPs for the oxidative coupling of phenols. The reaction took place in the presence of 
iodine as an oxidant. The iodine was incorporated into the phenol, followed by an oxidative C-C 
coupling to obtain a biphenyl (Figure 6). When unsubstituted phenol was used as a substrate, the 
yield of 75% was achieved (Figure 6a). The reaction was highly regioselective as, with α-naphtol only 
the 2,2’ coupled product and with β-naphtol the 3,3’ coupled one were obtained (Figure 6b,c). The 
outcome observed for β-naphtol was different than the typical selectivity described in literature for 
homogeneous catalysts.[34-36] Furthermore low catalyst loading and mild reaction conditions could be 
applied. Preliminary mechanistic investigations suggested that this is a radical process taking place 
after chemisorption of the reactants on the AgNP surface.[30] 
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Figure 6: AgNP catalyzed oxidative coupling of phenolic compounds; a) phenol, b) α-naphtol,          
c) β-naphtol.[30] 
1.2.1.3. AgNPs Used as Antimicrobial Agents 
Silver in its different forms has been used as a disinfectant for thousands of years.[5, 37-38] The first 
documented report came from Herodotus, an ancient Greek historian who lived in the fifth century 
BC. He described that water was stored in silver containers to keep it fresh for years.[37] Hippocrates, 
the father of modern medicine, described the use of silver powders in wound healing.[37] Silver was 
extensively used in medicine, until the first half of the 20th century. Electric colloids were the main 
tool in antimicrobial therapy until the development of antibiotics in 1942.[37] After this, the use of 
silver and silver salts for such purposes decreased, but it still found its application in different medical 
fields, especially in burn treatment.[39-40] 
Nowadays, as there are more and more multidrug-resistant bacteria strains developing, there is a 
high demand for new antibiotics.[41] Therefore silver becomes attractive again, as a possible drug 
candidate.  
AgNPs were also investigated for this purpose,[38, 42-44] as by using them, some drawbacks arising 
during therapy with silver ions, like deactivation upon reaction with biomaterial can be overcome. 
They are also more reactive due to the large surface to volume ratio compared to bulk silver.[42]  
A representative example of AgNPs application as antibacterial agent is the work of Sharma et al.[45] 
They synthesized nanoparticles of different sizes (25-50 nm) and tested their behavior against a 
broad spectrum of gram-negative and gram-positive bacteria, including some multi-drug resistant 
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strains. They have demonstrated that the AgNPs had an antibacterial effect towards all tested 
bacterial strains, including the multi-drug resistant strain, even at very low nanoparticle 
concentrations (≤ 2 µg/ mL AgNPs). Furthermore they found that the smallest nanoparticles, with a 
diameter of 25 nm, displayed the highest activity.[45] 
The mechanisms of how AgNPs act against the bacteria are not fully understood, but several possible 
pathways are currently being discussed (Figure 7).[46]  
 
Figure 7: Possible pathways of interaction between AgNPs and bacteria cells: interaction with the cell 
wall, with the DNA, with membrane proteins and formation of reactive oxygen species (ROS).[46] 
It is assumed that the nanoparticles attach to the cell membrane, disturbing its permeability and 
respiration functions.[47-48] They also penetrate into the cell.[49] The AgNPs interact with sulfur-
containing proteins as well as with phosphorus-containing molecules, like the DNA. Additional 
possible reaction pathways are the release of Ag+ ions leading to their interaction with proteins and 
DNA[44] and the silver induced formation of reactive oxygen species (ROS) that can damage the cell.[46] 
1.2.1.4. AgNPs Used in Electronics 
Due to their high electric and thermal conductivity, AgNPs find application in various electronic 
devices.[13, 50-51] They are utilized, for example in the printing of electronic circuits,[50, 52] as well as for 
construction of organic field-effect transistors (OFETs).[51]  
In the ink-jet printing methodology, an AgNP suspension is printed on a substrate. The nanoparticles 
show a dramatically lowered melting point compared to the melting point of the bulk material, due 
to the increase of surface energy.[53-54] The printed nanoparticle suspension can be used as 
microjunctions after sintering at low temperatures.[55] 
Lewis et al. have demonstrated the patterning of silver microelectrodes by omnidirectional printing 
of AgNPs on different substrates.[50] Using this technique they formed microelectrodes which are 
resistant against bending and stretching of the substrate and therefore suitable for fragile, three 
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dimensional devices, as well as for spanning interconnects for example for solar cell and light 
emitting diode arrays.[50] 
 
Figure 8: SEM image of planar arrays of silver microelectrodes patterned with: a) 1 µm nozzle, 
b) 5 µm nozzle, c) 10 µm nozzle.[50] 
Uniform and high aspect ratio motifs were achieved and their width and height are defined only by 
the diameter of the nozzle and the number of the printed layers (Figure 8). After a very short 
sintering time of less than 30 min the microelectrodes had an electrical resistance of                  
5.2 * 10-5 ohm * cm, which is almost the value of 10-6 ohm * cm that can be reached with bulk 
silver.[50] 
1.2.2. AgNP Generation 
As the properties of nanoparticles depend strongly on the preparation method, it is important to find 
appropriate synthetic conditions to control their morphology and through it also their properties.[12, 
56-58] Even though many different approaches have already been developed, controlled synthesis 
allowing to obtain nanoparticles of defined sizes and shapes still remains a challenge.  
There are two main approaches towards the generation of AgNPs, the top-down and the bottom-up 
approach.  
1.2.2.1. AgNP Generation Using the Top-Down Strategy 
In the top-down approach the nanostructure is obtained by miniaturization of the bulk silver using 
different techniques. Typically this is done by mechanical grinding, lithography, chemical vapour 
deposition or laser ablation and subsequent stabilization of the resulting nano-sized metal particles 
by additives.[59-60] Nanoparticles with diameters from 10 nm to 100 nm can be obtained in this way. 
One of the main drawbacks of the top-down approach, are the defects of the nanoparticle surface 
that arise during the synthesis[60] and influence the properties. For example in nanowires used in 
electronics, such imperfections would lead to a reduced conductivity and due to inelastic surface 
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scattering to the generation of excessive heat which would complicate the potential applicability of 
these nanodevices.[60] A selection of techniques mentioned above will be described in the following 
paragraphs. 
1.2.2.1.1. AgNP Generation Using Laser Ablation 
In 1993, laser ablation was introduced as a new methodology for nanoparticle generation by 
Henglein et al. without any stabilizer as additive.[61]  
The generation of AgNPs using this technique, followed a four step procedure.[62] First the ablation 
step was applied. A laser pulse (1064 nm, 310 mJ per pulse) was used to irradiate a silver foil in an 
aqueous solution to produce an Ag hydrosol. The next three steps involved irradiation of the 
hydrosol to reduce its mean size, first with laser pulses of the same wavelength, then with a 
wavelength of 532 nm (170 mJ per pulse) and again with the original wavelength.[62] The 
experimental setup is depicted in Figure 9. 
 
Figure 9: Schematic setup for laser ablation to generate AgNPs.[62] 
After the ablation step, the resulting particles were polydisperse with diameters around 100 m. After 
fragmentation the polydispersity of nanoparticles had decreased and diameters of about 30 nm were 
reached.[62]  
Other groups tried to improve this approach by using stabilizing additives like polyvinyl pyrrolidone 
(PVP)[63] and sodium dodecylsulfate (SDS).[64] The usage of stabilizing additives increased the 
efficiency of the laser ablation as well as stabilized the resulting nanoparticles.  
1.2.2.1.2. AgNP Generation Using Chemical Vapour Deposition 
Chemical vapour deposition (CVD) is a technique used for the application of a substrate onto a 
matrix.  
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Pal et al. described deposition of AgNPs in a diamond-like carbon (DLC) film using capacitively 
coupled plasma (CCP) CVD technique.[65] They used different methane and argon gas mixtures to test 
their influence on the deposition process on a glass substrate. The silver concentration was 
controlled by the argon concentration in the starting mixture. The size of the resulting AgNPs 
increased with increased silver concentration in the vapor from 11 nm to 36 nm.  
 
Figure 10: a) TEM image of nAg-DLC film deposited with a methane to argon mixture of 1:1, 
b) histogram.[65] 
1.2.2.2. AgNP Generation Using the Bottom-Up Strategy 
In the bottom-up approach the nanoparticles are obtained by assembling basic building blocks 
(atoms) one by one to end up with a nano-sized structure. In synthetic chemistry a similar approach 
is also used to generate more complex molecules. This is the method of choice when the size of the 
desired structure lies in the lower nanometer range (1-10 nm), which is not possible to obtain by the 
top-down strategy.[60] Also bigger particles of up to 100 nm are often generated using this strategy. 
The advantages of the bottom-up approach are the possibility to generate nanostructures with less 
defects and their more homogeneous chemical composition. This is due to the fact that through the 
assembly of the building blocks, a decrease of the Gibbs free energy is achieved, thus a state closer to 
a thermodynamic equilibrium is reached.[60] Another advantage of the method is the tunability of the 
building blocks used for the generation of nanoparticles allowing to obtain ones possessing the 
desired properties.[60] 
Typically the generation is performed by reduction of a silver salt in the presence of an additive to 
guide the nucleation and stabilize the resulting nanoparticles. The reduction is either done by 
irradiation of silver ions with visible light or by using a chemical reducing agent. There are many 
parameters which can be varied in the process to improve its outcome, like the silver salt, the 
reducing agent or the additives. The most common additives are polymers, like polyvinyl pyrrolidone 
(PVP)[66-69] or polyvinyl alcohol (PVA)[70], surfactants, like sodium dodecylsulfate (SDS)[71-72] or 
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cetyltrimethylammonium bromide (CTAB),[73] dendrimers,[74] and biomolecules like, DNA,[75] 
sugars,[43] proteins,[76] peptides[46, 77-78] and amino acids.[79] 
1.2.2.2.1. AgNP Generation Using the Photochemical Method  
Using the photochemical method for the generation of AgNPs offers some advantages like good 
spatial and temporal control, avoiding additional reducing agents.[80] The position of the light 
irradiation, as well as the irradiation time can be controlled. The nanoparticles are formed either by 
direct photoreduction of a metal source or by reduction via photochemically generated 
intermediates, like excited molecules and radicals.[81] It is very important to stabilize the 
nanoparticles obtained using this method to prevent their aggregation.  
In a study of Pal et al., ascorbic acid was used as a photoactive molecule in the generation of 
AgNPs.[82] The formation of nanoparticles, using AgNO3 with surfactant Triton X-100 as stabilizing 
additive, in the presence of ascorbic acid, was complete after 4 min of irradiation with a 15 W UV-
lamp. TEM studies revealed that the resulting AgNPs were polydisperse with diameters of 15 – 60 nm 
and some larger aggregates also present. In later studies, the same authors managed to demonstrate 
SERS activity of the nanoparticles.[82] 
The variability of the photochemical approach towards nanoparticle generation was shown by 
Scaiano et al..[80] They first generated small AgNP seeds by irradiation of an aqueous solution of the 
photoinitiator I-2959, AgNO3 and citrate with UV light (Figure 11). The growth of the particles 
stopped at a diameter of about 3 nm and a spherical shape due to the citrate binding to the 
nanoparticle surface. 
 
Figure 11: AgNP seed formation after irradiation of the reaction mixture with UV light.[80] 
The formed seeds were then irradiated with different wavelengths using narrow band LEDs. 
Depending on the wavelength, the spherical particles changed their morphology to various forms 
(Figure 12). For example at the wavelength of 405 nm, spherical AgNPs with an average diameter of 
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25 nm were obtained, whereas irradiation with 455 nm LED led to transformation into dodecahedral 
AgNPs.  
 
Figure 12: Schematic representation of the formation of AgNPs, the different solutions generated 
under LED irradiation at the indicated wavelength (in nm) and the corresponding shape that was 
found in TEM studies. Yellow spheres representing Ag (0) seeds, red spheres representing 
intermediate aggregates of Ag (0) that form during irradiation.[80] 
The reason for such outcome of the described process was the aggregation of the AgNP seeds in an 
intermediate step before they were influenced by the varied excitation wavelength and the induced 
electromagnetic field to grow into the respective morphologies (Figure 12).[80] 
Another example of the photochemical based generation of AgNPs is the work of Mirkin et al..[83-84] In 
their approach they also first synthesized small, spherical AgNPs with diameter below 10 nm, which 
were converted by irradiation with visible light to larger prism structures.[84] The spheres were 
synthesized using sodium borohydride as an external reducing agent, in the presence of sodium 
citrate and bis(p-sulphonatophenyl) phenylphosphine dehydrate dipotassium (BSSP) as stabilizing 
additives. Under irradiation with a narrowband light source (150 W xenon lamp with an optical 
bandpass filter (centre wavelength = 550 nm, width = 40 nm) for 50 h two types of particles were 
formed, nanoprisms with an average edge length of 70 nm ± 12 and bigger ones with an average 
edge length of 150 nm ± 16 (Figure 13). However the thickness of both types of species was almost 
the same (9.8 nm ± 1.0). 
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Figure 13: a) TEM image of Ag nanoprisms with two different sizes, b) - c) TEM images of stacks of 
nanoprisms, d) schematic representation of the proposed light-induced fusion growth. [84] 
The authors proposed a light-induced edge-selective particle fusion mechanism where four of the 
smaller prisms fuse into a bigger prism, as shown in Figure 13d. When an additional light beam of an 
appropriate wavelength, exciting the quadrupole plasmon of the smaller nanoprism (340 nm) was 
used, the formation of the bigger prisms was suppressed. Such photo-cooperativity provides a way of 
controlling the prism size with light, by preventing particle fusion, and by varying the first 
wavelength.[84] 
The photochemical method has been used quite successfully to control the size and shape, especially 
of anisotropic AgNPs. However the synthesis via such route is often time consuming and an 
expensive light source is required. Furthermore most of the techniques developed to date require a 
two step procedure. First smaller spherical nanoparticles need to be formed, which is often done by 
chemical reduction. It would be much more efficient if control over the morphology could already be 
achieved in the first step.  
1.2.2.2.2. AgNP Generation by Chemical Reduction  
Chemical reduction is the most frequently applied method for generation of AgNPs. Different 
approaches have been developed by many different groups yielding AgNPs of different sizes and 
shapes.[12, 56-57, 85] The synthesis of AgNPs by this approach is typically carried out using a metal 
precursor, a reducing agent and a stabilizing additive. The formation reaction consists of two stages 
which are nucleation and growth (Figure 14). The size and shape of the resulting nanoparticles 
depend on the relative rates of those two stages which can be controlled through careful adjustment 
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of the reaction parameters like concentration, pH and temperature.[5] Even though many approaches 
have been carried out so far it still remains a challenge to generate them in defined size and shapes.  
 
Figure 14: Mechanism of AgNP formation via chemical reduction starting from a solution of AgNO3.
[5] 
In 1978 Creighton et al. described one of the first methods to generate AgNPs.[86] They were formed 
by reduction of AgNO3 with an excess of ice-cold sodium borohydride. The resulting particles were 
spherical with diameters of 1 to 10 nm.[86] Then, in 1982 Lee and Meisel described a different method 
using sodium citrate as chemical reducing agent in a boiling aqueous solution.[87] Boiling of the 
solution was necessary for the reaction to proceed, because citrate is a much weaker reducing agent 
then sodium borohydride. The resulting nanoparticles were polydisperse, with diameters of 
60 nm ± 200.[56] Citrate is not only the reducing agent, but it also stabilizes the resulting AgNPs by 
binding to the nanoparticle surface. However oxidation products of citrate anions can also bind to 
the nanoparticle surface and affect the growth in an unfavorable fashion.  
These two reports mentioned above described the first two methods for the generation of AgNPs. 
Interestingly the two reducing agents used then are until now most frequently applied for such 
purpose.[85] 
Third reducing agent, ascorbic acid, has also been quite commonly used in the generation reaction. It 
is a weaker reducing agent than sodium borohydride, but at the same time, stronger than citrate. 
Matijević et al. described a method where ascorbic acid was used as reducing agent for AgNO3 
resulting in nanoparticles with a mean diameter of about 26 nm.[88] They used Dadax 19, a sodium 
salt of a high-molecular-weight naphthalene sulfonate formaldehyde condensate, as a stabilizing 
additive. Ascorbic acid was also used as reducing agent in a study of van Blaaderen et al..[89] In this 
case gum arabicum was applied for the stabilization of big particles with diameter of about 100 nm. 
Another popular method to obtain AgNPs is the Tollens reaction. In which, ammoniacal silver is 
reduced to elemental silver and an aldehyde is oxidized to a carboxylic acid. Xia et al. described that 
they were using ready-made silver-plating solution, containing ammonical silver and formaldehyde to 
generate AgNPs with diameters of 20 – 50 nm.[90]  
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Sugars, like glucose can also be used as reducing agents in the Tollens reaction. One example for such 
application was the study of Qiao et al..[67] When PVP was used as an additive, AgNPs with a narrow 
size distribution were formed. The authors assumed that it was a result of the coordination of 
nitrogen atoms in the polymer structure to the silver and formation of a protective layer for 
nanoparticle growth. For bigger nanoparticles with diameters of 500 - 1000 nm, both the nitrogen 
and the oxygen in the polymer were expected to be coordinating to the silver.[67]  
Carell et al. attached aldehyde moieties onto DNA bases incorporated into a DNA strain.[91] Using 
such platform in the Tollens reaction resulted in AgNP decorated DNA strains (Figure 15). The 
particles were stabilized by the carboxylic acid moieties formed by oxidation of the aldehyde residues 
during the reduction of the silver salt. 
 
Figure 15: a) Schematic presentation of the Tollens reaction using decorated DNA strain resulting in 
AgNP formation, b) TEM image of AgNP decorated DNA strains.[91] 
Wennemers et al. also used the Tollens reaction for the generation of AgNPs.[78] They attached 
aldehyde moieties to the backbone of oligoproline peptides, which adopt a defined secondary 
structure (chapter 1.4). Utilizing peptides of different lengths resulted in nanoparticles of various 
sizes. The size of the nanoparticles showed a linear correlation to the length of the used peptides. 
(Figure 16). Correlation of molecular dimension with the resulting nanoparticles morphology was 
observed for the first time. 
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Figure 16: a) - c) TEM images of AgNPs generated with peptides of different length: a) 2 nm, b) 5 nm, 
c) 8 nm, d) schematic representation of the AgNP generation reaction, e) correlation of the lengths of 
oligoprolines with the average diameter of the corresponding AgNPs.[78] 
A method often used for the generation of AgNPs is the polyol method. The Ag+ reduction is carried 
out by poly-alcohols, under reflux conditions.[5] Xia et al. described the generation of AgNPs using 
ethylene glycol as reducing agent and polyvinyl pyrrolidone (PVP) as a stabilizing additive. The 
resulting AgNPs had a cubic shape which was assumed to be due to the selective adsorption of PVP 
on different crystallographic planes (Figure 17).[66] 
 
Figure 17: a)-b) SEM images of slightly truncated cubic AgNPs generated using ethylene glycol as 
reducing agent in presence of PVP as stabilising agent.[66] 
1.2.2.2.3. Biosynthesis of AgNPs  
There are many examples of biological systems capable of producing nanostructures, with high 
specificity and precision.[57, 92-93] Even though silver and silver nanoparticles show antimicrobial 
activity (1.2.1.3) it was discovered that some bacterial strains which were exposed to a high silver 
1. Introduction 
 
 
17 
 
 
concentration were still able to grow. One example is the silver resistant strain Pseudomonas stutzeri 
AG259 which was found in the soil of silver mines.[94] Granqvist et al. reported the accumulation of 
nanosized crystals of diverse size and shape in the periplasmic space of the bacteria cell (Figure 
18).[95] It was reasoned that this accumulation protected the bacteria from the antibacterial effects of 
the silver ions. 
 
Figure 18: TEM image of P. Stutzeri AG259 showing AgNPs of various sizes.[95] 
The resistance mechanism and how the nanoparticles are formed, is still poorly understood. It is 
assumed that proteins expressed from a unique plasmid (pKK1) which this bacteria strain possesses, 
are responsible for the resistance.[96] One of bacteria’s genes, silE encodes for a 143 amino acid 
protein which binds to metal. It is structurally similar to a proposed copper binding protein found in a 
copper resistant E.coli strain. It lacks cysteine which is typically found in metal binding proteins.[96] 
Instead it has ten histidines which assumingly are binding to the metal. 
Many natural proteins and peptides are capable of directing the growth of AgNPs.[57] This is why they 
attract more and more attention as potential additives for the generation of nanoparticles. 
1.2.2.2.4. Generation of AgNPs with Peptides as Additives 
Peptides are attractive candidates to be used in the generation of AgNPs which is clearly reflected in 
the increasing amount of publications devoted to this topic in recent years.[57-58, 77-78, 85] Peptides 
possess self-assembly and recognition properties which are useful for the binding and promotion of 
the AgNPs nucleation and growth processes. The identification of appropriate peptides for such 
purpose is one of the main challenges in this field. 
Naik et al. identified peptides within a phage display library which bind to the surface of silver 
particles.[97] Three peptides AG3 (AYSSGAPPMPPF), AG4 (NPSSLFRYLPSD) and AG5 (SLATQPPRTPPV) 
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were able to reduce silver ions and direct the formation of AgNPs. An enrichment of proline and 
hydroxyl-containing amino acid residues was found in the hits from the library assay. Out of the 
found peptides, AG4 was the predominant sequence present. Using this peptide resulted in 
formation of AgNPs with diameters of 60 – 150 nm and hexagonal, spherical and triangular shapes 
(Figure 19). The authors stated that this peptide preferably binds to the Ag(111) surface which 
enhances the formation of polyhedral crystals with a face-centered-cubic (fcc) lattice structure. 
 
Figure 19: a)-c) TEM images of different morphologies that were obtained in the AgNP generation 
reaction using peptide AG4, d) TEM image of an edge of a truncated triangle, showing the plate 
thickness.[97] 
The three-dimensional structure of the peptide was predicted to be chair-like with the help of NMR 
data.[98] The same method was used to assign the amino acids Leu5, Phe6 and Arg7 as the silver-
interacting moieties as they showed the biggest signal shift upon addition of silver ions.[98] 
Wennemers et al. identified different tripeptides within a split-and-mix library as additives for the 
generation of AgNPs.[77] The different sequences had a decisive influence on the size and shape of 
resulting nanoparticles. For example, AgNPs with diameter of about 50 nm were generated in 
presence of peptide His-Ahx-Asp bound on a Tentagel resin. Using resin-bound peptide Ser-Ahx-Tyr 
resulted in much smaller AgNPs of about 10 nm in diameter.[77] These studies clearly suggest that the 
peptide sequences, as well as the functional groups they bear, are crucial for the morphology of 
resulting AgNPs.  
1. Introduction 
 
 
19 
 
 
 
Figure 20: SEM images of AgNPs generated with peptides bound on Tentagel resin: a) peptide His-
Ahx-Asp, b) peptide Ser-Ahx-Tyr.[77] 
Wright et al. examined the influence of a histidine-rich peptide (HRE), on the stabilization of 
AgNPs.[99-100] This peptide with the sequence AHHAHHAAD, is an epitope of the histidine rich 
protein II, which was implicated in the biomineralization of heme, copper and/or zinc in different 
organisms. They were able to generate spherical nanoparticles with an average diameter of 11.2 nm 
(Figure 21). However the particles showed a rather broad size distribution 
 
Figure 21: TEM image of AgNPs generated in the presence of the HRE peptide.[99] 
In the study of Xie et al., proteins from the green algae C. Vulgaris were used as additives for the 
generation of AgNPs.[101] The proteins were not only acting as stabilizing additives, but were also able 
to reduce the silver ions and therefore generate the AgNPs. The resulting nanoparticles had an 
average diameter of 44 nm and a plate-like shape (Figure 22a).  
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Figure 22: a) TEM image of AgNPs synthesized using the green algae C. Vulgaris. Arrows indicate 
overlapping particles, b) AgNPs generated using a rationally designed peptide DDY, arrows show 
truncated triangular silver nanoplates standing perpendicularly on the TEM grid.[101] 
Through chemical modification of the protein the authors found that tyrosine residues were 
responsible for the reduction and the acidic functional groups for the anisotropic growth into the 
nanoplate-like shape.[101] Using this information they designed a simple tripeptide, bearing a DDY 
sequence, with which they were able to generate silver nanoplates with a narrow size distribution 
(Figure 22b).[101] 
A study of Mandal et al. was also aimed at a rational design of peptides that can act as additives.[102] 
They synthesized the tripeptide H-Leu-Aib-Trp-OMe, containing tryptophan which was expected to 
act as a reducing moiety to form AgNPs. Using this peptide they were able to generate nanoparticles 
with an average diameter of 13.7 nm ± 2.0 (Figure 23). 
 
Figure 23: a) TEM image of AgNPs generated with the peptide H-Leu-Aib-Trp-OMe; b) Plausible 
oxidation pathway of tryptophan.[102] 
An oxidation pathway for the tryptophan moiety, supported by IR measurements, was outlined as 
shown in Figure 23b - leading to tryptophan, ditryptophan and kynureine as reaction products.[102] 
Zhang et al., used a plant extract from Capsicum annum L. for AgNP generation.[103] They suggested 
that the reducing ability of the peptide contained in the extract comes from the amide groups. They 
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supported this hypothesis by IR and electrochemical data. They detected that after the reduction of 
silver ions the NH plane bending vibration signal disappeared from the IR spectrum which points to 
an oxidation of the amide group.[103] The amide groups of cyclic peptides curcacycline A and B were 
also associated with the reduction of silver ions for generation of AgNPs in the study of Misra et 
al..[104-105] 
However peptides are not only used as stabilizing and reducing agents, but sometimes also as 
structure determining scaffolds. For example Gazit et al. used the dipeptide Phe-Phe that is cable of 
assembling into nanotubes, as a scaffold for the generation of silver nanowires.[106] The silver ions 
were reduced using sodium citrate. After enzymatic degradation of the peptide, the silver nanowire 
was released (Figure 24).  
 
Figure 24: Schematic representation of formation of silver nanowires using self-assembled peptide 
nanotubes as scaffolds.[106] 
Even though many studies were carried out, it is not yet fully understood how peptides act in the 
generation reaction. They typically possess different functional groups which influence their 
performance. The role of the individual functional groups is however also not clear, just as the 
influence of the secondary structure that the peptides provide. 
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1.3. Gold Nanoparticles (AuNPs) 
As already mentioned in chapter 1.1., the first publication on nanoparticles, written by Michael 
Faraday concerned AuNPs.[9] From that moment on, the amount of research on AuNPs gradually 
increased with every decade. Today they are one of the most researched nanostructures. In the 
following chapter, some of their possible applications will be highlighted. Their most common 
generation pathways will then be introduced.  
1.3.1. Applications of AuNPs 
1.3.1.1. AuNPs used in Imaging 
AuNPs show a LSPR, are easy modifiable on the surface and display a certain biocompatibility. This 
makes them excellent platforms for chemical and biological sensing.[107] 
Mirkin et al. used AuNPs with a diameter of 13 nm for sensing of complementary DNA.[108-109] They 
attached through a thiol moiety, non-complementary DNA oligonucleotides on the AuNP surface. 
After addition of oligonucleotide duplexes with complementary ‘sticky ends’, aggregation of the 
AuNPs occurred. This process was shown to be thermally reversible. The color change upon 
aggregation could be used for sensing of specific DNA sequences (Figure 25).  
 
Figure 25: Cuvettes with AuNPs, a) at 80°C, DNA-modified nanoparticles, not aggregated; b) solution 
cooled to room temperature before aggregation; c) formed aggregates at the bottom of the cuvette. 
Heating of b) and c) results again in state of a).[108] 
The first example of application of such a detection technique was presented by Leuvering et al..[110-
112] They developed sol particle immunoassays for molecules, like chorionic gonadotrophin, an 
indicator for pregnancy in urine and serum. Specific antibodies were bound to the surface of AuNPs. 
After detection and binding to the target molecule, the AuNPs aggregated which was indicated by a 
visible color change or could be detected with a spectrophotometer.  
Like silver, gold is also able to enhance Raman signals for the purposes of SERS.[107, 113] Halas et al. 
used AuNPs to monitor the protonation and deprotonation of surface bound mercaptobenzoic acid 
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by SERS.[114] The system which they developed proved to be a highly sensitive nanoscale pH-meter 
with an accuracy of ± 0.10 pH units. 
1.3.1.2. AuNPs used in Catalysis 
The application of AuNPs in catalysis has gained increasing interest in recent years.[115-116] It 
represents a bridge between homogeneous and heterogeneous catalysis. Interestingly the catalytic 
ability is strongly size dependent and disappears completely when the particles become too big.[115] 
AuNPs show an intrinsic catalytic activity, for example for aerobic oxidation of alcohols, 1,2-diols and 
CO as well as borohydride reduction and carbon-carbon cross-couplings.[115-116] 
A representative example for application of AuNPs in catalysis is the work of Tsukuda et al..[117-119] 
They prepared monodisperse AuNPs with an average diameter of 1.3 nm, using PVP as a stabilizing 
additive and investigated their performance in the catalytic oxidation of benzylic alcohols in water at 
room temperature (Figure 26) The catalytic activity was considerably higher when smaller AuNPs 
(1.3 nm vs. 9.5 nm) were used.  
 
Figure 26: a) Oxidation reaction with an AuNP catalyst, b) TEM image and histogram of AuNPs 
stabilized with PVP.[117] 
1.3.1.3. AuNPs used in Medicinal Applications 
AuNPs have many possible applications for medicinal purposes, like cancer therapy, in imaging or 
drug delivery into cells. Some examples will be presented in this chapter.  
El-Sayed et al. have demonstrated a system for nuclear targeting of AuNPs in cancer cells leading to 
cytokinesis arrest.[120] This resulted in an incomplete cell division and in the end in apoptosis. The 
researchers generated 30 nm AuNPs coated with polyethylene glycol that was conjugated with two 
peptides, RGD and a nuclear localization signal (NLS) peptide. After incubation of the AuNPs with 
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malignant epithelial cells HSC-3 and non-malignant epithelial cells HaCat, they were found to be 
specifically taken up into cancer cells, and exclusively cause the cytokinesis arrest in those cells 
(Figure 27).  
 
Figure 27: Real-time images of cell division of cancer cells. Upper pictures show the normal cell 
division cycle. In presence of AuNPs the cell division stopped at 75 min and a binucleate cell was 
formed. Scale bar: 10 µm.[120] 
AuNPs can also be employed as non-toxic carriers for drug and gene-delivery. The gold core provides 
stability and the outer layer flexibility for tuning the properties to optimize the delivery conditions. 
One possibility for selective drug delivery is the glutathione-mediated (GSH) release of prodrugs. A 
methodology study was carried out by Rotello et al. where they delivered a hydrophobic dye into 
human Hep G2 cells.[121] Due to significantly increased intracellular concentration of GSH a thiol 
exchange is triggered and the surface bound dye is released inside the cell (Figure 28).  
 
Figure 28: Schematic representation of the functionalized AuNPs and the GSH-mediated release. 
Microscopy image on the right side showing released fluorescence dye inside human Hep G2 
cells.[121] 
1.3.1.4. AuNPs used in Electronics 
By decreasing the size of nanoparticles down to 2 nm and beyond and therefore also their 
capacitance it is possible to control single electron movements, even at room temperature. Using this 
property allows to design single electron devices. 
In the work of Dadosh et al. the authors connected two AuNPs by dithiolated short organic 
molecules.[122] This system was electrostatically trapped between two metal electrodes which 
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allowed for studying the electrical conductance through organic molecules. 4,4-Biphenyldithiol (BDP), 
bis-(4-mercaptophenyl)-ether (BPE) and 1,4-benzenedimethanethiol (BDMT) were investigated 
(Figure 29). It was found that the oxygen in BPE and the methylene groups in BDMT suppress the 
electrical conductance of these compounds compared to that of BPD.  
 
Figure 29: a) The structures of the investigated organic molecules, b) schematic representation of the 
connected AuNPs, c)-d) TEM images of BDMT dimer, trimer and tetramer structures with 50 nm 
particles f) Dimer consisting of 10 nm AuNPs connected with BDMT.[122] 
1.3.2. AuNP Generation 
Similarly to the generation of AgNPs, also in the AuNP generation one of the main challenges lies in 
controlling their morphology which can be achieved through establishing the optimal conditions for 
the formation reaction.[12, 123-124] Many different generation processes have been developed and 
some of them will be highlighted in this chapter, again divided in the top-down and the bottom-up 
approaches. 
1.3.2.1. AuNP Generation Using the Top-Down Strategy 
As explained before, the top-down strategy is based on the miniaturization of the bulk material by 
physical methods. For example Electron-Beam Lithography is used in the generation of multi-shaped 
nanostructures down to 10 nm in size.[125] 
As described for the AgNP generation, laser ablation is also one of the most common techniques 
used for the preparation of AuNPs.[126] One example of laser ablation application was described by 
Meunier et al..[127] They generated monodispersed and functionalized spherical AuNPs with diameter 
between 2 and 80 nm, depending on the gold to stabilizing additive ratio (Figure 30).  
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Figure 30: Correlation between the size of AuNPs and the dextran (40 kDa) to gold ratio, a)-d) TEM 
images of AuNPs.[127] 
In the first step nanoparticle seeds were generated by femtosecond laser ablation of gold pellets, 
immersed in an aqueous dextran solution, which served as stabilizing additive. A second growth 
phase followed which was carried out under milder irradiation conditions. 
1.3.2.2. AuNP Generation Using the Bottom-Up Strategy 
The strategy for generation of AuNPs by the bottom-up approach typically involves the reduction of a 
gold salt in presence of a stabilizing additive. The reduction is carried out either by irradiation or by a 
chemical reducing agent. These methods are similar to those used in the bottom-up approach for the 
generation of AgNPs. Some examples of AuNPs formation using the bottom-up strategy will be 
highlighted in this chapter. 
1.3.2.2.1. AuNP Generation Using the Photochemical Method  
The photochemical reduction is often used for the generation of AuNPs, similarly to the 
photochemical generation of AgNPs.[81] In the work of Esumi et al. the AuNP formation was achieved 
by UV irradiation of a gold salt in the presence of the surfactant hexadexylpyridinium chloride (CPCl) 
as a stabilizing additive.[128] The resulting spherical nanoparticles were monodisperse with an average 
diameter of 9.3 nm (Figure 31). Other tested surfactants were not able to stabilize the AuNPs in a 
defined size and shape. 
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Figure 31: TEM image and the associated histogram of AuNPs generated in the presence of CPCl as a 
stabilizing additive by UV irradiation over 150 min..[128] 
1.3.2.2.2. AuNP Generation Using the Turkevich Method 
This method for AuNP formation was introduced in 1951 by Turkevich et al..[129] The procedure 
involves using citrate both as a reducing agent and a stabilizing moiety. Citrate is quickly added, to a 
boiling aqueous HAuCl4 solution resulting in formation of polydisperse AuNPs with an average 
diameter of 20 nm. The gold salt is reduced to elemental gold and at the same time the citrate is 
oxidized to dicarboxy acetone (Figure 32). The nanoparticle size could be adjusted by varying the 
citrate to gold salt ratio. The higher the citrate concentration, the smaller the generated 
nanoparticles.[130], This method was further optimized in many studies by adjusting other reaction 
parameters, like the temperature and pH.[124] The approach was later modified by Lee and Meisel for 
the generation of AgNPs (described in chapter 1.2.2.2.2).[87] 
 
Figure 32: AuNP generation using the Turkevich method.[124] 
1.3.2.2.3. AuNP Generation Using the Brust-Schiffrin Method 
This is a two phase generation process where chlorauric acid in water and tetraoctylammonium 
bromide (TOAB) in toluene react with sodium borohydride as a reducing agent. The additive TOAB is 
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then exchanged by an alkanethiol which stabilizes the nanoparticles with diameters between              
5 - 6 nm, low dispersity and cuboctahedral and icosahedral shapes. (Figure 33).[124, 131] 
 
Figure 33: Mechanism for metal nanoparticle synthesis by the Brust-Schiffrin Method.[131] 
This method has several advantages which also explains its extensive usage. It is a facile synthesis 
that can be carried out at room temperature, the resulting AuNPs are very stable and the additives 
can easily be substituted with their modified versions to functionalize the nanoparticles 
differently.[124, 131-132] 
1.3.2.2.4. AuNP Generation Using the Seed-Mediated Growth Method 
In this method small nanoparticle seeds are generated in the first step. In the second step these 
seeds are added into a solution containing chlorauric acid, stabilizing additives and a reducing agent. 
The second, growth stage is typically a slow process carried out with a mild reducing agent and which 
only occurs in presence of the AuNP seeds as catalysts. The growth therefore takes place only on the 
surface of the existing seeds and no new nanoparticles are formed. The resulting nanoparticles can 
have many different sizes and shapes, depending on the reducing agent, the additive and the 
reaction conditions. 
One example of such approach is the work of Murphy et al., in which they described the preparation 
of a huge variety of different structures depending on the experimental conditions.[133] The seeds 
were added to a growth solution, containing chlorauric acid, ascorbic acid as reducing agent and 
cetyltrimethylammonium bromide (CTAB) as stabilizing additive. The morphology of the resulting 
nanoparticles depended on the quantities of each of the reaction components and rods, hexagon-, 
cube-, triangle- and star-like shapes were identified.[133] 
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Figure 34: TEM images of AuNPs generated with the seed-mediated growth method by Murphy et al. 
with different shapes evolving depending on the reactant concentrations. Scale bar = 100 nm.[133] 
1.3.2.2.5. Biosynthesis of AuNP  
As in the case of AgNPs, also AuNPs can be generated by microbes.[134] For example Murray et al. 
have observed that the Bacillus subtilis were able to reduce Au3+ to Au(0) and generated AuNPs with 
diameters between 5 - 25 nm inside of the cell wall (Figure 35).[135] 
 
Figure 35: Cell wall of Bacillus subtilis with AuNPs. Scale bar = 100 nm.[135] 
Wang et al., used E. coli DH5α as a bionanofactory to reduce chloroauric acid and guide the 
nucleation of AuNPs.[136] They incubated the bacteria in a chloroauric acid solution and after a short 
time, AuNP generation was observed. TEM and SEM investigation proved the formation of 
nanoparticles that were bound to the cell surface. These bacteria were then used as a membrane 
surface-display system. By attaching hemoglobine together with the bacteria to a glassy carbon 
electrode the direct electron transfer between the protein and the electrodes could be investigated, 
to serve as a model to understand the electron-transfer mechanisms in the biological systems. [136] 
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1.3.2.2.6. Generation of AuNPs with Peptides as Additives 
One of the first groups who investigated the possible applicability of peptides for the generation of 
AuNPs was the group of Brown.[137-138] They developed a method to screen a cell-surface-displayed 
peptide library on E. coli cells. The cells were incubated in a gold salt solution containing sodium 
ascorbate, used as a reducing agent. Three polypeptides that accelerated the AuNP growth by 
binding to the surface were identified. One of them was chosen by the group of Chen and was 
further investigated as additive for the generation of AuNPs.[139] It was found that the peptides’s 
performance strongly depended on the reaction conditions such as the pH of the solution which 
needed to be adjusted carefully. 
Peptide AG3 (AYSSGAPPMPPF), identified within a phage display library in the study of Naik et al. for 
binding to silver nanoparticles (chapter 1.2.2.2.4) was further investigated for the ability to act as an 
additive in the AuNP generation process.[97, 140] The peptide proved capable of reducing Au3+ and also 
stabilizing the resulting AuNPs with a diameter of around 12.8 nm (Figure 36). The functional group 
of the tryptophan amino acid in the peptide was presumed to act as a reducing agent in the process.  
 
Figure 36: TEM images of AuNPs generated in the presence of peptide AG3, a) scale bar = 100 nm, b) 
scale bar = 20 nm.[140] 
This study showed the intrinsic versatility of peptides in stabilization of metal nanoparticles, as the 
peptide selected for the stabilization of AgNPs also showed a clear ability to act as an additive in the 
generation of AuNPs. 
Similar conclusions were drawn from the work of Wright et al. on the usage of peptides in the 
generation of metal nanoparticles.[99-100] As described before, they used the HRE peptide (chapter 
1.2.2.2.4) to stabilize AgNPs. However in the course of their study they also found this peptide 
suitable for stabilization of AuNPs with an average size of 9.5 m which was smaller than the resulting 
diameter obtained by the formation of AgNPs (11.2 nm).  
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Serizawa et al. investigated the generation of AuNPs in the presence of a basic model peptide 
containing the sequence RPTR, previously identified as an essential motif that binds specifically to 
film surfaces composed of isotactic poly(methyl methacrylate).[141] This peptide was modified with a 
cysteine which was expected to bind to the gold surface and then used in the AuNP generation 
reaction. The reduction took place in the HEPES buffer and resulted in nanoparticles with an average 
diameter of 10 nm (Figure 37). 
 
Figure 37: a) TEM image of AuNPs generated in the presence of CRPTR peptide, b) TEM image of 
AuNPs generated and stabilized by HEPES, c) histogram of AuNPs generated in the presence of CRPTR 
peptide, d) schematic representation of AuNP generation, e) UV-Vis spectrum of AuNPs generated in 
the presence of CRPTR.[141] 
Taking advantage of the versatile properties of peptides, the group of Matsui investigated the ability 
of sequenced peptide nanotubes to serve as templates for the generation of AuNPs.[142-143] Peptidic 
nanotubes were self-assembled from bis(N-R-amido-glycylglycine)-1,7-heptane dicarboxylate 
molecules. The histidine rich peptide AHHAHHAAD, reported to be able to act as additive in the 
nanoparticle formation, was immobilized onto the nanotube.[99-100] After incubation with a gold salt 
and an external reducing agent, the reduction and formation of AuNPs took place, resulting in 
nanoparticle decorated nanotubes (Figure 38).  
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Figure 38: a) Peptidic nanotubes with AuNPs nucleated at the Au3+ binding sites, b) TEM image of 
peptidic nanotube with AuNPs generated at pH 8, c) TEM image of peptidic nanotube with AuNPs 
generated at pH 11.5.[143] 
The size distribution AuNPs was narrow with an average diameter of 6 nm which is consistent with 
the spacing between the histidine-rich peptides on the nanotubes. A higher nanoparticle density was 
observed on the nanotubes at higher pH values (Figure 38).[143] This was explained by higher 
availability of the binding sites for ions at a higher pH which resulted in more nucleation sites during 
the reduction. 
The work of Rosi et al. shows a new approach for the assembly of AuNPs into well-defined 
superstructures.[144] They used a peptide, identified within a phage-display library for the binding to 
gold surfaces and attached dodecanoic acid at the N-terminus. These molecules self-assembled into a 
left-handed twisted-ribbon structure. If chloroauric acid was present, self-assembly occured 
simultaneously with AuNP formation, resulting in a left-handed gold nanoparticle double helix 
(Figure 39). The nanoparticles had an average diameter of 8.2 nm and approximately 22 were found 
per pitch distance. The individual fibers had lengths in a micrometer range. 
 
Figure 39: a) Schematic representation of the AuNP formation on the left-handed double helix, b) 
TEM image of AuNP double helix, c) 3D surface rendering of the tomographic volume from electron 
tomography data.[144] 
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The generation of AuNPs using peptides as additives is also not fully understood yet, just as it is with 
AgNPs. The particular role played by different functional groups needs to be further explored to be 
able to successfully and rationally design additives for the generation reaction. 
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1.4. Oligoprolines 
1.4.1. Structure and Biological Function 
Proline has several special properties compared to the other proteinogenic amino acids. It is the only 
cyclic amino acid and bears a secondary amine. When proline is incorporated into a peptide, the 
rotational freedom around the amide bond is conformationally constrained. This can result in the 
disruption of secondary structures like alpha helices or beta sheets within peptides or proteins. 
Additionally there is no proton available on the amide nitrogen for hydrogen bonding to support 
these structures. 
Small oligoproline peptides, starting from six proline units already adopt a defined helical secondary 
structure. Depending on the solvent, two different structures can be formed.[145-147] In aqueous 
solution a polyproline II (PPII) helix is observed (Figure 40). In the left-handed PPII helix all amide 
bonds are in trans conformation with a dihedral angle of 180°. Every third residue is stacked on top 
of each other resulting in a C3 symmetry when looking along the axis. The helical pitch is ~ 9.5 Å (Table 
1). 
 
Figure 40: Model of PPII (top) and PPI (bottom) structure. Models constructed using MacroModel 
software.  
In more hydrophobic solvents like nPrOH, the structure switches to the polyproline I (PPI) helix   
(Figure 40). This right-handed helix is more compact then the PPII helix which is reflected in the 
helical pitch of 5.6 Å. The amide bonds are in a cis conformation with a dihedral angle of 0° (Table 1).  
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Table 1: Characteristics of PPI and PPII helix secondary structure.[145-147]   
PPI PPII 
Right-handed helix Left-handed helix 
All cis amide bonds All trans amide bonds 
ɸ = -75°, ψ = +160°, ω = 0° ɸ = -75°, ψ = +145°, ω = 180° 
~ 5.6 Å / turn ~ 9.5 Å / turn 
3.3 amino acids per turn 3.0 amino acids per turn 
Formed in organic solvents Formed in aqueous solution 
 
Circular dichroism (CD) spectroscopy is a very useful analytical tool to identify and investigate the 
two secondary structures as they show a significant difference in the resulting spectra. In CD 
spectroscopy, the difference in absorption of right and left circularly polarized light is measured, 
which can be observed for optically active, chiral molecules. Peptides with a PPI conformation show a 
minimum at ~232 nm and a maximum at ~215 nm in their CD spectra.
[148-149] Peptides with the PPII 
structure have a distinct minimum at ~206 nm and a maximum at ~226 nm (Figure 41). 
 
Figure 41: Representative CD spectra of PPI conformation and PPII conformation.[148, 150] 
Proline-rich regions in proteins are found both in prokaryotes as well as eukaryotes often as multiple 
tandem repeats.[151] They are engaged in many cellular processes, for example in signaling pathways. 
Their binding specificity is supported by the unusual character of the amino acid proline. Different 
proline-rich motifs recognized inside cells in regulation processes are known. Six families of proline-
rich binding domains that recognize proline rich sequences have been described: the SH3 
domains,[152-153] the WW domain,[154-155] the EVH1 domains,[156-158] the GYF domains,[159-160] the UEV 
domains[161-162] and the single-domain[163-164] of profiling proteins. Another very prominent example 
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for proline rich peptides are the structural proteins collagen[165-166] and elastin[167] which are the main 
components of connective tissue in mammals and plants.[168] They are furthermore employed in cell-
cell recognition[168] and cell motility.[169] 
1.4.2. Functionalized Oligoproline as Molecular Scaffold 
Oligoprolines have gained much attention for application as a molecular scaffold as they provide a 
well-defined secondary structure that forms already at short chain lengths of only six residues. They 
can be easily functionalized in the ɣ-position of the proline ring by modification of e.g. hydroxy 
proline or azidoproline (Figure 42).[170-171]  
 
Figure 42: Model of an oligoproline 9mer in a PPII conformation with azidoproline in every third 
position. 
The azido group allows for different synthetic strategies to be employed. One possibility for 
functionalization through the azide moiety is Cu (I) catalyzed Huisgen’s 1,3 dipolar cycloaddition with 
alkynes, the so-called “click” reaction (Figure 43).[171-175] A second possibility is the reduction of the 
azide to an amine which can be easily derivatized further.[170]  
 
Figure 43: Functionalized oligoproline synthesized by sequential peptide coupling and “click” reaction 
steps on solid support.[171, 175] 
One example of the application of a functionalized oligoproline is a molecular ruler for the calibration 
of distance measurements in Förster or fluorescence resonance energy transfer (FRET) systems.[176-
178] This method is a tool to investigate protein-protein interactions and conformational changes in 
proteins.[179-180] 
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Oligoproline also turned out to be a suitable spacer for the investigation of electron transfer in 
peptides.[181-185] In the studies of Giese et al. they were able to identify an electron “hopping” 
mechanism in peptides and proteins over certain relay amino acids. By using oligoproline as spacer 
for their model peptides, it was possible to identify the optimal relative distance of the relay amino 
acids.[181-183] 
Another example for the usage of oligoprolines as a molecular scaffold is the study of Overkleeft et 
al..[186] They attached agonists of a G protein-coupled receptor (GPCR) to oligoprolines. They tested 
different functionalization patterns as well as different number of coupled ligands and found an 
increase in potency of the tumor targeting with peptides bearing more than one ligand compared to 
the monomeric counterparts.[186] 
The Wennemers group is using oligoprolines as molecular scaffolds for many different applications. 
One example is tumor targeting. Peptidic agonists as well as antagonists for the specific binding to 
GPCR were attached to the oligoproline backbone, taking advantage of the enhanced binding 
through the two different binding modes that the agonist and the antagonist are using.[187] 
Functionalized oligoprolines were also employed as cell-penetrating peptides (CPPs) where cationic 
groups were attached to their backbone which enhanced the cell permeability. Those peptides were 
also functionalized with a fluorescence dye which allowed for the observation of the penetration into 
an eukaryotic cell and the accumulation inside the nucleus.[150]  
Another field of research currently being explored by the group, is the application of functionalized 
oligoproline peptides for the calibration of spin label systems. Furthermore this scaffold is 
investigated in its applicability in self-assembly of oligoproline semiconductor compounds that are 
envisioned to be used in electronics.  
Last but not least, the functionalized oligoprolines were used as additives in the generation of AgNPs 
(chapter 1.2.2.2).[78] The oligoprolines functionalized with aldehyde moieties were employed as 
reducing agents, as well as stabilizing agents, displaying a unique linear correlation between the 
molecular dimensions of the peptide and the nanoscopic dimensions of the resulting AgNPs.[78] 
The application of oligoproline-based additives for the nanoparticle formation will be further 
discussed in the following chapter, presenting the main part of this work. 
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2. Objective 
The generation of metal nanoparticles has raised tremendous interest in recent years. They offer a 
huge variety of possible applications due to their unique properties which strongly depend on their 
morphology (chapter 1). However, the controlled formation of nanoparticles of desired, 
monodisperse sizes and shapes still remains a challenge which we intended to tackle with the 
research project described within the confines of this PhD thesis.  
We envisioned that peptidic additives could be a useful tool to achieve control over the synthesis and 
therefore the properties of the obtained nanoparticles. As our group has previously demonstrated, 
aldehyde-functionalized oligoprolines are able to act as additives in the generation of monodisperse 
AgNPs, displaying an unprecedented linear correlation between the length of the peptides and the 
sizes of resulting nanoparticles.[78] 
The aim of the work described in this thesis was the design and screening of different oligoproline 
based additives for the generation of metal nanoparticles. From the previous work, we knew that 
oligoprolines can serve as scaffold in the design of additives used in the formation of metal 
nanoparticles. Therefore, we wanted to use oligoprolines as scaffold, where different functional 
groups, beneficial for the generation reaction were attached (Figure 44). We intended to investigate 
the nanoparticle stabilizing ability of such functional groups, learn more about requirements for an 
efficient additive and determine the distinct influence of respective functional groups on the size and 
shape of resulting nanoparticles.  
 
Figure 44: Schematic representation of the metal nanoparticle formation using the designed additive 
with a helical backbone and attached metal binding sites. 
Guanidine, imidazole, primary amine, carboxylic acid, indole and pyrrolidinyl groups were chosen to 
be attached to the oligoproline backbone. The studied functional groups were selected depending on 
their ability to bind metal ions. Additional selection criteria were literature precedents of their 
presence in additives for nanoparticle formation.[12, 46, 57-58, 77-78, 96-101, 103-105, 137-144, 188]  
Based on this, we chose to test the ability of such functionalized, helical peptides to act as additives 
in the metal nanoparticle synthesis. Furthermore we wanted to investigate, if the defined and rigid 
backbone is beneficial for the generation reaction. The defined structure is expected to help 
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generate defined nanoparticles as it was observed in the previously investigated system with 
aldehyde-functionalized oligoprolines.[78] 
We decided to investigate both silver and gold nanoparticles, as they are both attractive targets for 
the synthesis due to the manifold possible applications. The synthesis is typically done by reduction 
of the respective metal salt, using a reducing agent in the presence of a stabilizing additive.  
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3. Results and Discussion 
3.1. Identification of Novel Oligoproline Based Additives for the 
Generation of Metal Nanoparticles 
In this thesis, the identification of peptidic additives is presented which were investigated in the 
generation of metal nanoparticles. First, the general design of the additives is discussed 
(Chapter 3.1.1.), where the backbone, as well as the choice of the attached functional groups is 
explained. Next, the syntheses of the building blocks and the peptides are presented (Chapter 3.1.2). 
Then, the analysis of the secondary structure of the peptides using circular dichroism (CD) 
spectroscopy is shown in chapter 3.1.3.. In the last two sections of this chapter, the use of the 
designed additives in the generation of metal nanoparticles is discussed. Chapter 3.1.4 focuses on 
the generation of AgNPs. The different peptides, used as additives are discussed separately. First the 
optimization of the reaction conditions is presented, followed by the screening of various peptides to 
address the questions about the roles, played by different parts of the additives, like the functional 
groups and the oligoproline backbone. The next part focuses on the use of the additives in the 
generation of AuNPs (Chapter 3.1.5). The last chapter presents some preliminary studies for the 
formation of PtNPs (Chapter 3.1.6). 
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3.1.1. Design 
Based on the results obtained in our group by using aldehyde-functionalized oligoproline as additives 
in the formation of AgNPs, we envisioned to design peptidic additives that can influence the 
formation of metal nanoparticles. We intended to learn more about the relation between the 
molecular additive and the resulting nanoparticles. In contrast to the system investigated before, we 
chose functional groups that are able to bind to silver ions and require an external reducing agent for 
the formation of nanoparticles.  
We used as a scaffold oligoprolines which provide for a defined secondary structure and for the 
possibility to attach functional groups in a defined spatial arrangement by introducing azidoproline in 
the sequence (chapter 1.4.). Furthermore they were already used in the design of additives for the 
generation of AgNPs by our group, where it was possible to generate nanoparticles in defined sizes 
and shapes (chapter 1.).[78] This peptide serves as a platform to install different functional groups. 
The binding of stabilizing moieties to the metal is supposed to be one of the crucial factors 
determining the final size and shape of the nanoparticles. The choice of potential stabilizing motifs 
was based on their ability to bind to Ag+. We anticipated that this property made them promising 
candidates to stabilize the nanoparticles in a defined morphology. Another reason, we based our 
choice on, was that the functional groups were already found in successful additives used in the 
generation of metal nanoparticles. [12, 46, 57-58, 77-78, 96-101, 103-105, 137-144, 188] 
The functional groups that were chosen were guanidine, imidazole, primary amine, carboxylic acid, 
indole and pyrrolidinyl groups (Figure 45).  
 
Figure 45: Functional groups that were attached to the oligoproline scaffold; a) guanidine; 
b) imidazole; c) primary amine; d) carboxylic acid; e) indole; f) (2-oxo-1-pyrrolidinyl) groups. 
These functional groups all have distinctly different binding energies to Ag+.[189-191] The relative 
binding energies of amino acid side chains to Ag+ in gas phase were determined theoretically and 
experimentally in a study of Lee et al.[189] Taking inspiration from this, some of the functional groups, 
that were found in the side chains of the discussed amino acids, were chosen to be used in this work. 
Furthermore the pyrrolidinyl group was investigated, due to its application in the polymer 
polyvinylpyrrolidone (PVP), which is one of the most common additives, used for the metal 
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nanoparticle generation (chapter 1.2. and 1.3.). [66-67]  Not only this group, but all of the chosen ones 
were found to be parts of investigated additives described in literature.[57-58, 66, 79, 102, 192-195] Typically 
these additives either not provided for a defined secondary structure or there was more than one 
type of functional group in the additive present. The individual role of the functional groups 
remained unclear. Therefore, we only attached one type of functional group in one peptide, to be 
able to assign the differences in morphology of the resulting nanoparticles to the used functional 
groups. 
The functionalities were bound to the backbone through an amide bond, with an additional short, 
alkyl spacer separating them from the scaffold (Figure 46).  
 
Figure 46: Designed peptides 17a - 22c. 
The amide bond connection was chosen over the formation of a triazole in the Huisgens 1,3-dipolar 
cycloaddition to attach the functional group. Even though the reduction of the azide is an additional 
step in the synthesis, we assumed that the aromatic ring formed in this reaction would influence the 
formation process, due to its ability to bind to Ag+.[196] To investigate the influence of the amide bond 
we synthesized a peptide bearing only an amide group on the backbone of the peptide (Figure 47, 
peptide 31). 
To address the question, whether a defined three dimensional structure is really needed for an 
additive to act in an efficient way, peptides with a flexible backbone, bearing imidazole and 
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guanidine groups were designed (Figure 47, peptides 29a - 30c). These functional groups were 
chosen because their rigid counterparts, when used in the generation of AgNPs, resulted in 
nanoparticles with defined sizes and shapes. 
In addition, oligoprolines bearing primary amino and guanidine groups as derivatives without a linker 
between the functional group and the backbone were constructed. They served as models to study 
the influence of the flexibility of the linker, connecting the functional groups to the oligoproline 
scaffold, on the properties of the additives (Figure 47, peptides 23a - 24c).  
 
Figure 47: Designed peptides 23a - 24c, 29a - 31. 
The C-terminal carboxamide group was preferred over a C-terminal carboxylic acid group as well as 
an amide group at the N-terminus instead of the free amine, to prevent charged termini, which could 
influence the performance of the obtained additives. Moreover capped termini stabilize the PPII 
structure in comparison to the free termini in water.[197]  
To test the influence of the backbone in the generation reaction we also synthesize unfunctionalized 
oligoprolines (Figure 48). 
 
Figure 48: Designed peptides 25  
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3.1.2. Syntheses of the Peptides 
3.1.2.1. Syntheses of Azidoproline Containing Building Blocks 
To incorporate azidoproline in the peptides, Fmoc-(4S)Azp-OH was synthesized (Scheme 1), as 
previously described in our group.[170, 198-199]  
 
Scheme 1: Synthesis of Fmoc-(4S)Azp-OH 7 
The synthesis started with commercially available H-(4R)Hyp-OH 1. The amino acid was transformed 
into H-(4R)Hyp-OMe 2 using thionyl chloride and MeOH for the esterification of the carboxylic acid. 
Then, the amine was protected with a tert-butyl oxycarbonyl (Boc) group. The hydroxy group of the 
resulting Boc-(4R)Hyp-OMe 3 was converted in the corresponding mesylate followed by a 
nucleophilic substitution at the activated C4 with sodium azide, to give Boc-(4S)Azp-OMe 4. After 
hydrolysis of the methyl ester and cleavage of the Boc protecting group, the amine was re-protected 
with Fmoc-Cl to yield the desired product Fmoc-(4S)Azp-OH 7. All of the reactions proceeded in good 
to quantitative yields to give an overall yield of 62% of 7 over seven steps.  
It was shown in our group that the synthesis and purification of longer peptides with the monomeric 
building block 7 was difficult. Therefore the trimeric building block, Fmoc-Pro-(4S)Azp-Pro-OH 13 was 
synthesized. Fewer fragments were formed in peptide synthesis using the trimer 13, due to the 
reduced amount of coupling steps which clearly simplified the purification. The synthesis of this 
trimeric building block was carried out as previously described (Scheme 2).[198] 
For the synthesis of the trimer 13, Boc-(4S)Azp-OH 4 was deprotected to obtain the free amine 8 
followed by coupling of Boc-Pro-OH, leading to compound 9. The methyl ester was saponificated and 
H-Pro-OMe was coupled to the dimer to give Boc-Pro-(4S)Azp-Pro-OMe 11. 
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Scheme 2: Synthesis of Fmoc-Pro-(4S)Azp-Pro-OH 13. 
Subsequently the Boc group was removed and the ester hydrolysed. The last step was an Fmoc 
protection of the amine 12 with Fmoc-Cl to give Fmoc-Pro-(4S)Azp-Pro-OH 13. The overall yield was 
15% starting from H-Hyp-OH 1 over eleven steps. 
3.1.2.2. Syntheses of the Peptides 
The oligoproline peptides, containing azidoproline in every third position, were synthesized according 
to standard solid phase peptide synthesis (SPPS) protocols, using the Fmoc/tBu strategy (Scheme 3; 
5.3.).  
 
Scheme 3: Synthesis of peptides 17a – 20c on solid support (Rink amide-ChemMatrix®). 
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The synthesis was carried out on Rink amide-ChemMatrix® resin which results in a C-terminal 
carboxamide after cleavage from the resin. The peptides were synthesized by automated peptide 
synthesis using 4.0 equivalents of the respective Fmoc protected amino acid (Chapter 5.3.4). HCTU 
(4.0 equiv) was used as coupling reagent together with iPr2NEt (12 equiv) as base. Each coupling step 
was followed by Fmoc deprotection using piperidine (40% (v/v)) in DMF, followed by several washing 
steps. After the peptide synthesis, an acetylation of the N-terminus was carried out, using Ac2O and 
NEt3 to yield peptide 14. The next step was the reduction of the azide group using Staudinger 
conditions to obtain the amine 15 (Chapter 5.3.7).[200] Then, the desired functional group was 
coupled as a carboxylic acid derivative to the amine 15. Cleavage from the resin yielded the desired 
peptides 17a – 20c (Scheme 3). 
For peptide 21a-c, bearing primary amine groups and peptide 22a-c, bearing guanidine groups the 
strategy had to be adapted (Scheme 4). After coupling of Fmoc-GABA to peptide 15 on solid support, 
Fmoc deprotection using piperidine (20% (v/v)) in DMF was carried out. This was followed by 
cleavage to yield peptides 21a-c, bearing primary amines.  
 
Scheme 4: Synthesis of peptides 21a-c and 22a-c on solid support (Rink amide-ChemMatrix®). 
In the synthesis of the guanidine-functionalized peptides 22a-c, an additional guanidylation was 
performed after the Fmoc-deprotection, using N,N’-di-Boc-N’’-trifluoromethane sulfonylguanidine 
and NEt3. Then peptide 22a-c were cleaved from the resin. 
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Peptides 23a-c, bearing primary amino groups and 24a-c, bearing guanidine groups, both types 
without a linker, were synthesized in a similar manner. Peptides 23a-c, bearing primary amino groups 
were obtained by cleaving peptide 15 from the resin. The guanidine-functionalized peptides 24a-c 
were synthesized via guanidylation of peptide 15, followed by cleavage from the resin (Scheme 5). 
 
Scheme 5: Synthesis of peptides 24a-c. 
The unfunctionalized oligoprolines 25 was synthesized by standard SPPS, using the Fmoc/tBu 
strategy on Rink amide-ChemMatrix® (Figure 49). The synthesis was followed by N-acetylation to 
obtain a capped N-terminus. 
 
Figure 49: Oligoprolines 25. 
The flexible peptides 29a-c and 30a-c were synthesized using standard SPPS with the respective 
Fmoc amino acids followed by acetylation of the N-terminus (Figure 50). 
 
Figure 50: Flexible peptides 29a-c and 30a-c. 
After cleavage of the peptides they were purified using RP-HPLC. TFA was used to remove the 
peptides from the acid labile Rink amide resin. Thus the peptides were obtained and isolated as TFA 
salts. Since the TFA might influence the nanoparticle formation, the peptides were “desalted” by an 
ion exchange column (5.3.10.). The removal of TFA was confirmed by 19F-NMR. The usage of TFA was 
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preferred over the usage of another acid, like HCl because it was possible to easily control the 
removal using 19F-NMR. 
For peptides 18a-c, bearing carboxylic acid groups, ion exchange chromatography could not be used. 
The acidic peptides cannot be eluted from the column. Even though, there is no counter ion present 
that binds to TFA in those peptides, there was an excess observed in 19F-NMR that unfortunately 
could not be removed by repeated precipitation. To remove the TFA, a second RP-HPLC purification 
was carried out, using solvent mixtures without TFA. It was necessary to make two purification steps, 
as using solvent mixtures without TFA, resulted in a significant peak broadening.  
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3.1.3. Conformational Analysis 
To investigate the secondary structures of the functionalized oligoprolines, CD spectroscopic studies 
were performed. The peptides were dissolved in ultrapure water and the measurements were 
carried out at 25°C. The ellipticity is given as the molar ellipticity, taking into account the 
concentration of the peptide solution, calculated for only one amino acid residue, to be able to 
compare different concentrations and lengths of peptides.  
In Figure 51 is the CD spectrum of the unfunctionalized oligoproline presented. It has a minimum at 
206 nm and a maximum at 226 nm which is indicative for a PPII helix (chapter 1.4.).[148, 201-202] This 
spectrum served as reference for a PPII structure for the functionalized oligoprolines. 
 
Figure 51: CD spectrum of peptide 25. 
In Figure 52 the CD spectra of peptides 17a-c, bearing imidazole moieties, are shown. The longer the 
peptide, the more intense is the minimum at 206 nm. Beside this change in intensity, it was observed 
that the introduction of the functional groups had no influence on the shape of the CD spectra 
(compare to Figure 51). The same is true for the other functionalized peptides (Figure 52). In case of 
peptide 19a, bearing an indole moiety a blue shift of the minimum is observed (Figure 52c). A 
possible reason for this is the presence of an aromatic group which is by itself a strong chromophore 
and therefore has a bigger influence on the ellipticity of the peptide. Due to the aromatic character 
of the indole in the side chains, peptides 19b and 19c showed a decreased solubility in water. This 
significantly obstructed the spectroscopic analysis. However the spectra recorded at very low 
concentrations clearly showed also a PPII structure. 
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Figure 52: CD spectra of a) peptides 17a-c, b) peptides 18a-c, c) peptide 19a, d) peptides 20a-c, 
e) peptides 21a-c, f) peptides 22a-c. 
In Figure 53 the spectra of the guanidine-functionalized peptides 22a, 24a and the unfunctionalized 
oligoproline 25 are shown. The unfunctionalized peptide 25 forms a PPII helix and therefore served 
as reference. The other two peptides have a guanidine group attached to the backbone. In peptide 
24a, the functional group is attached directly to the proline ring, whereas in peptide 22a, an 
additional linker connects the functional group to the backbone. These differences in the side chain 
have an influence on the intensity of the minima in the CD spectra. The minimum of unfunctionalized 
oligoproline 25 is the most intense and the one of peptide 22a the least intense. The observed 
changes probably result from the influence of the functional groups on the absorption. This effect is 
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more dominant in the case of peptide 22a, probably due to the fact that the additional amide groups 
from the linker are contributing to the CD signal.  
Clearly a PPII structure is formed in all of the investigated oligoproline based peptides, as they all had 
a maximum at 226 nm which is most indicative for a PPII helix. More profound information, also 
about the attached functional groups, would only be provided by an X-ray structure. It was tried to 
crystallize an oligoproline under various conditions. So far no crystals were obtained (Appendix). 
 
Figure 53: CD spectra of peptides 22a, 24a and 25. 
The peptides which were designed to adopt no defined secondary structure had CD spectra that 
indicate a random coil structure. The CD spectra of the flexible peptides 29a, bearing an imidazole 
moiety and 30a, bearing a guanidine moiety are shown in Figure 54. These spectra both display a 
minimum around 195 nm and a maximum around 216 nm which are indicative for a random coil 
structure.[203-204] In such a structure the amino acids are oriented randomly and are observed as a 
statistical distribution of shapes. These peptides were designed to have no defined secondary 
structure in order to investigate the influence of this property from the additives, on the generation 
of metal nanoparticles.  
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Figure 54: CD spectra of peptides 29a and 30a. 
The CD spectra of the longer peptides 29b, 29c and 30b, 30c are shown in the appendix.  
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3.1.4. Silver Nanoparticle (AgNP) Formation 
We tested the different peptides for their ability to act as additives in the formation of AgNPs. First 
the reaction conditions needed to be optimized, by testing different reducing agents, varying the pH 
and the ratio of Ag+ to functional groups present in the reaction. The optimization studies were 
carried out in each case using the shortest peptide. Next we applied the optimized conditions in the 
formation reaction using also the longer derivatives. 
We tested flexible derivatives of the designed additives to understand more about the role of the 
rigid backbone, we used in the stabilization of nanoparticles in defined size and shapes. We also 
evaluated the role of the linker between the functional group and the peptidic scaffold by testing 
peptides with and without a linker.  
In our investigation, we also evaluated the possibility of using the additives as reducing agents by 
themselves and at the same time as stabilizing moieties. Therefore the formation reaction was 
carried out in the absence of an external reducing agent. 
3.1.4.1. AgNP Formation in the Presence of Peptides Bearing Guanidine Moieties  
3.1.4.1.1. Optimization of the Reaction Conditions: Peptide 22a 
Investigation of guanidine-functionalized peptides 22a-c and their ability to act as additives in the 
AgNP formation reaction required first the optimization of the reaction conditions. Ascorbic acid and 
sodium borohydride were chosen as external reducing agent, as they allowed us, to vary the strength 
of the reducing agent (chapter 1.2.2., 1.3.2.).[85, 87, 205] To find the optimal conditions for the formation 
reaction first, the reducing agents were tested and then the pH of the reaction and the ratio of Ag+ to 
functional groups present in the reaction were varied. 
Peptide 22a, bearing two guanidine moieties, was used for the optimization of the reaction 
conditions. This peptide was the shortest peptide from the series, bearing two guanidine moieties, 
pointing in the same direction in space.  
The evaluation of the external reducing agents showed, that well defined AgNPs were generated, 
using ascorbic acid, whereas aggregates formed, when the stronger reducing agent sodium 
borohydride was used. As a consequence, ascorbic acid was chosen as reducing agent, for the 
following experiments.  
In the beginning a ratio of Ag+ to guanidine groups of 1:5 was used with a silver concentration of 
0.25 mM. Different studies reported in the literature described, an excess of additive to be 
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advantageous.[5, 43] Therefore this ratio seemed to be a reasonable starting point. Different pH values 
were tested, as they result in different protonation states of the entailed functional groups. We 
expected the pH, to have a significant influence on the binding strength of the additive to the silver 
and therefore on the ability for it to act as an additive.[102, 206] When the guanidine groups are not 
protonated, they can provide their electron lone pair, resulting in a stronger binding. If the functional 
group is protonated, it is positively charged and therefore repels the equally positively charged silver 
ions, which probably leads to a reduced control over the nanoparticle formation. By dissolving 
peptide 22a in water, a solution with a pH around 9.6 was obtained. We also tested the reaction at 
pH 3, pH 11 and 12. Aqueous sodium hydroxide solution and nitric acid were used to adjust the pH. 
Then, AgNO3 was dissolved and after 15 minutes of equilibration time, the reducing agent was 
added. The results are shown in Figure 55. 
 
Figure 55: a) Peptide 22a; formation of AgNPs in the presence of peptide 22a at different pH values; 
a) UV-Vis spectra, b) TEM of AgNPs generated at pH 11, c) TEM of AgNPs generated at pH 12. 
Analysis was carried out after one day. 
At pH 3 and pH 9.6, the formed AgNPs aggregated within one hour, which can be seen in the UV-Vis 
spectra. With increasing pH values, the stability of AgNPs increased. However a statistical evaluation 
showed that at pH 12, the distribution of the nanoparticle sizes was slightly narrower. To our delight, 
under these conditions and in the presence of peptide 22a, monodisperse AgNPs were obtained. 
They were found to have a spherical shape with an average diameter of 12 nm and a narrow size 
distribution (12.0 nm ± 2.2), which was determined using transmission electron microscopy (TEM) 
(Figure 56). 
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Figure 56: Formation of AgNPs generated in the presence of peptide 22a with Ag+ to functional group 
ratio of 1:5 at pH 12; a) TEM image, b) Histogram, c) EDX spectrum, d) STEM image. Analysis was 
carried out after one day. 
In literature it is described that free Ag+ is known to form Ag2O at basic pH in aqueous solution.
[207] As 
the formation takes place at basic pH, we tested if the resulting nanoparticles consisted of Ag (0) as it 
was intended, by energy dispersive X-ray (EDX) spectroscopy. It was shown that the nanoparticles 
consist of pure Ag (0) (Figure 56c). In the spectrum, silver peaks are observed and no oxygen peak. 
Copper peaks were originating from the copper grid on which the measurement was carried out. No 
Ag2O was formed what suggests that Ag
+ was stabilized by binding with the peptide, preventing the 
oxide formation.  
At the higher pH values tested, the guanidine group is protonated to a smaller extent. Using the 
Henderson-Hasselbalch equation (1) we calculated the degree of protonation.[208] If we assume that 
the pKa value of the functional group is 12.48 like it is found in the corresponding amino acid arginine 
for the guanidine group, the functional group is to an extend of 69 % protonated at a pH of 12. At 
pH 11, the rate of protonation was increased to 97%.  
          
       
       
  (1) 
When the guanidine groups are not protonated, the free electron pairs can participate in the binding 
to the Ag (0), which might lead to a higher degree of control over the morphology of the 
nanoparticles. Additionally, the strength of the reducing agent, ascorbic acid, is increased at higher 
pH values, as the presence of the ascorbate anion is proposed to play a crucial role in the reduction 
process.[205, 209] This presumably facilitates the reduction of Ag+ stabilized in aqueous solution by the 
guanidine moieties.  
To test the influence of different peptide concentrations on the process, ratios of Ag+ to guanidine 
groups of 1:1 and 1:10 were tested with a constant AgNO3 concentration of 0.25 mM (Figure 57).  
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Figure 57: Formation of AgNPs generated in presence of peptide 22a with ratio of Ag+ to functional 
groups of 1:1 a) UV-Vis spectrum, b) TEM image, c) histogram; 1:5 d) UV-Vis spectrum, e) TEM image, 
f) histogram; and 1:10: g) UV-Vis spectrum, h) TEM image, i) histogram. Analysis was carried out after 
one day. 
When a ratio of 1:1 was applied, the resulting AgNPs were polydisperse as shown in TEM (Figure 
57b, c). Also when a ratio of 1:10 was used, the nanoparticles showed a broader size distribution 
compared to those generated in the presence of guanidine-functionalized peptide with a ratio of 1:5. 
These results prove that the ratio of Ag+ to guanidine group of 1:5 is optimal for the AgNP 
generation. Below and above this, the resulting AgNPs were less stable or less monodisperse, 
respectively.  
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3.1.4.1.2. Testing Peptides of Different Lengths: 22a-c 
With the optimized conditions for the generation of stable and monodisperse nanoparticles in the 
presence of guanidine-functionalized oligoprolines in hand, we next explored the influence of the 
peptide length on the resulting size and shape. Therefore we tested the formation reaction with an 
Ag+ to guanidine group ratio of 1:5, at pH 12 using ascorbic acid as external reducing agent in the 
presence of peptides 22a-c. The results are shown in Figure 58. 
 
Figure 58: Formation of AgNPs in the presence of peptides 22a (n = 2), 22b (n = 4) and 22c (n = 6): 
a) peptide 22a-c, b) UV-Vis spectra, c) correlation between the length of peptides 22a-c and the size 
of the resulting AgNPs, d) TEM image of AgNPs formed in presence of peptide 22a, e) TEM image of 
AgNPs formed in presence of peptide 22b, f) TEM image of AgNPs formed in presence of peptide 22c. 
Analysis was carried out after one day. 
Pleasingly, in the presence of all three different length of the guanidine-functionalized peptide    
(22a-c), monodisperse nanoparticles were formed (Figure 58). They all had an average diameter of 
12 nm, demonstrating a minor influence of the length of the peptides to the morphology of the 
resulting AgNPs. It seems, as if there is a slight tendency for a decrease in size with increasing length 
of the peptide. But these variations are so small that the slope is negligible, taking the standard 
deviation into account. In case of guanidine-functionalized peptides 22a-c, an increase in the amount 
of functional groups on the peptide had no significant influence on the size and shape of the resulting 
AgNPs. Two possible binding sites were sufficient to stabilize monodisperse AgNPs in defined size and 
shape. 
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The guanidine-functionalized oligoprolines proved to be able to act as additives in the AgNP 
formation reaction. The exact mechanism of stabilization is not yet understood, but the protonation 
state of the respective functional groups seems to be a very important factor. The nanoparticles 
were more stable if there was a higher degree of non protonated guanidine group present as 
observed in the pH dependent formation reactions. Therefore it seems likely that the binding ability 
is crucial for the controlled formation. Guanidine has a delocalized electron density which might be 
beneficial for the binding event. We also found that the ratio of the stabilizing moieties present 
during the reaction have a distinct influence on the size distribution of the resulting nanoparticles.  
3.1.4.1.3. Testing the Importance of the Peptide Flexibility: Peptides 30a-c 
An important feature of the design of the additives is the defined secondary structure provided by 
the oligoproline backbone. To test, whether the secondary structure was of any importance for the 
stabilization of AgNPs in a defined way, we tested flexible peptides 30a-c as additives. They bear the 
same number of guanidine groups like the corresponding oligoproline counterparts 22a-c, but lack a 
defined secondary structure (chapter 3.1.3) as evidenced by the CD spectroscopic studies. The 
flexible peptides were tested as additives in the formation reaction of AgNPs under the conditions 
optimized for the guanidine-functionalized oligoprolines 22a-c (Figure 59). An Ag+ to guanidine group 
ratio of 1:5 was used with a silver concentration of 0.25 mM at pH 12, with ascorbic acid as external 
reducing agent. The results are shown in Figure 59. 
3. Results and Discussion 
 
 
59 
 
 
 
Figure 59: a) Peptides 30a-c; formation of AgNPs in presence of peptides 30a: b) UV-Vis spectra, 
e) TEM image; with peptide 30b c) UV-Vis spectra, f) TEM image; with peptide 30c d) UV-Vis spectra, 
g) TEM image. Analysis was carried out after one day. 
The resulting nanoparticles were polydisperse and aggregated within one day as visualized by UV-Vis 
spectroscopy. Interestingly, these results clearly prove that the secondary structure is essential for 
the ability to act as additive. 
3.1.4.1.4. Investigating the Importance of the Linker: Peptide 24a 
The guanidine group is attached on the backbone by a linker in the peptides 22a-c. To investigate the 
influence of the linker, peptides 24a-c were evaluated. They bear guanidine groups like the peptides 
22a-c, but lack a linker between the oligoproline backbone and the functional group. To compare the 
results obtained with peptides 22a-c, the same conditions found to be optimal for the generation 
process, were applied. An Ag+ to guanidine group ratio of 1:5 at pH 12, with ascorbic acid as external 
reducing agent was used. The results are shown in Figure 60. 
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Figure 60: a) Peptide 24a; formation of AgNPs in presence of peptide 24a: a) UV-Vis spectra, b) TEM 
image. Analysis was carried out after one day. 
The obtained AgNPs were bigger in size, than those obtained in the presence of peptide 22a-c and 
aggregated within one day (Figure 60). Due to the fast aggregation, it was not possible to carry out a 
statistical evaluation of the average size. The formed AgNPs had a defined shape, judging from the 
TEM image, but the additive seems to provide insufficient stability to prevent aggregation. 
Concluding from these results, the additional flexibility of functional groups in peptides 22a-c due to 
the linker is advantageous, when they act as an additive. Probably, this additional flexibility allows 
the functional group to be positioned in an optimal way for the binding and with this for the 
stabiliziation of the AgNPs in a defined size and shape. 
3.1.4.1.5. Investigating the Role of the Additional Amide in the Linker: Peptide 31 
To determine whether the amide bond connecting the functional groups to the backbone of the 
studied peptides had by itself an effect on the nanoparticle generation process, we tested 
peptide 31. This oligoproline bears an acetylated aminoproline in every third position similar to the 
peptides bearing a functional group. The optimal conditions found for the guanidine-functionalized 
oligoproline 22a-c were used in the nanoparticle formation reaction. An Ag+ to amide group ratio of 
1:5 with an AgNO3 concentration of 0.25 mM, at pH 12 and ascorbic acid as external reducing agent 
were used.  
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Figure 61: a) Peptide 31; AgNPs formed in the presence of peptide 31; b) UV-Vis spectra, c) TEM 
image of AgNPs formed in the presence of peptide 31. Analysis was carried out after one hour. 
Nanoparticles formation was observed (Figure 61). However, the nanoparticles were polydisperse in 
size and shape. Oligoproline 31 proved capable of stabilizing nanoparticles. However an additional 
functional group was crucial to form AgNPs in a defined size and shape. 
3.1.4.1.6. Generation of AgNPs in the Presence of Peptide 22a-c without Additional 
Reducing Agent 
The formation reaction without external reducing agent was carried out, to test if the guanidine-
functionalized peptides 22a-c were able to reduce silver ions by themselves and at the same time, 
still be able to stabilize the resulting nanoparticles. It was reported in previous studies, that 
nanoparticle generation was achieved, using amino acids and peptides without additional reducing 
agents (chapter 1.2.).[97, 101-102, 210-213] Especially the amino acids tyrosine and tryptophan, either on 
their own or incorporated into peptides, have been used for nanoparticles formation,[97, 102, 212] taking 
advantage of their redox potential. But also other amino acids, like arginine, aspartic acid, glutamic 
acid, and lysine were reported to be applicable in the reduction of metal salts, generating 
nanoparticles.[210-211, 213-214] Even though this approach was applied in several studies, the exact 
mechanism is not yet understood.  
As before, we first tested different pH values, using a ratio of Ag+ to functional group of 1:5, as it was 
found to be the best in the formation reaction with an external reducing agent. Dissolving 
peptide 22a in H2O resulted in a solution with a pH value of 9.6. We also tested solutions of pH 11 
and pH 12 in the reaction. After addition of the AgNO3 solution we monitored the reaction by UV-Vis 
spectroscopy, for up to three weeks.  
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Figure 62: Formation of AgNPs generated in presence of peptide 22a at pH 12 without reducing 
agent: a) UV-Vis spectra, b) TEM image, c) histogram. Analysis was carried out after one day. 
At the two lower pH values, there was no AgNP formation observed. But at pH 12 nanoparticles were 
formed (Figure 62). They were smaller, than those generated with ascorbic acid as reducing agent, 
but also spherical in shape with an average diameter of 6.3 nm with a narrow dispersity. 
Interestingly, the resulting size in the case without an external reducing agent is about half the size, 
than those formed with ascorbic acid. Probably, the oxidized functional group had different 
stabilizing properties resulting in differently sized nanoparticles. The reduction only possible at 
higher pH values indicates that the hydroxyl ions took part in the reduction process by providing 
electrons for the reduction. Next, we tested the longer guanidine-functionalized peptides 22b and 
22c.  
 
Figure 63: Formation of AgNPs in the presence of peptides 22a (n = 2), 22b (n = 4) and 22c (n = 6) without 
additional reducing agent at pH 12: a) peptide 22a-c, b) UV-Vis spectra, c) correlation between the length 
of peptides 22a-c and the size of the resulting AgNPs, d) TEM image of AgNPs formed in presence of 
peptide 22a, e) TEM image of AgNPs formed in presence of peptide 22b, f) TEM image of AgNPs formed in 
presence of peptide 22c. Analysis was carried out after one day. 
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These experiments resulted in about the same size of the AgNPs as obtained with peptide 22a. 
However, the size distribution obtained is broader than found for the AgNPs formed in the reaction 
with additional reducing agent (Figure 58, Figure 63). The current state of our research does not 
provide yet a clear explanation for the mechanism of the reduction. Nevertheless, it is very 
interesting that it occurs only at higher pH values. It seems, that in the case of this peptide, the 
reductive capability is enhanced at higher pH values, as reduction occurred only at pH 12. This was 
also found for ascorbic acid, where the deprotonation is important for the reduction      
properties.[205, 209] The protonation state seems to be also very important for the ability to act as 
additive, for the guanidine-functionalized oligoprolines, when no external reducing agent was used. 
However, the resulting size distribution shows a higher dispersity which probably is due to a 
decreased binding ability of the oxidized functional group to the metal surface. 
Recently, Lamani et al reported the application of different guanidine salts as catalysts for the 
reduction of olefins in presence of hydrazine.[215] Furthermore, Ishikawas study showed that a 
guanidine derivative was able to reduce DMSO to DMS.[216] These investigations further support our 
observation that this functional group displays a significant potential for the application as a reducing 
agent in a variety of systems.   
3. Results and Discussion 
 
 
64 
 
 
3.1.4.2. AgNP Generation in the Presence of Peptides Bearing Imidazole Moieties 
3.1.4.2.1. Optimization of the Reaction Conditions: Peptide 17a 
After the investigation of guanidine-functionalized peptides 22a-c, we also wanted to test the 
imidazole-functionalized peptides 17a-c as additives in the AgNP formation reaction. Like before, this 
first required the optimization of reaction conditions to be performed. In preliminary experiments, 
we tested sodium borohydride and ascorbic acid as external reducing agents in the process. Using 
ascorbic acid as a reducing agent, no nanoparticles formation was observed, neither by UV-Vis nor by 
TEM. Therefore sodium borohydride was used in the following experiments, as AgNP generation was 
observed in presence of peptide 17a. The need of a stronger reducing agent is probably due to the 
strong binding of Ag+ to the imidazole group. Like reported in literature, the binding energy 
determined in the gas phase of the guanidine group to Ag+ is stronger than the one of imidazole 
(ΔΔG°His = 18 kcal/ mol, ΔΔG°Arg >26.8 kcal/ mol).
[189-191] However the values given are measured and 
calculated in the gas phase that do not consider the hydration of the functional group. This is 
expected to be considerable higher for guanidine than for imidazole.[217-218] This would explain the 
stronger binding and therefore the need of a stronger reducing agent. Since the experiments with 
guanidine-functionalized peptide 22a-c had shown that an Ag+ to functional group ratio of 1:5 is 
optimal (chapter 3.1.4.1), this ratio was used as a start for the optimization studies with the 
imidazole-functionalized oligoproline peptide 17a. Also in this case, the 6mer oligoproline bearing 
two imidazole groups was used for the optimization of the formation conditions. First the influence 
of pH on the reaction was tested. When the peptide was dissolved in water, a solution with pH 9 was 
obtained. Analogous to guanidine-functionalized peptides 22a-c the nanoparticle formation was 
furthermore tested at pH 3, pH 11 and pH 12 (Figure 64). After adjustment of the pH of the peptide 
solution, AgNO3 was dissolved and the mixture was equilibrated for 15 minutes before the reducing 
agent was added. 
 
Figure 64: AgNPs generated in presence of peptide 17a at different pH values; a) peptide 17a;   
b) UV-Vis spectra, c) TEM image of AgNPs formed at pH 11. Analysis was carried out after one day. 
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At pH 3 the AgNPs aggregated within one hour as observed by UV-Vis. Only large aggregates were 
found in TEM. The nanoparticles obtained at pH 9 and pH 12 were polydisperse and in UV-Vis spectra 
a broad plasmon resonance was detected (Figure 64b). Pleasingly, nanoparticles generated at pH 11 
were monodisperse with an average diameter of 4 nm and spherical in shape, as observed by TEM 
(Figure 64, Figure 65). These nanoparticles were much smaller than those formed in the presence of 
the guanidine-functionalized peptides 22a-c. 
 
Figure 65: AgNPs generated with peptide 17a with Ag+ to functional group ratio of 1:5 at pH 11; 
a) TEM image, b) Histogram, c) EDX spectrum, d) STEM image. Analysis was carried out after one day. 
To confirm the oxidation state of the nanoparticles, we performed EDX measurement. We found that 
also in this case the nanoparticles consisted of pure Ag (0) and no Ag2O was formed like it was found 
before in (Figure 65c). The copper peaks were observed due to the measurement on a copper grid. 
The imidazole groups have a lower basicity compared to guanidine residues present in compounds 
22a-c. Therefore at pH 11 the imidazole group is predominantly non-protonated. If we assume that 
the pKa value of the imidazole group is about the same like in histidine (pKa = 6.04), at pH 11 the 
imidazole is not protonated, according to the Henderson-Hasselbalch equation (1) 
(chapter 3.1.4.1.1). The results of our experiments for the imidazole-functionalized as well as for the 
guanidine-functionalized peptides suggest that the free electron pair needs to be available for the 
stabilization of Ag+ in order to obtain monodisperse AgNPs. However, the nanoparticles obtained at 
pH 12 were polydisperse in size and shape. A higher pH value was not advantageous and may even 
hamper the stabilization of the AgNPs in defined size and shape, probably due to the presence of an 
increased amount of hydroxy groups in solution. 
To evaluate the influence of the different quantities of the additive in the generation process, we 
varied the Ag+ to imidazol group ratio (from 1:5 to 1:1 and 1:10 (Figure 66)).  
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Figure 66: AgNPs formed in presence of peptide 17a with ratios of Ag+ to functional group ratio of 1:1 
a) UV-Vis spectrum, b) TEM image, c) histogram; of 1:5 d) UV-Vis spectrum, e) TEM image, 
f) histogram; and of 1:10 g) UV-Vis spectrum, h) TEM image, i) histogram. Analysis was carried out 
after one day. 
The increase as well as the decrease of the peptide concentration led to a slight decrease in 
nanoparticle stability. Furthermore the size distribution was also a bit broader than in the originally 
used ratio (Figure 66). Therefore in the further reaction a ratio of 1:5 of Ag+ to imidazole groups, at 
pH 11 with sodium borohydride were used.  
The formation reaction resulted in monodisperse, spherical nanoparticles. Like the guanidine group, 
the imidazole group is a basic moiety, which is probably advantageous for the stabilization of the 
AgNPs. The differences in sizes, comparing the AgNPs resulting from the generation with guanidine-
functionalized peptides 22a-c and with imidazole-functionalized peptide 17a suggest a different 
stabilizing mechanism. However, also different reducing agents were used which probably had an 
influence on the growing of the particles. 
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3.1.4.2.2. Testing Peptides of Different Lengths: Peptides 17a-c 
Having developed optimal conditions for nanoparticle formation with imidazole-functionalized 
peptide 17a, also the longer peptides 17b and 17c were applied as additives in the formation of 
AgNPs (Figure 67). An Ag+ to imidazole group ratio of 1:5, at pH 11 with sodium borohydride as 
external reducing agent was used. 
 
Figure 67: Formation of AgNPs with peptides 17a (n = 2), 17b (n = 4), 17c (n = 6): a) peptides 17a-c, 
b) UV-Vis spectra, c) correlation between the length of peptides 17a-c and the size of the resulting 
AgNPs, d) TEM image of AgNPs formed in the presence of peptide 17a, e) TEM image of AgNPs 
formed in the presence of peptide 17b, f) TEM image of AgNPs formed in the presence of peptide 
17c. Analysis was carried out after one day. 
With all three lengths of the imidazole-functionalized oligoprolines used as additives monodisperse, 
spherical AgNPs were formed with an average diameter of 4 nm (Figure 67). The UV-Vis absorption 
intensity decreases with increasing length of the peptides used as additive (Figure 67b). This reflects 
a smaller concentration of formed nanoparticles. It seems like the reduction efficiency is decreased 
with increased length of the peptide used as additive. However, the difference in length of the 
additive had no significant effect on the resulting size of nanoparticles. They were about the same as 
the ones obtained with peptide 17a bearing two imidazole moieties. Two functional groups seemed 
to be sufficient for the stabilization of monodisperse nanoparticles under optimized conditions. 
These results are consistent with the results obtained for the previous investigated peptide where 
similar observations were made. It appears that there is a slight negative slope in the graph 
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correlating the size of the nanoparticles and the length of the peptide. However, these variations are 
in the range of the standard deviations and the slope can be neglected. 
3.1.4.2.3. Testing the Importance of Peptide Flexibility: Peptides 29a-c 
To evaluate the importance of the oligoproline backbone of the studied imidazole-functionalized 
additives, we prepared like before in the investigation for the guanidine-functionalized   
peptides 22a-c, the flexible peptides 29a-c. The imidazole groups were provided by histidines which 
were connected by aminohexanoic acids units. They bear the same number of imidazole moieties as 
in peptides 17a-c, but adopt a random coil structure as shown by CD spectroscopy (Figure 54). 
Peptide 29a was tested in the process of AgNP generation under the same conditions as found 
optimal for peptides 17a-c which was an Ag+ to imidazole ratio of 1:5 at pH 11 with sodium 
borohydride as external reducing agent (Figure 68). 
 
Figure 68: a) peptide 29a; AgNPs generated in the presence of peptide 29a: b) UV-Vis spectra, c) TEM 
image. Analysis was carried out after one day. 
Only polydisperse nanoparticles were formed, which aggregated within one day (Figure 68). The 
flexible peptides bearing the investigated functional group were not able to stabilize the 
nanoparticles in a defined size and shape. Pleasingly, the study confirmed that the rigid structure of 
the backbone is a crucial factor that needs to be considered when designing a peptidic additive as it 
was found for guanidine-functionalized peptides 22a-c and their flexible derivatives 30a-c. 
3.1.4.2.4. Investigating the Role of the Additional Amide in the Linker: Peptide 31 
Using the imidazole-functionalized peptide 17a-c required the application of the stronger reducing 
agent sodium borohydride. We therefore wanted to determine, whether the amide bond connecting 
the functional groups to the backbone of the studied peptides has by itself an effect on the 
nanoparticle generation process under the optimized conditions. To do this, we carried out the 
formation reaction using peptide 31 bearing an acetylated aminoproline in every third position, as 
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additive. We used an Ag+ to functional group ratio of 1:5, at pH 11 with sodium borohydride as 
external reducing agent. 
 
Figure 69: a) Peptide 31; AgNPs formed in the presence of peptide 31 using sodium borohydride at 
pH 11; b) UV-Vis spectra, c) TEM image of. Analysis was carried out after one hour. 
Nanoparticles formation was observed in presence of peptide 31 (Figure 69). However, they were 
polydisperse in size and shape. In agreement with the results obtained before, when ascorbic acid 
was used as external reducing agent (chapter 3.1.4.1.5), oligoproline 31 proved capable of stabilizing 
nanoparticles. However, these results underline the conclusion that a suitable functional group is 
crucial to form AgNPs in a defined size and shape. 
3.1.4.2.5. Generation of AgNPs in the Presence of Peptide 17a-c without Additional 
Reducing Agent 
In chapter 3.1.4.1.6 we described for the guanidine-functionalized peptides 22a-c, the possibility of 
achieving nanoparticle formation without an additional reducing agent. Therefore, we tested the 
formation reaction also with the imidazole-functionalized peptides 17a-c in absence of an external 
reducing agent. The reaction was performed at different pH values (pH 9, pH 11 and pH 12) and with 
different Ag+ to imidazole ratios (1:1, 1:5, 1:10). Nevertheless, nanoparticle formation was not 
observed, neither by UV-Vis nor by TEM, even after two weeks time. One possible reason is the high 
binding affinity of imidazole to Ag+, which also made it necessary to use a stronger reducing agent - 
sodium borohydride, in the previous investigation, and which here probably inhibits the reduction of 
Ag+ by the peptide.  
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3.1.4.3. AgNP Generation in the Presence of Peptides Bearing Primary Amine Moieties 
3.1.4.3.1. Optimization of the Reaction Conditions: Peptide 21a 
The next peptides we tested for its ability to act as additive in the formation reaction were the 
amine-functionalized peptides 21a-c. As it was found to be crucial to optimize the reaction conditions 
for the previous investigated peptides, we also started with the evaluation of the optimal reaction 
conditions.  
Preliminary tests showed, that when sodium borohydride was used as external reducing agent, the 
resulting AgNPs aggregated within minutes. Applying ascorbic acid instead, resulted in stable 
nanoparticles, therefore this reducing agent was used. Initially a ratio of Ag+ to amino groups of 1:5 
was used, as it was found to give the best results for the previously studied peptides.  
Again, different pH values were tested. Peptide 21a, bearing two primary amino groups on the 
backbone was used for the optimization of the reaction conditions. When it was dissolved in water, it 
resulted in a solution with pH 9.5. In addition to that we also screened the reaction at pH 3, pH 11 
and 12. The results are shown in Figure 70. 
 
Figure 70: a) Peptide 21a; AgNPs generated in presence of peptide 21a at different pH values; AgNPs 
formed at pH 11: b) TEM image; c) histogram; d) UV-Vis spectra; AgNPs formed at pH 12: e) TEM 
image, f) histogram. Analysis was carried out after one day. 
No nanoparticle formation occurred in the reaction performed at pH 3. A small plasmon absorbance 
was detected in UV-Vis at pH 9.5, which disappeared within one hour. AgNPs with an average 
diameter of about 32 nm formed at pH 11 and of about 22 nm at pH 12. Their morphology varied 
3. Results and Discussion 
 
 
71 
 
 
from almost spherical to hexagons as well as truncated triangles. This results were very different to 
the shapes resulted with the previous investigated peptides used as additives where we found 
spherical shapes. The diversity in morphology caused a rather broad size distribution in both cases. A 
characteristic shoulder appeared in the UV-Vis spectrum which is indicative of a non-spherical shape 
formation. The size distribution of the resulting AgNPs was slightly narrower at pH 12, why the 
following experiments were carried out at this pH. Again we performed EDX measurement to confirm 
that only Ag (0) was formed and that no Ag2O formation occurred (Figure 71). As observed for the 
AgNPs generated in the presence of guanidine-functionalized peptides 22a-c and imidazole-
functionalized peptides 17a-c copper peaks are observed due to the copper grid on which the sample 
was applied for the measurements (Figure 71). 
 
Figure 71: a) EDX spectrum for AgNPs formed at pH 12 in presence of peptide 21a, b) STEM image. 
Analysis was carried out after one day. 
To test, whether by variation of the peptide concentration, AgNPs with a more narrow size and shape 
distribution can be obtained, Ag+ to amino group ratios of 1:1 and 1:10 were used (Figure 72). 
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Figure 72: AgNPs generated in presence of peptide 21a at different ratios of Ag+ to functional groups; 
1:1: a) UV-Vis spectrum, d) TEM image; 1:5: b) UV-Vis spectrum, e) TEM image; 1:10: c) UV-Vis 
spectrum, f) TEM image. Analysis was carried out after one day. 
When a ratio of 1:1 was used, the nanoparticles were less stable and showed a high tendency to 
aggregate (Figure 72a, d). Ratios of 1:5 and 1:10 both led to AgNPs of very similar morphologies. But 
at a ratio of 1:10 there was not hexagonal shape observed. The obtained shapes showed a rather 
undefined morphology. The stability decreased with increasing peptide concentration and 
aggregation of the nanoparticles occurred like it was found before, for the other investigated 
peptides.  
These results suggest that the primary amino functionalities on the peptide backbone provide 
insufficient stabilization to achieve a narrow size and shape distribution. Interestingly, the moiety 
seems to support anisotropic growth, resulting in the non-spherical shapes observed. This tendency 
is also not directed to one shape. Therefore this functional group probably is not optimal for the 
formation of defined sizes and shapes. 
3.1.4.3.2. Testing Peptides of Different Lengths: Peptides 21a-c 
Even though the formation reaction using amine-functionalized peptide 21a did not resulted in 
nanoparticles with a narrow size distribution, the formation reaction was also tested in the presence 
of the longer amine-functionalized peptides 21b and 21c. The same conditions, found to be best for 
the formation of AgNPs in the presence of the amine-functionalized peptide 21a were applied. The 
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nanoparticles were generated, using a ratio of Ag+ to amino groups of 1:5, at pH 12 with ascorbic acid 
as reducing agent (Figure 73).  
 
Figure 73: a) Peptides 21-c; AgNPs generated in the presence of peptides 21a-c: b) UV-Vis spectra, 
c) TEM image of AgNPs generated in the presence of peptide 21a; d TEM image of AgNPs generated 
in the presence of peptide 21b; e) TEM image of AgNPs generated in the presence of peptide 21c. 
Analysis was carried out after one day. 
The resulting AgNPs, formed in the presence of all three length of the amine-functionalized 
oligoprolines 21a-c were non-spherical in shape and had an average diameter of 22 nm.  
The screening of the length of the additives led to similar conclusions as in the case of guanidine-
functionalized peptides 22a-c and imidazole-functionalized peptides 17a-c (chapter 3.1.4.1.2 and 
3.1.4.2.2 respectively). The properties of resulting nanoparticles did not differ significantly from 
those obtained with the shortest peptide in the series (21a). They displayed the same morphology as 
well as the same broad size distribution. These findings allowed us to draw the conclusion that in this 
system the nature of the functional groups in the additive is the size and shape determining factor. 
3.1.4.3.3. Investigating the Importance of the Linker: Peptide 23a 
Similar to the study presented in 3.1.4.1.4 for the guanidine-functionalized peptides, we synthesized 
peptides 23a-c with the amino-groups directly attached to the backbone of the peptide, to 
investigate the influence of the linker in the formation reaction. In peptides 23a-c aminoproline is 
incorporated in every third position in the peptide sequence. The same conditions, as used for 
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amino-functionalized peptides 21a-c were applied in the generation reactions to be able to directly 
compare the obtained results. An Ag+ to amino-group ratio of 1:5, at pH 12 with ascorbic acid as 
reducing agent was used. 
 
Figure 74: a) Peptide 23a; AgNPs generated in presence of peptide 23a: b) UV-Vis spectrum, c) TEM 
image, d) histogram. Analysis was carried out after one day. 
As can be seen in Figure 74, the resulting AgNPs were about the same in size and shape compared to 
those, generated with amine-functionalized peptides 21a-c which have a linker between the 
functional group and the backbone (Figure 70d-e) using the same reaction conditions. The resulting 
nanoparticles were about 21 nm in size and different shapes were observed. However the different 
shapes did not form in such pronounced way, as observed for the amine-functionalized peptide with 
the linker. Maybe the additional flexibility coming from the linker is helping the formation of the 
different shapes as observed in the presence of peptide 21a-c. 
These results are very different to those obtained in the comparative study of guanidine-
functionalized peptides 22a-c and peptides 24a-c where the resulting nanoparticles were 
monodisperse in the presence of the peptide with linker and aggregated in the presence of the 
peptide without the linker (chapter 3.1.4.1.4). This may also be due to the fact, that the amino group 
in the additive is under the investigated conditions not able to stabilize monodisperse nanoparticles. 
Therefore a variation of the linker in these particular amine-functionalized peptides does not affect 
the size and shape of the resulting nanoparticles in such drastic way. 
3.1.4.3.4. Generation of AgNPs in the Presence of Peptide 21a-c without Additional 
Reducing Agent 
As in the case of previously studied compounds, we also tested the possibility of achieving 
nanoparticle formation using amine-functionalized peptides 21a-c in the absence of an external 
reducing agent. We performed the reaction at different pH values (pH 9, pH 11 and pH 12) using an 
Ag+ to amine group ratio of 1:5 and the test were carried out using the shortest amine-functionlized 
peptide 21a.  
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Figure 75: a) Peptide 21a; AgNPs generation in presence of peptide 21a without additional reducing 
agent: b) UV-Vis spectra, b) TEM image of AgNPs formed at pH 12. Analysis was carried out after 
one day. 
Nanoparticle formation with peptide 21a was observed only at pH 12 similarly to the findings for 
peptide 22 (Figure 75). The resulting nanoparticles were polydisperse and started to aggregate within 
one day. This showed that reduction of Ag+ with the primary amino functionalities attached to the 
oligoproline backbone is possible. Similar observation has already been reported for lysine, the 
amino acid bearing a primary amino group, just like the designed peptides 21a-c.[213] However, 
microwave radiation was necessary to activate the reaction, whereas in our case, room temperature 
was sufficient to achieve reduction of the Ag+ ions. Even though the peptide was able to reduce Ag+, 
it was unfortunately not able to additionally stabilize the resulting nanoparticles in a defined size and 
shape. Possibly the oxidation product of the peptide is disturbing the stabilization of the 
nanoparticles. 
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3.1.4.4. AgNP Generation in the Presence of Peptides Bearing Carboxylic Acid Moieties 
3.1.4.4.1. Optimization of the Reaction Conditions: Peptide 18a 
The next peptides we evaluated were oligoprolines 18a-c, functionalized with carboxylic acid 
moieties to act as additives in the AgNP formation. After the evaluation of the peptides bearing basic 
nitrogen containing groups, these peptides were expected to have different properties. These 
peptides were the same, which developed during the formation reaction using the Tollens reaction 
and which stabilized the resulting AgNPs in defined sizes and shapes reported before in our group.[78] 
The formation reaction which was intended to be used here was different to the Tollens reaction. 
Therefore, we again first screened for the optimal conditions.  
A ratio of Ag+ to carboxylic acid moiety of 1:5 was used in the beginning, like in the investigations for 
the other peptides before. In initial experiments we tested ascorbic acid and sodium borohydride as 
external reducing agents. Using sodium borohydride resulted in fast aggregation of the formed 
nanoparticles. When ascorbic acid was utilized, more stable nanoparticles were formed. Therefore 
ascorbic acid was used in the following experiments as external reducing agent.  
Different pH values in the reaction were tested (Figure 76). Dissolving the peptide in water resulted 
in a solution with a pH value of 4. Additionally the reaction was investigated at pH 10 and pH 12. 
After adjustment of the pH, AgNO3 was dissolved. The mixture was equilibrated for 15 minutes 
before ascorbic acid was added. 
 
Figure 76: a) Peptide 18a; AgNPs formed in presence of peptide 18a at different pH values: b) UV-Vis 
spectra, c) TEM image (pH 10), d) TEM image (pH 12). Analysis was carried out after one day. 
Formation of AgNPs was not achieved at pH 4. When the reaction was carried out at pH 10 and 
pH 12, nanoparticle generation was observed. However the nanoparticles were polydisperse in size 
and shape and aggregated within one day (Figure 76).  
Peptides 18a-c, bearing carboxylic acid moieties were successful in stabilizing nanoparticles in the 
previously reported system where nanoparticle formation was achieved via an in situ reduction of 
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aldehyde moieties attached on the backbone.[78] In the course of the reaction, the carboxylic acid 
moieties were formed which were able to stabilize the AgNPs at the same time when the silver ions 
were reduced resulting in nanoparticles in defined sizes and shapes. With the external reducing 
agent, we used in these experiments, the peptides were not able to stabilize the nanoparticles. 
Therefore, we attempted to form AgNPs using the Tollens reaction in the studied system. Several 
aldehydes were tested as potential reducing agents: acetaldehyde, formic acid and formaldehyde. 
According to the reaction stoichiometry two Ag+ ions are reduced when one aldehyde moiety is 
oxidized. Therefore a ratio of Ag+ to reducing agent of 2:1 was used, as it was already found to be 
optimal in the previous reported system.[78] The same Ag+ to peptide bound carboxylic acid ratio was 
applied. In the course of the reaction, initially a [Ag(NH3)2]
+ complex is formed by treating AgNO3 with 
NH4OH solution. The Ag
+ is then reduced to Ag (0), whereas the aldehyde or formic acid was oxidized 
to the corresponding carboxylic acid or CO2 respectively. The results obtained with the different 
reducing agents are shown in Figure 77. 
 
Figure 77: AgNPs generated in the presence of peptide 18a under Tollens conditions with different 
reducing agents; Acetaldehyde: a) UV-Vis spectra, d) TEM image; Formic acid: b) UV-Vis spectra, 
e) TEM image; Formaldehyde: c) UV-Vis spectra, f) TEM image. Analysis was carried out after 
one day. 
In all of the three cases, reduction of Ag+ was observed. The slowest reduction took place when using 
acetaldehyde after one day nanoparticle formation was monitored by the UV-Vis (Figure 77a, d). 
However, TEM analysis showed that only polydisperse nanoparticles were formed. In this case, acetic 
acid is the oxidation product which may interfere with the stabilization of the AgNPs by peptide 18a, 
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functionalized with carboxylic acid moieties. Formic acid and formaldehyde were chosen for the 
study because they form carbonic acid and CO2 respectively, which were assumed not to affect the 
nanoparticle stabilization by the additive. In both cases however, almost no nanoparticle formation 
was observed by UV-Vis and only some aggregates were found in TEM (Figure 77b, c, e, f). Thus the 
Tollens reaction seems to produce monodisperse nanoparticles only when the aldehyde moieties are 
directly attached to the oligoproline backbone and are in the course of the reaction transformed into 
the stabilizing carboxylic acid residues like it was shown before.[78, 91] 
To test if a different reducing agent may allow for the stabilization of formed nanoparticles by 
peptide 18a, bearing carboxylic acid moieties, hydrazine was used (Figure 78). An Ag+ to carboxylic 
acid ratio of 1:5 was used at pH 12. 
 
Figure 78: a) Peptide 18a; AgNPs generated in the presence of peptide 18a with hydrazine as 
reducing agent; b) UV-Vis spectrum, c) TEM image. Analysis was carried out after one day. 
Nanoparticles were obtained using hydrazine as external reducing agent. Two plasmon bands were 
observed in the UV-Vis spectrum which is indicative of a non-spherical shape that can also be seen in 
Figure 78c. However, the majority of nanoparticles formed, were polydisperse and of an undefined 
shape. 
In summary, we tested if these particular peptides, functionalized with carboxylic acid moieties were 
able to act as additives for AgNP formation. The carboxylic acid was found to be successfully applied 
for this purpose not only in the system described above, but also in others, reported in the 
literature.[101, 211, 219] However, obtaining monodisperse nanoparticles of defined sizes and shapes was 
not possible with peptides 18a-c, bearing carboxylic acid moieties in the conditions studied in the 
course of this work. In the previous investigated system, the carboxylic acid was formed in the 
reducing process and the nucleation took place directly on the backbone, whereas in this system the 
nucleation took place in solution, which was probably responsible for the difference in ability of 
stabilization and the resulting nanoparticles. 
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3.1.4.4.2. Generation of AgNPs in the Presence of Peptide 18a-c without Additional 
Reducing Agent 
The formation of AgNPs using peptide 18a, bearing carboxylic acid, was tested in the absence of a 
reducing agent as some of the previous investigated peptides proved capable of reduce silver ions by 
themselves. Additionally literature precedents prove that glutamic acid and aspartic acid were both 
successfully applied as reducing agents for the formation of silver nanoparticles.[101, 211, 219] We 
screened different pH values in our experiments as this was found to be an important factor in the 
reported examples and in our experience. Dissolving the peptide in water resulted in a solution with 
pH 4. We furthermore also tested pH 10 and pH 12. After adjustment of the pH, AgNO3 was added 
and the formation was monitored by UV-Vis and TEM.  
 
Figure 79: a) Peptide 18a; AgNPs formed in the presence of peptide 18a without additional reducing 
agent at different pH values; b) UV-Vis spectra, c) TEM image of AgNPs formed at pH 12. Analysis was 
carried out after one day. 
The results are shown in Figure 79. At pH 4 and pH 10, no nanoparticle formation was observed. As 
for the previously tested peptides, also in this case, nanoparticle formation was only found to occur 
at pH 12. However, the resulting AgNPs were polydisperse and aggregated within one day. This 
showed that peptide 18a, bearing carboxylic acids has a certain reducing power, just like the 
guanidine-functionalized peptides 22a-c and amine-functionalized peptides 21a-c described before. 
The stabilizing ability of these peptides after the reduction seemed to be insufficient to allow for 
monodisperse AgNPs to be obtained.   
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3.1.4.5. AgNP Generation in the Presence of Peptides Bearing Indole Moieties  
3.1.4.5.1. Optimization of the Reaction Conditions: Peptide 19a 
The next series of studied peptides 19a-c had indole moieties attached to the oligoproline backbone. 
Their design was inspired by the amino acid tryptophan. This amino acid was successfully used in 
many different approaches for the generation of metal nanoparticles.[102, 192]  
Again our investigation started with optimization of the reaction conditions. As before, a ratio of Ag+ 
to indole moiety of 1:5 was initially used. Because the longer derivatives had a decreased solubility in 
water, additionally 27.5 % (v/v) of DMSO were added to the solution, which was found to be the 
smallest volume possible to be able to dissolve the longest peptide in water. DMSO was chosen as it 
was already reported in literature to a suitable co-solvent to dissolve tryptophan-rich peptides for 
the formation of AuNPs.[192] Even though we anticipated that the peptide itself would have a certain 
reducing capability, first external reducing agents, sodium borohydride and ascorbic acid, were 
evaluated, as it was the case with the previously tested peptides. Using sodium borohydride resulted 
in fast aggregation and precipitation of Ag (0). With ascorbic acid, nanoparticles were formed and 
fast aggregation did not occur.  
The influence of the pH on the generation reaction was evaluated next, as it was found to be an 
important factor in the formation reaction for the previous investigated peptides. When indole-
functionalized peptide 19a was dissolved in water, a solution with pH 7 was obtained. Additionally, 
the reactions were tested at pH 11 and pH 12 (Figure 80). After the adjustment of the pH, AgNO3 was 
dissolved and equilibrated for 15 minutes. Then ascorbic acid was added and the formation reaction 
was monitored by UV-Vis spectroscopy and analyzed by TEM. 
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Figure 80: a) Peptide 19a; AgNPs generated in presence of peptide 19a at different pH values: b) UV-
Vis spectrum, c) TEM image of AgNPs generated at pH 7: d) TEM image of AgNPs generated at pH 11, 
e) TEM image of AgNPs generated at pH 12. Analysis was carried out after one day. 
The AgNPs formed at pH 7 were polydisperse in sizes ranging from 20 to 100 nm with non-spherical 
shapes (Figure 80c). With increasing pH the plasmon absorbance intensity increased, which could be 
due to increased reducing strength of ascorbic acid at higher pH values. [205, 209] At pH 11 and pH 12 
the nanoparticles had diameters between 2 nm and 30 nm. It was chosen to continue the 
optimization at pH 11 as no significant difference between the two pH values was observed.  
In a control experiment, the influence of DMSO was evaluated. The formation reaction was carried 
out with and without DMSO. The shortest indole-functionalized peptide 19a was soluble in water and 
therefore used in these experiments. The resulting AgNPs were identical in size and shape. This 
showed that DMSO was not influencing the formation reaction in this system. 
To further improve the formation reaction, the concentration of the peptide additive was altered. 
Ag+ to indole moiety ratios of 1:1 and 1:10 were tested at pH 11 using ascorbic acid as external 
reducing agent (Figure 81). 
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Figure 81: AgNPs generated in presence of peptide 19a at pH 11 with different Ag+ to functional 
groups ratios; 1:1 a) UV-Vis spectrum, d) TEM image; 1:5: b) UV-Vis spectrum, e) TEM image; 1:10: 
c) UV-Vis spectra, f) TEM image. Analysis was carried out after one day. 
The changes in the Ag+ to indole group ratio had no positive influence on the nanoparticles size 
distribution. On the contrary, broadening was observed. When less peptide was used in the 
generation reaction, polydisperse nanoparticles were formed. At a ratio of 1:10, the plasmon 
absorbance was low in intensity and bigger particles, up to 50 nm in diameter appeared. Thus this 
peptide seems unable to stabilize nanoparticles in a defined size and shape when an external 
reducing agent is used.  
3.1.4.5.2. Generation of AgNPs in the Presence of Peptide 19a-c without Additional 
Reducing Agent  
The ability of indole-functionalized peptide 19a to reduce Ag+ and stabilize the resulting AgNPs 
without additional reducing agent was investigated next. As we established earlier, the pH of the 
reaction environment plays a very important role in the case of the investigated systems, therefore 
we started our investigation with the evaluation of different pH values. A ratio of Ag+ to indole 
moiety of 1:5 was used in the beginning. As mentioned before, dissolving the peptide in water 
resulted in a solution of pH 7. Furthermore the reduction was also tested at pH 10 and pH 12. After 
adjustment of the pH, AgNO3 was added and the formation process was monitored by UV-Vis 
spectroscopy and analyzed by TEM (Figure 82). Also these experiments were carried out with 27.5% 
(v/v) DMSO in water. 
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Figure 82: a) Peptide 19a; Formation of AgNPs at different pH values in the presence of peptide 19a 
without additional reducing agent: b) UV-Vis spectra, c) TEM image at pH 12; d) histogram of AgNPs 
formed at pH 12. Analysis was carried out after two days. 
The experiments showed that formation of AgNPs was only achieved at pH 12 after two days. The 
generated nanoparticles had a narrower size distribution compared to the AgNPs formed with an 
external reducing agent. They were about 5.3 nm in diameter with a narrow dispersity and of a 
spherical shape (Figure 82b). The indole-functionalized peptide 19a was able to reduce Ag+ and also 
stabilize the resulting AgNPs. The reduction probably takes place like proposed by the group of 
Mandal presented in the introduction chapter (Chapter 1.2.2.; Figure 83), leading to dimerized indole 
moieties, kynureine and the reobtained indole moiety which are assumed to be the stabilizing 
moieties for the resulting AgNPs.[102] 
 
Figure 83: Reduction process proposed by the group of Mandal et al. using tryptophan containing 
peptides.  
To further improve the nanoparticle formation, the amount of the used indole-functionalized peptide 
additive 19a was varied (Figure 84). The reaction was performed at Ag+ to indole moiety ratios of 1:1, 
1:3, 1:5 and 1:10 at a pH of 12. 
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Figure 84: AgNPs generated in presence of peptide 19a with different Ag+ to functional group ratios 
at pH 12; 1:1 a) UV-Vis spectrum, b) TEM image, c) histogram; 1:3 d) UV-Vis spectrum, e) TEM image, 
f) histogram; 1:5 g) UV-Vis spectrum, h) TEM image, i) histogram; 1:10 j) UV-Vis spectrum, k) TEM 
image, l) histogram. Analysis was carried out after one day.  
At the lowest and highest peptide concentration, the resulting nanoparticles were the least 
monodisperse. At the ratios of 1:3 and 1:5 the nanoparticles developed a regular shape, with smaller 
nanoparticles formed at a ratio of 1:5. At a ratio of 1:3 the nanoparticles had an average diameter of 
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9.5 nm. Because the intensity was much higher in UV-Vis at this ratio and the size distribution was 
about the same than with a ratio of 1:5, the further tests were carried out with an Ag+ to indole 
moiety ratio of 1:3.  
To evaluate the influence of the length of the peptide chain on the nanoparticle formation, also the 
longer indole-functionalized peptides 19b and 19c were tested as additives in the reaction (Figure 
85). The tests were performed in the optimised reaction conditions, without an additional reducing 
agent, with an Ag+ to indole group ratio of 1:3 at pH 12 using 27.5% DMSO (v/v) in water. 
 
Figure 85: a) Peptide 19a-c; Formation of AgNPs in the presence of peptides 19a (n = 2), 19b (n = 4) 
and 19c (n = 6): b) UV-Vis spectra, c) correlation between the length of peptides 19a-c and the size of 
the resulting AgNPs, d) TEM image of AgNPs formed in presence of peptide 19a, e) TEM image of 
AgNPs formed in presence of peptide 19b, f) TEM image of AgNPs formed in presence of peptide 19c. 
Analysis was carried out after one day. 
Nanoparticles obtained with 19a and 19b had about the same size and shape. Those generated with 
the longest indole-functionalized peptide 19c were smaller (5.8 nm) and with a narrower size 
distribution. The plasmon absorbance showed a decrease in intensity with increasing length of the 
peptide. This could indicate that the peptides reducing strength decreases with increasing amount of 
the indole moieties on its backbone. Like the results obtained before for the guanidine-functionalized 
with peptides 22a-c and the imidazole-functionalized peptides 17a-c used with additional reducing 
agent, also in this case the AgNPs were about the same in size and shape in the presence of indole-
functionalized peptides 19a-c independent of the length of the used additive. These results underline 
the observations that were made before, that the length of the oligoprolines did not significantly 
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influence the resulting size and shapes. The functional groups attached on the backbone were the 
main influence to the morphology and as the experiments with the flexible peptides showed, also the 
spatial arrangement are important for them to be able to act as additives.   
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3.1.4.6. AgNP Generation in the Presence of Peptides Bearing Pyrrolidinyl Moieties 
3.1.4.6.1. Optimization of the Reaction Conditions: Peptide 20a 
Peptides 20a-c bearing pyrrolidinyl groups were also tested as potential additives in the generation 
of AgNPs. This functional group is part of one of the most commonly used additives in the metal 
nanoparticle generation, the polymer polyvinylpyrrolidone (PVP).[66-67] Even though the polymer 
contains an excess of pyrrolidinyl groups, we estimated that a limited number of these functionalities 
should be sufficient to stabilize the AgNPs.  
As in all previous cases, the reaction conditions were to be optimized first. Sodium borohydride and 
ascorbic acid were again tested as reducing agents. The nanoparticles generated with sodium 
borohydride did not aggregate within the first hours, but showed polydisperse and undefined 
shapes. Therefore sodium ascorbate was used in the following experiments, where more regular 
shapes were observed. A ratio of Ag+ to pyrrolidinyl group of 1:4 was used for the evaluation of the 
optimal pH value. This ratio was slightly different to the previous studies. Dissolving the peptide in 
water resulted in a solution of pH 7. Tests at pH 10 and pH 12 were carried out as well (Figure 86). 
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Figure 86: a) Peptide 20a; AgNPs generated in presence of peptide 20a at different pH values. pH 7: 
b) UV-Vis spectrum, c), d) TEM image; pH 10: e) UV-Vis spectrum, f), g) TEM image; pH 12: h) UV-Vis 
spectrum, i) TEM image: Analysis was carried out after one day.  
The nanoparticles formed at pH 12 were polydisperse in size and shape. At lower pH values, the 
nanoparticles showed more defined shapes, but the sizes were also polydisperse. Additionally, 
another shape evolved. At pH 7 and pH 10 nanorods were found (Figure 86c, f). Surprisingly, there 
was only one peak observed in UV-Vis. A typical sign of rod formation is the appearance of a 
longitudinal plasmon peak. It is not visible in this case, probably due to the small amount of rods 
compared to the spherical nanoparticles. The pyrrolidinyl group attached to the oligoproline 
backbone was able to successfully stabilize AgNPs. The stabilization probably occurred over the 
nitrogen atom in the pyrrolidinyl group as it was found for the PVP polymer, described in 
literature.[67] To see, if the formation of the rods can be enhanced or if it is possible to form 
monodisperse nanoparticles using this peptide, further screening of conditions was performed. 
At pH 7, the ratio of Ag+ to pyrrolidinyl groups was varied from the initial 1:4 to 1:5, 1:10 but also 4:1. 
The results are shown in Figure 87.  
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Figure 87: AgNPs generated in presence of peptide 20a using different Ag+ to functional group ratios: 
a) UV-Vis spectra; b) 4:1 TEM image, c) 1:4 TEM image, d) 1:5 TEM image, e) 1:10 TEM image. 
Analysis was carried out after one day.  
Using the different ratios of pyrrolidinyl groups resulted in AgNPs in all cases. It seems that 1:4 is the 
optimal ratio in the case of the pyrrolidinyl-functionalized peptide 20a. The rods formed in these 
conditions were ranging from 50 nm up to 400 nm in length. At a ratio of 1:10 there were also some 
rods appearing but they were shorter with length from about 50 nm to 200 nm.  
Next, we wanted to investigate whether longer pyrrolidinyl group functionalized peptides 20b and 
20c might lead to formation of an increased amount of nanorods or monodisperse nanoparticles. The 
experiments were carried out under the established conditions with an Ag+ to pyrrolidinyl group ratio 
of 1:4, at pH 7 using ascorbic acid as external reducing agent.  
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Figure 88: a) Peptide 20a-c; Formation of AgNPs in the presence of peptides 20a (n = 2), 20b (n = 4) 
and 20c (n = 6): b) UV-Vis spectra, c) TEM image of AgNPs formed in presence of peptide 20a, d) TEM 
image of AgNPs formed in presence of peptide 20b, e) TEM image of AgNPs formed in presence of 
peptide 20c. Analysis was carried out after one day. 
In the presence of all peptides, AgNPs were formed (Figure 88). However with the longer peptides, 
no rod formation was observed and the formation reaction did not led to more uniform sizes and 
shapes. 
3.1.4.6.2. Generation of AgNPs in the Presence of Peptide 20a-c without Additional 
Reducing Agent  
The AgNPs generation reaction was also evaluated without an external reducing agent, to test the 
reducing capability of pyrrolidinyl-functionalized peptide 20a towards Ag+ and the ability to act as a 
stabilizing agent at the same time. To evaluate these properties, suitable reaction conditions had to 
be found. First of all the optimal pH value was determined. As mentioned before, dissolving the 
peptide 20a in water resulted in a solution of pH 7. Additionally pH 12 and pH 13 were tested. Higher 
pH values than in the previous study were chosen, as the experiments with other peptides showed 
that the reduction of Ag+ occurs only at pH 12. Like before, a ratio of Ag+ to pyrrolidinyl group of 1:5 
was initially used. 
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Figure 89: a) Peptide 20a; AgNPs generated in the presence of peptide 20a without additional 
reducing agents at different pH values: b) UV-Vis spectra, c) TEM image of AgNPs formed at pH 12, 
d) TEM image of AgNPs formed at pH 13. Analysis was carried out after one day. 
The results are shown in Figure 89. Nanoparticle formation was observed at pH 12 and pH 13. In the 
latter conditions, the plasmon absorbance was very low and the nanoparticles aggregated very fast 
after the formation (Figure 89c). The nanoparticles formed at pH 12 were polydisperse but did not 
aggregate as fast as at pH 13.  
To improve the size and shape distribution of the AgNPs, the ratio of Ag+ to pyrrolidinyl group was 
varied. Ratios of 1:4, 1:5, 1:10 and 1:50 were tested at pH 12 (Figure 90).  
 
Figure 90: AgNPs generated in the presence of peptide 20a without additional reducing agent with 
different Ag+ to functional group ratios; 1:4: a) UV-Vis spectrum, b) TEM image; 1:5: c) UV-Vis 
spectrum, d) TEM image; 1:10: e) UV-Vis spectrum, f) TEM image; 1:50: g) UV-Vis spectrum, h) TEM 
image. Analysis was carried out after one day.  
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None of the conducted experiments led to an improvement of the size and shape distribution. The 
nanoparticles obtained at ratios of 1:4 and 1:10 were very similar to the ones formed at the ratio of 
1:5. When a ratio of 1:50 was used, the nanoparticles had even less defined shapes. Furthermore, 
the increased peptide concentration resulted in a decrease in AgNPs stability. Rod formation was not 
observed in any of the cases, in contrast to the experiments conducted with an external reducing 
agent. This implies that the oxidized functional groups, on the peptide backbone have very different 
stabilization capabilities towards Ag (0) nanostructures. In summary, reduction of Ag+ and 
stabilization of formed AgNPs is possible with pyrrolidinyl-functionalized peptide 20a, but the 
resulting AgNPs did not develop a defined size and shape under the conditions investigated in the 
course of this work.   
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3.1.4.7. AgNP Generation in the Presence of Unfunctionalized Peptide 25 
To investigate the influence of the scaffold to the formation reaction and whether unfunctionalized 
oligoprolines can also act as additives, we tested unfunctionalized oligoproline 25 as additive. This 
peptide can probably bind through the amide bond to the Ag (0) which may be enough to act as 
additives in the formation reaction. The properties of peptide 25 were studied using sodium 
borohydride and ascorbic acid as external reducing agents as they were used in the course of this 
study. A tenfold excess of the peptide was applied in the test reaction. It carried out at a pH 12 which 
was adjusted using aqueous sodium hydroxide solution. This amount was used, because in this 
peptide, no functional groups can serve as reference and an excess was intended to be used. 
 
Figure 91: a) Peptide 25; AgNPs formed in the presence of peptide 25 with sodium borohydride and 
ascorbic acid; b) UV-Vis spectra, c) TEM image of AgNPs formed with sodium borohydride, d) TEM 
image of AgNPs formed with ascorbic acid. Analysis was carried out after one hour. 
The results are shown in Figure 91. In both cases polydisperse AgNPs were formed. Interestingly, a 
new nanoparticle shape, hollow spheres, was detected in the experiment using sodium borohydride. 
To further investigate this finding and to see if it is possible to enhance the amount of the hollow 
spheres formed, we varied the Ag+ to peptide ratios in the following experiments. Ratios of 1:1, 1:5, 
1:10 and 1:50 were tested (Figure 92).  
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Figure 92: AgNPs generated in presence of peptide 25 with sodium borohydride under different Ag+ 
to peptide ratios: a) UV-Vis spectra, b) TEM image of nanoparticles generated at a ratio of 1:1; c) TEM 
image of nanoparticles generated with a ratio of 1:5; d) TEM image of nanoparticles generated at a 
ratio of 1:10, e) TEM image of nanoparticles generated at a ratio of 1:50. Analysis was carried out 
after one hour.  
The amount of hollow spheres did not increase in any of the reactions compared to the initial test, 
although such shapes were also observed at the ratio of 1:5.  
 
Figure 93: a) Peptide 25; b) UV-Vis spectra; c) TEM image of AgNPs generated in the presence of 
peptide 25 after 1 hour; d) TEM image of AgNPs generated in the presence of peptide 25 after 1 day.  
It was found, that this shape disappeared within one day (Figure 93). We therefore assumed that the 
hollow spheres are probably intermediates in the nanoparticle formation process which are not 
sufficiently stabilized and therefore dissapear in the course of the reaction. The binding of the amide 
groups to the Ag+ could possibly lead to an enhanced local concentration of the oligoprolines which 
does not occur with the larger peptide derivatives bearing charged functional groups. This is probably 
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why this shape was never found in the previous studies, where functionalized oligoprolines were 
used as additives.   
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3.1.5. Gold Nanoparticle (AuNP) Generation 
Next, we also tested the designed peptides for their ability to act as additives in the formation of 
AuNPs. Peptidic additives were reported to be able to act as additives for the formation of     
AuNPs.[12, 57-58, 99-100, 137-144] Even though the design was aiming for the formation of AgNPs, we 
envisioned the designed peptides, to have also considerable ability in the stabilization of AuNPs. Like 
before, first we were optimizing the reaction conditions using the shortest of each peptide by 
variation of the pH and the Au3+ to functional group ratio. The optimal conditions were applied using 
also the longer derivatives as additives in the generation reaction.  
As described in the previous chapter, some of the peptides proved to be able to reduce silver ions 
and stabilize AgNPs. Therefore, we also evaluated the reducing and stabilizing properties of these 
peptides without additional reducing agent in the formation of AuNPs. 
3.1.5.1. AuNP Generation in the Presence of Peptides Bearing Guanidine Moieties  
3.1.5.1.1. Optimization of the Reaction Conditions: Peptide 22a 
We started the evaluation of the ability to act as an additive with the guanidine-functionalized 
peptides 22a-c. Like in all previous cases, optimal conditions, required to generate AuNPs needed to 
be evaluated. Peptide 22a, bearing two guanidine moieties, was used as a model compound for this 
purpose. Ascorbic acid was applied as external reducing agent as it was found to perform best, in the 
formation of AgNPs (3.1.4.1). With a ratio of Au3+ to guanidine groups of 1:5, different pH values 
were tested. As reported before, a solution with a pH of 9.5 was obtained when peptide 22a was 
dissolved in water. We tested the reaction furthermore at pH 11 and pH 12. Aqueous sodium 
hydroxide solution was used to adjust the pH. Then HAuCl4 was dissolved, equilibrated for 15 
minutes and ascorbic acid was added. 
 
Figure 94: a) Peptide 22a; AuNPs formed in the presence of peptide 22a at different pH values; 
b) UV-Vis spectra, c) TEM image of AuNPs generated at pH 11, d) TEM image of AuNPs generated at 
pH 12. Analysis was carried out after one day. 
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The results are shown in Figure 94. No nanoparticle formation was observed at pH 9.5. At pH 11 and 
pH 12 a plasmon absorbance band at 520 nm was found by UV-Vis spectroscopy (Figure 94a), 
indicating AuNP formation. TEM microscopy revealed that at pH 11 monodisperse spherical particles 
were formed with an average diameter of 12 nm (11.6 nm ± 1.6). The nanoparticles obtained at 
pH 12 had a different shape with no clear geometrical form and with an average diameter of about 
14 nm (13.5 nm ± 6.3). Both pH values resulted in different sizes and shapes. This is a convenient 
method to adjust the morphology by just changing the pH value. These results are in contrast to the 
investigation with AgNPs where only at one pH value defined nanoparticles were formed. The 
guanidine group acts very different in the formation of AuNPs and it seems to be able to tune size 
and shape with the different pH values.  
As we calculated with the Henderson-Hasselbalch equation the grade of protonation of the 
guanidine-functionalized peptide is very different at pH 11 and at pH 12 (chapter 3.1.4.1). This is 
probably the reason for the difference in the resulting nanoparticles.  
3.1.5.1.2. Testing Peptides of Different Length: Peptides 22a-c 
To investigate the influence of the length of the peptide on the nanoparticle generation process, the 
experiments with longer guanidine-functionalized derivatives 22b and 22c were carried out. The 
reactions were performed at pH 11 and at pH 12, using a ratio of Au3+ to functional group of 1:5 and 
ascorbic acid as external reducing agent. First of all we tested the reaction at pH 11 which resulted in 
nanoparticles with an average size of 12 nm in the experiments using the shortest guanidine 
functionalized peptide 22a. First we adjusted the pH of the solution before the HAuCl4 was added 
and equilibrated for 15 minutes followed by the addition of ascorbic acid (Figure 95).  
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Figure 95: a) Peptide 22a-c; AuNPs formed in the presence of peptides 22a (n = 2), 22b (n = 4) and 
22c (n = 6) at pH 11: b) UV-Vis spectra, c) correlation between the length of peptides 22a-c and the 
size of the resulting AgNPs, d) TEM image of AgNPs formed in presence of peptide 22a, e) TEM image 
of AgNPs formed in presence of peptide 22b, f) TEM image of AgNPs formed in presence of 
peptide 22c. Analysis was carried out after one day. 
With all three lengths of the guanidine-functionalized oligoprolines, monodisperse spherical AuNPs 
were formed with an average diameter of about 9 nm. The reaction conditions resulted in 
monodisperse nanoparticles with defined size and shape. The size of the nanoparticles was smaller 
than the size of the AgNP formed in the presence of this peptide. Similar to the formation of AgNPs, 
the different length did not have a significant influence on the resulting size. These results underline 
the findings from the investigation so far, that the functional groups are the main factor that 
influences the size and shape.  
Next we were evaluating the formation reaction with all three lengths of the peptide at pH 12 (Figure 
96).  
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Figure 96: a) Peptide 22a-c; AuNPs formed in the presence of peptides 22a (n = 2), 22b (n = 4) and 
22c (n = 6) at pH 12: b) UV-Vis spectra, c) correlation between the length of peptides 22a-c and the 
size of the resulting AgNPs, d) TEM image of AgNPs formed in presence of peptide 22a, e) TEM image 
of AgNPs formed in presence of peptide 22b, f) TEM image of AgNPs formed in presence of 
peptide 22c. Analysis was carried out after one day. 
The results are shown in Figure 96. At pH 12, AuNPs were formed with all three guanidine-
functionalized oligoprolines 22a-c with about the same size and shape. They showed the same 
undefined non-spherical shape, different to those formed at pH 11. The intensity of the plasmon 
absorbance of the nanoparticles generated in the presence of peptides 22b and 22c was very small. 
However, the AuNPs were all of about the same size and shape (Figure 96c-f). Just as observed 
previously for pH 11, also in the case of pH 12, the length of the peptidic additive had little influence 
on the size and shape of resulting nanoparticles.  
Although the size of AuNPs obtained with peptides 22a-c is actually comparable to the size of the 
obtained AgNPs, they show an interesting dependence on the pH to the resulting size and shape. This 
clearly proves, that the results obtained for one metal cannot be directly transferred to another one 
as they were found to behave quite differently and thus individual optimization is required for each 
group of peptides. This difference was already reported in literature, for example in the studies of 
Wright et al where they investigated the HRE peptide for its ability to act as additive in the formation 
of different metal nanoparticles[99-100] or in the studies from Naik et al. where they tested the 
AG4 peptide, identified within a library screening, also as additive for different metal nanoparticles[97, 
140] (Introduction). 
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3.1.5.1.3. Investigating the Importance of the Linker: Peptide 24a 
In line with the investigation for the AgNP formation, we also tested peptides 24a-c, bearing 
guanidine groups, attached directly to the oligoproline backbone, as additive in the AuNP formation. 
By removing the linker we wanted to determine whether the flexibility of the functional groups has 
any impact on the formation reaction or properties of AuNPs. We performed the generation reaction 
at different pH values (9.5, 11, 12), using an Au3+ to functional group ratio of 1:5 (Figure 97) using 
ascorbic acid as reducing agent. The pH values were adjusted and the gold salt was dissolved. After 
15 minutes of equilibration the reducing agent was added. 
 
Figure 97: a) Peptide 24a; AuNPs generated in the presence of peptide 24a; b) UV-Vis spectra, c) TEM 
image of AuNPs generated at pH 9.5, d) TEM image of AuNPs generated at pH 11. Analysis was 
carried out after one day. 
The plasmon absorbance had a very low intensity as observed in UV-Vis spectroscopy (Figure 97a). At 
pH 9.5 the absorption band was very broad and the maximum was around 580 nm. The nanoparticles 
formed at this pH were polydisperse and aggregated within one day (Figure 97b). No nanoparticle 
formation was observed at pH 12. The formation process carried out at pH 11, resulted in 
monodisperse spherical AuNPs with an average size of 9 nm (9.0 nm ± 1.7). These huge differences 
were quite surprising. This means that in the case of this peptide the pH value played a crucial role in 
the formation of AuNPs and needs to be adjusted carefully. In contrary to the experiments with the 
guanidine-functionalized oligoprolines with the linker 21a-c, only the formation reaction at pH 11 
resulted in AuNPs with defined size and shape. Also in this case, the linker seems to play a distinct 
role in the ability to act as additive like it was already found for AgNPs. However in contrary to the 
formation of AgNPs, here it was possible in both cases to form monodisperse nanoparticles under 
the same conditions. To further investigate this system, the formation was carried out using all three 
different length of the guanidine-functionalized oligoprolines 24a-c. In the formation reaction an Au3+ 
to guanidine ratio of 1:5, at pH 11 using ascorbic acid as external reducing agent were used (Figure 
98). 
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Figure 98: a) Peptide 24a-c; AuNPs formed in the presence of peptides 24a (n = 2), 24b (n = 4) and 
24c (n = 6) at pH 11: b) UV-Vis spectra, c) correlation between the length of peptides 24a-c and the 
size of the resulting AgNPs, d) TEM image of AgNPs formed in presence of peptide 24a, e) TEM image 
of AgNPs formed in presence of peptide 24b, f) TEM image of AgNPs formed in presence of 
peptide 24c. Analysis was carried out after one day. 
The results are shown in Figure 98. With all three different lengths monodisperse spherical 
nanoparticles were formed. They all had in average the same diameter (Figure 98c-f). This behaviour 
when comparing the different length of the peptides in their ability to act as an additive was already 
found in the previous experiments with the other investigated peptides. Also in this case, it was 
found that the conditions and the functional groups have the most dominant influence on the final 
size and shape. The length of the peptide seems to play only a minor role. 
3.1.5.1.4. Generation of AuNPs in the Presence of Peptide 22a-c without Additional 
Reducing Agent 
After the successful reduction and stabilization, that was achieved using solely guanidine-
functionalized oligoproline 22a-c to form AgNPs, we also evaluated the ability of these peptides to 
generate AuNPs without an additional reducing agent present. Different pH values were tested 
(pH 9.5, pH 11, pH 12) but no nanoparticle formation was observed, neither by UV-Vis spectroscopy, 
nor by TEM. This might be explained by the difference in the reduction potential of silver (E° = 
0.799 V) and gold (E°= 1.691 V). For the reduction of Au3+ three electrons were needed which peptide 
22a-c seems not able to provide.   
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3.1.5.2. AuNP Generation in the Presence of Peptides Bearing Imidazole Moieties  
The utility of imidazole-functionalized oligoprolines 17a-c as additive in the AuNP formation was 
evaluated next. These peptides were found to be efficient additives in the AgNPs generation reaction 
yielding monodisperse nanoparticles (chapter 3.1.4.2). First the optimal conditions found for the 
formation of AgNPs were applied. We performed the generation reaction at pH 11 with an Au3+ to 
imidazole group ratio of 1:5, using sodium borohydride as a reducing agent. We were delighted to 
see that under these conditions, originally optimized for AgNPs, also AuNPs were formed in a 
monodisperse fashion (Figure 99). 
 
Figure 99: a) Peptides 17a-c; AuNPs formed in the presence of peptide 17a (n = 2), 17b (n = 4) and 
17c (n = 6): b) UV-Vis spectra, c) correlation between the length of peptides 17a-c and the size of the 
resulting AuNPs, d) TEM image of AuNPs formed in the presence of peptide 17a, e) TEM image of 
AuNPs formed in the presence of peptide 17b, f) TEM image of AuNPs formed in the presence of 
peptide 17c. Analysis was carried out after one day. 
As show in Figure 99, there was no big difference in the size and shape of the AuNPs, when 
imidazole-functionalized peptides 17a-c of different lengths were used as additives. They were all 
around 2 nm (2.4 nm ± 0.6) in diameter with a spherical shape and a narrow size distribution.  
These findings suggest that these conditions are optimal for the application of peptides 17a-c as 
additives in the nanoparticle formation, regardless if silver or gold is the investigated metal and 
therefore no further screening was required. However, the resulting sizes were different in each 
case. These results were in direct contrast to the results from the investigation made with guanidine-
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functionalized oligoprolines 21a-c and 24a-c where differences in the ability to act as additive and 
the resulting nanoparticles were found between AgNPs and AuNPs. At the current state of our 
research the conditions needs to be individually tested for each additive.   
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3.1.5.3. AuNP Generation in the Presence of Peptides Bearing Primary Amine 
Moieties 
3.1.5.3.1. Optimization of the Reaction Conditions: Peptide 21a 
To evaluate the AuNP formation using peptide 21a, bearing primary amino groups, reaction 
conditions that proved successful in the AgNP generation were used as a starting point for the study. 
A ratio of Au3+ to functional group of 1:5 and ascorbic acid as reducing agent were used and different 
pH values were tested. By dissolving the peptide in water, a solution of pH 9.5 was obtained. 
Additionally pH values of 11 and 12 were tested in the formation reaction.  
 
Figure 100: a) Peptide 21a; AuNPs formed in the presence of peptide 21a at different pH values; 
b) UV-Vis spectra, c) TEM image of AuNPs generated at pH 9.5. Analysis was carried out after 
one day. 
The results are shown in Figure 100. Nanoparticle formation was observed only at pH 9.5. However 
they were polydisperse, as seen in TEM (Figure 100c). The amine-functionalized peptide 21a seems 
not able to stabilize AuNPs in defined size and shape.  
When this peptide was used as an additive in the AgNP generation, non-spherical nanoparticles were 
formed. In the case of AuNPs, no defined nanoparticle formation was achieved. Similar to the case of 
guanidine-functionalized peptides 22a-c, application of amino-functionalized peptide 21a gave very 
different results in the AuNP formation, compared to its results in the AgNP generation. The 
conditions and functional groups of the additive that can be applied in the process are an individual 
matter for each metal in case of the investigated peptides.  
3.1.5.3.2. Investigating the Importance of the Linker: Peptide 23a 
As the experiment in the presence of amine-functionalized peptide 21a, bearing a flexible linker, did 
not form AuNPs of a defined size and shape, we decided to investigate whether attachment of a 
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primary amino group directly to the oligoproline backbone, without an additional linker, might 
change the outcome of the nanoparticle formation reaction.  
We carried out the generation of AuNPs in the presence of peptide 23a using an Au3+ to amine group 
ratio of 1:5 screening different pH values. A solution with a pH of 8.5 was obtained by dissolving the 
peptide in water. We also performed the reaction at pH 11 and pH 12 with ascorbic acid as the 
reducing agent (Figure 101). 
 
Figure 101: a) Peptide 23a; AuNPs generated in the presence of peptide 23a at different pH values; 
b) TEM image at pH 8.5, c) histogram of AuNPs generated at pH 8.5; d) UV-Vis spectra, e) TEM image 
at pH 11, f) histogram of AuNPs generated at pH 11; g) TEM image at pH 12. Analysis was carried out 
after one day. 
The results are shown in Figure 101. In contrary to the results obtained with the amine-
functionalized oligoprolines with linker 21a, with peptide 23a lacking a linker between amine group 
and the backbone, monodisperse, spherical nanoparticles were formed at pH 8.5 and 11. The ones 
formed at pH 8.5 were about 8 nm in diameter and those obtained at pH 11 were more or less half 
that size (3.6 nm). The nanoparticles formed at pH 12 were polydisperse and aggregated within a 
day. As already found before, also in this case, the pH of the reaction mixture had a very strong 
impact on the size and shape of the resulting nanoparticles. The size difference was about 4 nm with 
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the pH difference of about 2.5 pH values. These results were further investigated by testing the other 
lengths of the amine-functionalized oligoproline 23a-c as additives in the AuNP formation reaction at 
the two different pH values. First, we carried out the reaction at pH 8.5 using again ascorbic acid as 
external reducing agent. 
 
Figure 102: a) Peptides 23a-c; AuNPs formed in the presence of peptide 23a (n = 2), 23b (n = 4) and 
23c (n = 6) at pH 8.5: b) UV-Vis spectra, c) correlation between the length of peptides 23a-c and the 
size of the resulting AuNPs, d) TEM image of AuNPs formed in the presence of peptide 23a, e) TEM 
image of AuNPs formed in the presence of peptide 23b, f) TEM image of AuNPs formed in the 
presence of peptide 23c. Analysis was carried out after one day. 
The results are shown in Figure 102. The nanoparticles formed at pH 8.5 using the amine-
functionalized peptides 23a-c had about the same size and shape like it was found in the 
investigations of the different peptides before. However the AuNPs formed with the longest 
derivative 23c had a much broader size distribution and aggregated within one day. These 
observations are in contrary to the observations made before when the length of the peptide did not 
affect the resulting size and shape. This is probably due to the missing linker which might hinder the 
stabilization when the peptide becomes longer. 
To further investigate this system, the formation reaction was also carried out in the presence of 
peptides 23a-c at pH 11 (Figure 103) 
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Figure 103: a) Peptides 23a-c; AuNPs formed in the presence of peptide 23a (n = 2), 23b (n = 4) and 
23c (n = 6) at pH 11: b) UV-Vis spectra, c) correlation between the length of peptides 23a-c and the 
size of the resulting AuNPs, d) TEM image of AuNPs formed in the presence of peptide 23a, e) TEM 
image of AuNPs formed in the presence of peptide 23b, f) TEM image of AuNPs formed in the 
presence of peptide 23c. Analysis was carried out after one day. 
The results are shown in Figure 103. In all three cases, spherical AuNPs were formed. However, using 
peptide 23b as additive resulted in AuNPs with a high dispersity and which were aggregating within 
one day. In the presence of the longest amine-functionalized peptide 23c, the AuNPs formed were 
bigger in diameter as the nanoparticles formed in the presence of the shorter derivatives 23a-b 
(Figure 103c). These peptides clearly behave differently than found before, where no differences in 
resulting nanoparticles were found when using different lengths of the same kind of peptides. The 
longest derivative 23c did not to stabilize the nanoparticles in the same size as it was found for the 
shortest oligoproline 23a. This is probably due to the missing linker which allows the functional group 
to adopt to the different conditions and which is hindered by the increased rigidity present in the 
peptide without linker, used in these experiments. 
3.1.5.3.3. Generation of AuNPs in the Presence of Peptide 21a without Additional 
Reducing Agent 
Next, we evaluated the ability of peptide 21a to reduce Au3+ in solution. In the case of silver, 
reduction was achieved using this peptide, but no defined nanoparticles were formed. To test this for 
gold, the AuNP formation reaction was performed in the absence of an external reducing agent at a 
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ratio of Au3+ to functional group of 1:5. Different pH values (9.5, 11, 12) were tested. However, 
nanoparticle formation was not observed in any of the three experiments.  
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3.1.5.4. AuNP Generation in the Presence of Peptides Bearing Carboxylic Acid Moieties 
3.1.5.4.1. Optimization of the Reaction Conditions: Peptide 18a 
Next peptide 18a, bearing carboxylic acid moieties was studied for the ability to act as additive in the 
AuNP generation. Previously, we have shown that using this peptide, it was not possible to stabilize 
AgNPs in a defined size and shape (chapter 3.1.4.4).  
To evaluate the ability of carboxylic acid-functionalized peptides 18a-c to act as additive in the AuNP 
formation reaction, as shown in the investigation of the other peptides, first the reaction conditions 
needed to be optimized. We screened different pH values, applying an Au3+ to functional group ratio 
of 1:5 and ascorbic acid as external reducing agent in each experiment. A solution with a pH of 4 was 
obtained by dissolving the peptide 18a in water. Additionally the reaction was performed at pH 10 
and pH 12. After pH adjustment and equilibration with the metal salt, the external reducing agent 
was added and the formation reaction was monitored by UV-Vis and analyzed by TEM. 
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Figure 104: a) Peptide 18a; AuNPs generated in the presence of peptide 18a at different pH values; 
b) TEM image at pH 4, c) histogram of AuNPs generated at pH 4; d) UV-Vis spectra, e) TEM image at 
pH 10, f) histogram of AuNPs generated at pH 10; g) TEM image at pH 12. Analysis was carried out 
after one day. 
Nanoparticle formation was observed at all investigated pH values (Figure 104). At pH 4 they were 
polydisperse with an average diameter of 18 nm. Many different shapes were found, including 
spheres, truncated triangles and hexagons with diameters between 1 nm and 50 nm (Figure 104b-c). 
The AuNPs formed at pH 10 had an average diameter of 20 nm, but were also polydisperse. On the 
contrary to those obtained at pH 4 they were all more or less spherical but also varied in diameter 
between 1 nm and 50 nm. At pH 12, only polydisperse nanoparticles, without a defined shape were 
found. The AuNPs were aggregating within two days as can be seen in Figure 104f. Application of 
peptide 18a, bearing carboxylic acid groups as an additive resulted exclusively in formation of 
polydisperse nanoparticles not only in the case of silver, but also as shown in this chapter, in the case 
of gold.  
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3.1.5.4.2. Generation of AuNPs in Presence of Peptide 18a without Additional 
Reducing Agent 
The capability of peptide 18a, to reduce Au3+ was also evaluated. The reactions were carried out at 
an Au3+ to functional group ratio of 1:5 without external reducing agent at different pH values as we 
did already for the other peptides before, to screen for optimal reaction conditions. The tests with 
peptide 18a were performed at pH 4, 8 and 12. 
 
Figure 105: a) Peptide 18a; AuNPs generated in the presence of peptide 18a without additional 
reducing agent at pH 12, b) UV-Vis spectrum at pH 12, c) TEM image. Analysis was carried out after 
two days. 
Nanoparticle formation was observed only at pH 12 (Figure 105). The reduction was relatively slow. 
After two days a plasmon absorbance appeared in the UV-Vis spectrum. The resulting AuNPs were 
polydisperse and of a non-defined shape.  
This peptide is able to reduce Au3+ ions just as it was for the case with Ag+. However, it is, also in this 
case, not able to stabilize the formed nanoparticles after reduction of the metal ions. 
  
3. Results and Discussion 
 
 
112 
 
 
3.1.5.5. AuNP Generation in the Presence of Peptides Bearing Indole Moieties  
3.1.5.5.1. Optimization of the Reaction Conditions Using Peptide 19a without 
Additional Reducing Agent 
The last compounds studied as a potential additive in the AuNP formation were peptides 19a-c, 
bearing indole moieties on the backbone. The AuNP generation was performed without additional 
reducing agent, as the indole motif already has a considerable reducing capability like already 
demonstrated in the AgNP formation (chapter 3.1.4.5). First we used the shortest peptide 19a for the 
screening for the optimal conditions. A ratio of Au3+ to functional group of 1:3 was used, as it was 
found to be optimal for the generation of AgNPs with this peptide. We tested pH values of 7, 
obtained by dissolving peptide 19a in water, 10 and 12 (Figure 106).  
 
Figure 106: a) Peptide 19a; AuNPs formed in the presence of peptide 19a at different pH values, 
b) UV-Vis spectra, c) TEM image at pH 12; d) histogram of AuNPs at pH 12. Analysis was carried out 
after one day. 
Nanoparticle formation was only observed at pH 12. The resulting AuNPs were polydisperse in size 
and shape. It seems that the oxidized form of the peptide is not able to stabilize the particles in a 
monodisperse fashion. In case of AgNP formation this peptide was able to act as additive and 
reducing agent resulting in monodisperse nanoparticles. With the indole-functionalized peptide 19a, 
used as additive in the formation of AuNP, non-spherical polydisperse nanoparticles with an average 
diameter of 33.5 nm were formed (Figure 106).  
3.1.5.5.2. Testing Peptides with Different Lengths: Peptides 19a-c 
The longer derivatives of indole-functionalized peptide 19a, 19b and 19c were also tested in the 
nanoparticle generation at pH 12 with a ratio of Au3+ to functional group of 1:3 in the absence of an 
external reducing agent, as this pH value was found to be the only one, nanoparticle formation was 
observed for peptide 19a.  
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Figure 107: AuNPs generated in the presence of peptides 19a (n = 2), 19b (n = 4) and 19c (n = 6): 
a) UV-Vis spectra, b) TEM image of AuNPs formed in presence of peptide 18a, c) histogram of AuNPs 
formed in presence of peptide 19a, d) TEM image of AgNPs formed in presence of peptide 19b, 
e) histogram of AuNPs formed in presence of peptide 19b, f) TEM image of AgNPs formed in 
presence of peptide 19c, g) histogram of AuNPs formed in presence of peptide 19c. Analysis was 
carried out after one day. 
The results are shown in Figure 107. Unfortunately, application of longer peptides also yielded 
polydisperse nanoparticles. Interestingly, their average size decreased with increasing length of the 
peptides. The size distribution also did narrow slightly. Nonetheless, they were still polydisperse. 
The indole moieties are also able to act as reducing agents for Au3+ ions, just as it was observed for 
Ag+ (chapter 3.1.4.5.2). However, they are not able to stabilize the nanoparticles in defined sizes and 
shapes.  
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3.1.6. Platinum Nanoparticle (PtNP) Generation 
After the studies on the generation of AgNPs and AuNPs we decided to carry out some preliminary 
tests with imidazole-functionalized peptide 17a-c, as a potential additive in the formation of PtNPs. 
These nanoparticles are highly attractive targets, due to their potential applications in catalysis and 
medicinal chemistry.[12, 220] These peptides were chosen, due to their ability to act as additive for the 
defined formation of AgNPs as well as AuNPs. 
Like in all previous cases, we first evaluated the pH for the generation reaction. A Pt2+ to imidazole 
group ratio of 1:5 was used, as this was found to be the optimal conditions for this peptide as an 
additive (chapter 3.1.4.2.1.). Two equivalents of sodium borohydride as reducing agent were used as 
preliminary experiments showed that the reduction using only one equivalent of reducing agent was 
not complete. We tested the generation reaction at pH 9, obtained by dissolving peptide 17a in 
water, and pH 12. The formation was analyzed using TEM (Figure 108).  
 
Figure 108: a) Peptide 17a; PtNPs generated in the presence of peptide 17a, b) TEM image of PtNPs 
at pH 9, c) TEM image of PtNPs at pH 12. Analysis was carried out after one day. 
Monodisperse nanoparticles were formed in both experiments. They were spherical in shape and 
about 3 nm in diameter. As pH doesn’t seem to play a significant role in this case, we decided to use 
pH 9 for the following experiments, to omit the adjustment step for each reaction. These findings are 
different to those obtained in the formation of AgNPs and AuNPs.  
Under these conditions, the generation of nanoparticles in the presence of the longer imidazole-
functionalized peptides 17b and 17c was also performed (Figure 109).  
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Figure 109: PtNPs generated in the presence of peptide 17a (n = 2), 17b (n = 4) and 17c (n = 6): 
a) correlation between the length of peptides 17a-c and the size of the resulting PtNPs, b) TEM image 
of PtNPs formed in the presence of peptide 17a, c) TEM image of PtNPs formed in the presence of 
peptide 17b, d) TEM image of PtNPs formed in the presence of peptide 17c. e) histogram of PtNPs 
generated in the presence of 17a, f) histogram of PtNPs generated in the presence of 17b, 
g) histogram of PtNPs generated in the presence of 17c. Analysis was carried out after one day. 
The resulting nanoparticles were monodisperse with a diameter of around 3 nm for each of the 
investigated peptides. The difference in backbone length had no influence on the size and shape of 
nanoparticles, as already observed for other metals with this and the other investigated peptides.  
Generation of PtNPs was successfully achieved using imidazole-functionalized peptides 17a-c as 
additives. This is a very promising result as it renders the possibility for a more in-depth investigation 
of platinum and in the future maybe, even studies on other metals. 
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3.2. Additive for the AgNP Generation Based on a Simple 
Tripeptide 
Following up, on the investigations carried out in our group, where tripeptides, suitable to act as 
additives for nanoparticle formation were identified within a split-and-mix library,[77, 206] we chose 
one peptide and attempted to improve its performance. To achieve this, structural changes were 
made by introducing additional amino acids in the sequence. Peptide Ac-His-Ahx-Asp-NH2 32 was 
selected (Figure 110a) for our study.[77, 206] When it was applied as an additive using ascorbic acid as 
external reducing agent, AgNPs with an average diameter of 29 nm were formed. Unfortunately in 
the beginning of this study there were problems with the stabilization of these nanoparticles by the 
peptide. For this reason we attempted to tune the additive’s performance by structural 
modifications. The problems with the stability of the nanoparticles formed in the presence of the 
tripeptides 32 were solved during this study in the PhD thesis of Conelious Pfumbidzai.[206] 
3.2.1. Design 
Two crucial changes were made in the structure of peptide 32. First the amount of functional groups, 
imidazole and carboxylic acid, per one molecule was increased by a factor of two. We envisioned that 
this will increase the additive’s binding affinity which will be beneficial for the stabilization of 
resulting AgNPs. Furthermore, we incorporated proline units in the sequence. The structure of the 
modified peptide 33 is shown in Figure 110b, whereas the structure of the tripeptide 32 being the 
inspiration for the new design is displayed in Figure 110a. 
 
Figure 110: a) Structure of peptide 32, b) structure of peptide 33. 
3.2.2. Synthesis and Conformational Analysis 
The synthesis was carried out using standard SPPS protocols (5.3.) on Rink amide – ChemMatrix 
resin, followed by acetylation of the N-terminus and cleavage with TFA. To investigate the secondary 
structure CD spectroscopy was carried out (Figure 111). It was expected that the peptide has a 
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decreased flexibility due to the many prolines in the sequence and therefore not adopt a random coil 
structure. 
 
Figure 111: CD spectra of peptides 32 and 33. 
The CD spectra of peptide 32 and 33 are presented in Figure 111. Peptide 32 adopts a random coil 
structure with a minimum at 195 nm and a maximum at 216 nm. The spectrum of peptide 33 shows a 
shift of the minimum to a wavelength of 206 nm which is characteristic of a PPII structure. However, 
no maximum is observed which suggests that the secondary structure of 33 is considerably different 
to the previously studied oligoproline-based peptides, but also not form a random coil.  
3.2.3. Silver Nanoparticle (AgNP) Generation 
First, the ability of peptide 33 to act as an additive in the nanoparticle generation was tested. 
Ascorbic acid was used in the beginning. This reducing agent was also successfully used in 
combination with peptide 32 in our previous studies.[77, 206] Then we expanded the investigation by 
using the stronger reducing agent sodium borohydride. To screen the versatility of the new peptide 
to act as additive, we also tested the usage of light for the reduction of Ag+.  
3.2.3.1. AgNP Generation Using Ascorbic Acid as Reducing Agent 
The performance of peptide 33 was evaluated. Optimized conditions, found in the previous study of 
an Ag+ to functional group ratio of 1:10 at pH 10 with 1.2 equivalents of ascorbic acid were used. The 
formation reaction was performed in the presence of peptides 32 and 33 to be able to compare the 
performance and resulting size and shape of the formed AgNPs. 
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Figure 112: AgNPs generated using ascorbic acid as reducing agent in the presence of peptide 32: 
a) UV-Vis spectrum, b) TEM image, c) histogram; AgNPs generated using ascorbic acid as reducing 
agent in the presence of peptide 33: d) UV-Vis spectrum, e) TEM image, f) histogram. Analysis was 
carried out after one day. 
The results are shown in Figure 112. Nanoparticles formed in both cases. The ones formed in the 
presence of tripeptide 32 had a truncated hexagon like shape with an average diameter of 29 nm, as 
already reported before.[77, 206] Nanoparticles generated in the presence of the new peptide 33 had 
an average diameter of 18 nm and were of about the same shape. The modifications in the additive 
are the reason for the 11 nm difference in diameter. Presumably the increased amount of functional 
groups supports a faster surface passivation, therefore yielding smaller nanoparticles. This 
assumption is also supported by a more narrow size distribution of the nanoparticles generated in 
presence of peptide 33 compared to those generated in presence of peptide 32 (Figure 112c, f). 
Furthermore there was a big difference in intensity of UV-Vis absorbance (Figure 112a, d), which can 
be explained by a lower concentration of nanoparticles formed in presence of peptide 33. 
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3.2.3.2. AgNP Generation Using Sodium Borohydride as a Reducing Agent 
To explore the scope of peptide 33’s applicability as additive for the nanoparticle generation, we also 
performed the reaction using a stronger reducing agent - sodium borohydride.  
In this case, first optimal conditions needed to be evaluated. An Ag+ to functional group ratio of 1:5 
and 1.2 equivalents of sodium borohydride were initially applied and different pH values were 
screened. A solution with pH 8 was obtained by dissolving the peptide in water. Furthermore the 
generation reaction was also tested at pH 11 and at pH 12. 
 
Figure 113: AgNPs generated in the presence of peptide 33 at different pH values using sodium 
borohydride as reducing agent; a) UV-Vis spectra, b) TEM image at pH 8, c) TEM image at pH 11; 
d) TEM image at pH 12. Analysis was carried out after one day. 
The results are shown in Figure 113. The formation of AgNPs was observed at all pH values having a 
spherical shape. At pH 11 there was a regular size distribution observed. The average diameter of the 
AgNPs generated in this experiment was 3 nm. At pH 8 and pH 12 a broader size distribution was 
obtained. Therefore, the further investigations were carried out at pH 11. To further improve the 
outcome of the generation reaction different Ag+ to functional group ratios were tested. To cover a 
broad range, ratios of 10:1, 5:1, 1:5 and 1:10 were applied.  
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Figure 114: AgNPs generated in the presence of peptide 33 using different Ag+ to functional group 
ratios and sodium borohydride as reducing agent: 10:1 a) UV-Vis spectrum, b) TEM image, 
c) histogram, 5:1 d) UV-Vis spectrum, e) TEM image, f) histogram, 1:5 g) UV-Vis spectrum, h) TEM 
image, i) histogram, 1:10 j) UV-Vis spectrum, k) TEM image, l) histogram. Analysis was carried out 
after one day. 
The results are shown in Figure 114. The formed AgNPs were all between 3 and 5 nm in diameter. 
However the optimal ratio, resulting in the most narrow size distribution was the original used ratio 
of 1:5 as already found in the investigations for the oligoproline based peptides as additives. 
Spherical nanoparticles with an average diameter of 3 nm were obtained (Figure 114g-i). 
Having optimized the reaction conditions, we next wanted to investigate the differences in resulting 
nanoparticles depending on which peptide (32 or 33) was used as an additive. We therefore 
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performed the generation reaction, in the presence of both peptides in the established conditions (a 
ratio of Ag+ to functional group of 1:5, pH 11, sodium borohydride) in order to be able to compare 
the results. 
 
Figure 115: AgNPs generated in the presence of peptide 33: a) UV-Vis spectrum, b) TEM image, 
c) histogram; AgNPs generated in the presence of peptide 32: d) UV-Vis spectrum, e) TEM image. 
Analysis was carried out after one day. 
Tripeptide 33 was not able to stabilize AgNPs in defined size and shape (Figure 115d-e). The resulting 
nanoparticles were polydisperse with an undefined shape and aggregated within two days. On the 
other hand, applying the new peptide 33 yielded spherical nanoparticles with an average diameter of 
3 nm, as described before (Figure 115a-c). 
With the new peptide, used as additive in the formation reaction of AgNPs, we are able to improve 
the quality of generated nanoparticles. Furthermore, it allowed us to use different reducing agents in 
the reaction, yielding differently sized monodisperse nanoparticles. With ascorbic acid, the 
nanoparticles were about 18 nm in diameter, whereas with sodium borohydride they were much 
smaller, with an average diameter of 3 nm. Formation of larger particles with ascorbic acid compared 
to smaller particles obtained with sodium borohydride was already observed in other systems 
described in the literature.[86, 89] However, it is remarkable, that we can use the same additive with 
both reducing agents and that under both conditions, monodisperse AgNPs were formed. 
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3.2.3.3. AgNP Generation Using Visible Light 
Reduction of Ag+ can also be achieved with visible light (Introduction).[80, 188, 221] This approach was for 
example successfully applied in the library screening conducted in our group.[77, 206] However, the 
investigated tripeptide 32 was not identified within the screening using light as reducing agent, but in 
the screening using chemical reduction. We tested the AgNP formation via light reduction using the 
newly designed peptide 33 as additive.  
In a preliminary test, an Ag+ to functional group ratio of 1:1 was used. Silver salt was added and this 
mixture was exposed to ambient light. Then it was observed if any nanoparticle formation took place. 
After a few minutes the solution became yellow and showed plasmon absorbance in UV-Vis, which is 
indicative for AgNP formation. The analysis by TEM confirmed this assumption.  
We then started the screening to determine the optimal conditions for the generation process. First, 
we tested different pH values. As mentioned before, when peptide 33 was dissolved in water, a 
solution with a pH of 8 was obtained. We therefore tested pH 8 but also pH 10 and pH 12. The 
solution was exposed for one hour to ambient light and then kept in the dark. 
 
Figure 116: AgNPs generated in the presence of peptide 33 at different pH values using ambient 
light: a) UV-Vis spectra, b) TEM image at pH 8, c) TEM image at pH 10, d) TEM image at pH 12. 
Analysis was carried out after one day. 
As presented in Figure 116, nanoparticle formation was observed at all tested pH values. However, 
they were all polydisperse. The ones generated at pH 12 were the most defined regarding their 
shape and therefore, this pH was used in the following experiments. 
To improve the formation reaction, irradiation with defined wavelengths was attempted. The 
wavelengths of 254 nm and 366 nm were used. We used the same Ag+ to functional group ratio of 
1:1 like in the experiments before as well as the same pH (pH 12). The reaction was carried out, 
exposing the mixtures of silver salt and peptide at the desired pH, for one hour to the irradiation 
source. After this time, it was kept in the dark and the formation process was monitored by UV-Vis 
spectroscopy and analyzed by TEM. 
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Figure 117: AgNPs generated in the presence of peptide 33 using irradiation with light of different 
wavelengths: a) UV-Vis spectra, b) TEM image (254 nm), c) TEM image (366 nm). Analysis was carried 
out after one day.  
Nanoparticle formation was achieved under both conditions as shown in Figure 117. The 
nanoparticles formed upon irradiation with a wavelength of 254 nm were spherical with a diameter 
of about 8 nm (7.8 nm ± 4.8). The AgNPs generated upon irradiation with a wavelength of 366 nm 
were polydisperse and aggregated within two days. Therefore we decided to use irradiation with a 
wavelength of 254 nm for the following experiments. To further improve the conditions we then 
tested Ag+ to functional group ratios of 10:1, 5:1, 1:1, 1:5 and 1:10 (Figure 118). 
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Figure 118: AgNPs generated in the presence of peptide 33 using different Ag+ to functional group 
ratios and irradiation with a wavelength of 254 nm; 10:1 a) UV-Vis spectrum, b) TEM image, 5:1 
c) UV-Vis spectrum, d) TEM image, 1:1 e) UV-Vis spectrum, f) TEM image,, 1:5 g) UV-Vis spectrum, 
h) TEM image, 1:10 i) UV-Vis spectrum, j) TEM image. Analysis was carried out after one day. 
As shown in Figure 118, neither lower, nor higher peptide concentration was beneficial for the 
generation reaction. The experiments were less peptide was used, led to a broader size distribution 
and aggregation of the nanoparticles (Figure 118a-d). When a higher peptide concentration was 
applied, less AgNPs were formed as can be seen in the respective UV-Vis spectra, represented by a 
lower intense plasmon absorbance band (Figure 118g, i). Additionally, no improvement in the size 
distribution was achieved. In contrary, it resulted in a broader size distribution. For the ratio of 1:5 an 
average diameter of 7.8 nm ± 7.4 was found and with a ratio of 1:10 a diameter of 6.8 nm ± 10.6.  
Finally the reaction was also carried out, under the optimized conditions using tripeptide 32 as 
additive to compare its ability to act as an additive for the generation of AgNPs by irradiation. An Ag+ 
to functional group ratio of 1:1 at pH 12 using irradiation with a wavelength of 254 nm were applied. 
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Figure 119: AgNPs generated by irradiation (254 nm) in the presence of peptide 32 and peptide 33; 
a) UV-Vis spectra, b) TEM image of AgNPs generated in the presence 33, c) TEM image of AgNPs 
generated in the presence 32. Analysis was carried out after one day. 
As shown in Figure 119, nanoparticle formation was also observed, when tripeptide 32 was used as 
additive. However the resulting AgNPs were polydisperse under these conditions. 
This results show, that also in the case of AgNP formation using visible light to reduce the Ag+, the 
newly designed peptide 33 was more versatile in comparison to tripeptidic additive 32 in stabilizing 
the AgNPs in defined size and shape.  
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4. Summary and Outlook 
In the course of this work, we investigated different peptidic additives for their ability to act in the 
formation reaction of metal nanoparticles. The peptides had an oligoproline backbone, 
functionalized in every third position. This resulted in the functional groups pointing in the same 
direction in space. The groups attached were chosen based on their ability to bind to silver ions in the 
gas phase, which we expected to be a crucial factor to be able to act as stabilizing moiety in the 
nanoparticle formation. Therefore guanidine, imidazole, primary amine, carboxylic acid, indole and 
pyrrolidinyl groups were attached to an oligoproline backbone with different lengths. 
We investigated the secondary structure of the new peptides with CD spectroscopy. A defined PPII 
helical structure was found for all the peptides which showed that the functionalization on the 
backbone did not influence the defined secondary structure of the oligoproline backbone. 
First of all the reaction conditions for the formation needed to be optimized. The formation reaction 
was carried out in an aqueous solution of the respective metal salt in the presence of a peptides used 
as additive. Ascorbic acid and sodium borohydride were evaluated as external reducing agent. The 
formation was also carried out without an external reducing agent, to test the ability of the peptides 
as reducing agent and stabilizer at the same time. Different pH values were screened for the 
formation reaction which turned out to be crucial to obtain defined nanoparticles. In the course of 
the optimization, furthermore the ratio of metal to peptide was altered. The formation reaction was 
first evaluated for silver nanoparticles (AgNPs) using the different peptidic additives and then for the 
formation of gold nanoparticles (AuNPs). 
In the investigation of AgNPs, using ascorbic acid as external reducing agent, monodisperse spherical 
AgNPs were formed with an average diameter of 12 nm with the peptides 22a-c, functionalized with 
guanidine groups. With sodium borohydride as external reducing agent, monodisperse nanoparticles 
only formed in the presence of imidazole-functionalized peptides 17a-c. Ascorbic acid was not strong 
enough to reduce the metal ions in the presence of this peptide, but using sodium borohydride 
resulted in monodisperse AgNPs (4 nm). In the generation reaction using ascorbic acid in the 
presence of amine-functionalized oligoprolines 21a-c interestingly, non-spherical shapes were found. 
Also in the case of pyrrolidinyl-functionalized peptides 20a-c using ascorbic acid a new shape, rods 
were found. In the presence of the other investigated peptides in the formation reaction of AgNPs 
using ascorbic acid, only polydisperse nanoparticles were obtained. When we tested the ability of the 
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peptidic additives to act as reducing agents as well as stabilizing moiety, we found monodisperse 
AgNPs formed in the presence of guanidine-functionalized peptides 22a-c (6 nm) as well as with the 
indole-functionalized peptides 19a-c (10 nm). 
We observed that the length of the peptide had only a minor influence on the resulting morphology. 
To test the importance of the oligoproline backbone, to be able to act as an additive, we used flexible 
derivatives of the guanidine-functionalized and imidazole-functionalized peptides. These functional 
groups were chosen because the corresponding oligoprolines resulted in monodisperse 
nanoparticles. In the presence of these peptides only polydisperse AgNPs were formed which 
aggregated within a day. We therefore concluded, that the spatial orientation is essential for the 
additives to act in the formation of metal nanoparticles.  
Next we evaluated the peptidic additives in the formation reaction of AuNPs. With ascorbic acid as 
external reducing agent, two of the investigated peptides were able to stabilize monodisperse 
nanoparticles: In the presence of peptides with guanidine functional groups (24a-c, 9 nm) and amine-
functional groups (23a-c, 8 nm at pH 8.5, 4 nm at pH 11) attached on the backbone. Interestingly, 
using the latter peptides 23a-c showed different stabilizing abilities depending on the pH of the 
reaction resulting in differently sized nanoparticles. With sodium borohydride as external reducing 
agent, it was possible to obtain monodisperse AuNPs in the presence of imidazole-functionalized 
peptides 17a-c (2 nm).  
In the case of AuNP with none of the investigated peptides monodisperse nanoparticles were formed 
without an additional reducing agent, they were all polydisperse. Reduction took place, but the 
peptides were not able to successfully stabilize the AuNPs in defined size and shape.  
We also tested the influence of the linker for the guanidine and the amine-functionalized peptides by 
screening peptides with and without linker between the functional group and the oligoproline 
backbone. The results were very different depending on the metal and the functional group. In the 
case of the guanidine group in the formation of the AgNPs it proved to be important to have a certain 
flexibility which is provided by the linker. The formation reaction in the presence of the peptide 
without the linker resulted in bigger aggregates whereas with the linker monodisperse nanoparticles 
were formed. In the AuNP formation, the resulting nanoparticles formed in the presence of the two 
kind of peptides, were very similar in size and shape.  
When the peptide with an amine group attached was tested in the formation of AgNPs, the 
nanoparticles formed in the presence of the peptides with and without linker, had about the same 
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size and shape. In both cases polydisperse nanoparticles with non-spherical shapes were formed. 
When they were used in the formation of AuNPs, the nanoparticles were polydisperse when the 
additive with linker was used and monodisperse with the additive without linker. In this case the 
increased rigidity was beneficial for the stabilization in defined size and shape. These very diverse 
results showed clearly that first, the results obtained for silver and for gold cannot be directly 
compared and second that the degree of flexibility needed is very dependent on the functional group 
and metal. 
In order to expand the variability of the peptidic additives towards other metals, we evaluated the 
usage of imidazole-functionalized peptides 17a-c as additives in the platinum nanoparticle (PtNP) 
formation. It was possible to use this peptidic additive in the formation reaction which resulted in 
monodisperse nanoparticles for all three lengths of the peptide (3 nm). These results showed that it 
is possible to extend the research using these peptidic additives for the formation of other metals. 
We furthermore attempted the design of new additives based on tripeptides indentified within split-
and-mix libraries. We found the new designed peptide 33, bearing imidazole and carboxylic acid 
groups was able to act as additive in the AgNP formation using mild and strong chemical reducing 
agents, resulting in both cases in monodisperse AgNPs with different sizes (18 nm using ascorbic acid, 
3 nm using sodium borohydride). It was furthermore possible to use irradiation for the reduction in 
the presence of the same new designed peptide (8 nm). 
Future investigations will be driven by two main interests. First, there is the question, how the 
stabilization takes place to result in nanoparticles with defined size and shape. With this work we 
already gained some insight into the needs of the design of a peptidic additive that is able to stabilize 
metal nanoparticles in defined size and shapes. The oligoproline backbone proved to be essential as 
well as the choice of the attached functional group. Different functional groups could be investigated 
in future studies to expand the scope for application, like for example phenols. The distance of the 
functional groups to the backbone, depending on the group and the metal, turned out to be 
important. However no clear tendency was so far observed. This would be another open question 
which needs to be investigated further. Also not yet understood is the binding mode responsible for 
the final size and shape and how we can tune the morphology further to obtain desired sizes and 
shapes. For example X-ray studies could be carried out to determine the crystal plane that the 
functional groups are binding to, to learn more about the direct correlation between the binding and 
the morphology. As we found the oligoproline to be a good scaffold we can functionalize it with for 
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example different types of functional groups on one peptide and use them in the formation reaction 
to test the influence of two different binders on the resulting morphology. Here we could take 
advantage from the library studies, carried out before and chose functional groups that proved to be 
able to act as additives there.[206] 
A second interest is, to use the metal nanoparticles in applications. The AgNPs could be used in 
antimicrobial applications, as it was already successfully demonstrated by our group with 
nanoparticles formed in the presence of tripeptides indentified within a split-and-mix library.[206] A 
second possibility which would be interesting for all of the investigated nanoparticles, is the 
application in catalysis. As it was presented in the introduction, there are already some examples for 
catalysis using metal nanoparticles. However this field still needs to be developed further. Here it 
would be also very interesting to extend the investigations to other metals, like it was already 
successfully demonstrated for platinum. 
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5. Experimental Procedures 
5.1. Materials and Instruments 
Solvents and reagents were of the highest commercially available grade and used without further 
purification. They were purchased from Aldrich, Fischer, Fluka and Acros Organics. Solvents used for 
HPLC were used in HPLC-grade quality. Water used in HPLC and reaction was filtered in a Mili-Q 
system (Milipore) and when used for nanoparticle generation it was purchased from Aldrich in 
ultrapure quality. Solvents that were used for column chromatography and extractions were distilled 
from a technical grade before using.  
Chromatography 
Reactions were monitored using thin layer chromatography using Merck silica gel 60 F254 aluminum 
plates. The plates were analyzed by UV (254 nm) radiation by staining with ninhydrin or KMnO4 
solution. For purification via flash chromatography, Fluka high purity grade silica gel 60, 230-
400 mesh was used. 
At the University of Basel, analytical RP-HPLC was performed on a Shimadzu HPLC (Prominence) and 
at the ETH Zurich on a Dionex UHPLC, Ultimate 3000. The analytical columns used were a Reprosil 
gold 120 C18 (150 x 4 mm, 5 μm) and a Phenomenex Acris Peptide 1 7u XB-C18 (100 x 2.1 mm) with a 
flow of 1mL/min for the HPLC system. On the UHPLC system at the ETH Zurich analytical columns 
Reprosil gold 120 C18 (3 μm) and Phenomenex Acris Peptide 1 7u XB-C18 (3 μm) with a flow of 
0.7 mL/min or 0.5 mL/min were used respectively. The preparative RP-HPLC was carried out at the 
University of Basel on a LC-10 system from Shimadzu and at the ETH Zurich on a Dionex UHPLC, 
Ultimate 3000 using in both cases a Reprosil gold 100 C18 (150 x 10 mm, 5 μm) with a flow of 
6 mL/min. Two different solvents were used. Solvent A was assigned to be pure acetonitrile and 
solvent B was a mixture of 1 % acetonitrile and 0.1 % TFA in Mili-Q pure water.  
NMR spectra (1H -, 13C - and 19F - NMR) were recorded on a Bruker DPX 400 (University of Basel), a 
Varian Mercury-vx 300 and a Bruker AVIII400 (both ETH Zurich). Deuterated solvents were purchased 
from Cambridge Isotope Laboratories. Chemical shifts (δ) are given in ppm referring to 
tetramethylsilane (TMS) or the residual solvent peak. The signals are listed as s = singlet, d = doublet, 
t = triplet, q = quartet and m = multiplet. All measured spectra were recorded at room temperature. 
Coupling constants are given in Hz.  
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Mass Analysis 
MALDI-TOF (Matrix-assisted laser desorption/ionization – time of flight mass) spectrometry was 
carried out using an applied Biosystems Voyager-DE PRO apparatus (University of Basel) and a Bruker 
solariX 94 (ETH Zurich). The matrices used were 2,5 - Dihydroxbenzoic acid (5 mg/mL in 
CH3CN/ H2O/ EtOH 1:1:1) and 4 – nitroanilin (10 mg/mL in CH2Cl2/ MeOH 9:1). The values are given in 
the ratio of atom mass per charge (m/z).  
ESI – MS (electrospray ionization mass spectrometry) was performed on a Bruker Amazon speed. LC-
MS (liquid chromatography mass spectrometry) was done with a Dionex UHPLC, Ultimate 3000 using 
a Reprosil gold C18 (125 x 3 mm, 3 μm) and a Phenomenex (3 μm) with a flow of 0.7 mL/min or 
0.5 mL/min respectively. The values are given in the ratio of atom mass per charge (m/z).  
UV-Vis Spectroscopy 
For UV-Vis spectroscopy, Micro Fisherbrand Disposable Cuvettes (Methacrylate) (path length 1 cm) 
were used in a Varian Carry 300 Bio. 
Electron Microscopy 
TEM (transmission electron microscopy) measurements were carried out on a Philips EM 400 
microscope (80 kV) at the Zentrum für Mikroskopie in the Pharmazentrum in the University of Basel, 
on a Philips CM 12 (100 kV) at the electron microscopy center (EMEZ) of the ETH Zurich and on a 
Philips CM 100 (80 kV) at the Zentrum für Mikroskopie in the University of Zurich. EDX measurements 
were done on a FEI Tecnai F30 FEG at the EMEZ. Samples were prepared by depositing a drop on a 
carbon-coated copper grid with 200 or 400 mesh size. After drying on air the grids were analyzed. 
The grids were provided by the Zentrum für Mikroskopie (University of Basel) or purchased from 
Quantifoil (Germany).  
Solid Phase Peptide Synthesis 
Solid phase peptide synthesis (SPPS) was performed using the Fmoc-Strategy[222]. The used resins 
were ChemMatrix from pcas BioMatrix and Biotage or 2-chlorotrityl chloride resin from Rapp 
Polymere. Amino acids and coupling reagents are from Bachem, IRIS Biotech and Protein 
Technologies.  
For automated peptide synthesis a Syro I Peptide Synthesizer (Biotage, Upsala, Sweden) was used. 
 
 
5. Experimental Procedures 
 
 
132 
 
 
Lyophylization 
For drying of the peptides an Eppendorf Concentrator plus or an Alpha 2-4 LD plus lyophilizator 
(Christ) was used 
CD Spectroscopy 
Circular Dichroism (CD) spectroscopy was done using a Chirascan (University of Basel) and a 
Chirascan Plus (ETH Zurich) both from Applied Photophysics Ltd (UK). The measurements were 
carried out in quartz SUPRASIL cuvettes (Hellma, Typ 114-QS, d = 1 mm). 
Evaluation of Nanoparticle Size 
The analysis of the nanoparticle size was carried out using the software Image J (from the National 
Institutes of Health, USA Government). The resulting data was then converted into histograms using 
Sigma plotTM (Systat software). The errors given are the standard deviations. 
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5.2. Builiding Block Synthesis for SPPS 
5.2.1. Synthesis of Fmoc-(4S)Azp-OH 
Synthesis of H-(R)Hyp-OMe*HCl 
 
100 g of H-Hyp-OH (0.763 mol, 1.0 equiv) were dissolved in 1200 mL MeOH. While cooling with an ice 
bath, 1.5 equiv (83 mL, 1.144 mol) thionyl chloride were added dropwise within 1 h. Then the 
solution was stirred under reflux for 18 h. After cooling to room temperature, the solvent was 
removed under reduced pressure. The product was obtained as 138.6 g of a white powder 
(0.763 mol, quant). 
TLC (SiO2, CH2Cl2/ MeOH 9:1, ninhydrin): Rf = 0.53 
1H-NMR (400 MHz, DMSO-d6): δ = 10.50 (s, 1H, NH2), 9.41 (s, 1H, NH), 5.36 (s, 1H, OH), 4.43 (dd, J =  
10.8, 7.6, 1H, Hα), 4.38 (m, 1H, Hγ‘), 3.72 (s, 3H, OMe), 3.36 (dd, J = 12.0, 4.3, 1H, Hδ), 3.04 (d, J = 12.0, 
1H, Hδ), 2.17 (dd, J = 13.3, 7.3, 1H, Hβ), 2.06 (m, 1H, Hβ‘). 
13C-NMR (100 MHz, DMSO-d6): δ = 169.0 (Cq, CO2), 68.4 (CH, Cγ), 57.3 (CH, Cα), 52.9 (CH3, CH3), 52.8 
(CH2, Cδ), 36.8 (CH2, Cβ). 
MS (ESI, pos) m/z = 145.8 [M]+, 146.6 [M + H]+, (145.07 g/mol calculated for C6H11NO3) 
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Synthesis of Boc-(4R)Hyp-Ome 
 
139 g H-Hyp-OMe*HCl (0.763 mol, 1 equiv) were dissolved in an aqueous solution of NaHCO3 (1M, 
1760 mL, 2.3 equiv) and then a solution of 200 g Boc2O (0.916 mol, 1.2 equiv) in dioxane (333 mL) 
was slowly added under inert atmosphere. The reaction mixture was stirred at room temperature for 
18 h. Then it was extracted with EtOAc and the combined organic layers were washed with 1 M HCl 
and dried over MgSO4. The solvent was removed under reduced pressure yielding 151.5 g of the 
product as colorless crystals (0.618 mol, 81%). 
TLC (SiO2, CH2Cl2/ MeOH 9:1, ninhydrin): Rf = 0.54 
1H- and 13C-NMR show a double set of peaks due to the cis and trans conformers around the tertiary 
carbamate in a ratio of 1:1.8.  
 
1H-NMR (400 MHz, DMSO-d6, major conformer): δ = 5.09 (d, J = 3.6, 1H, OH), 4.25 (m, 1H, Hγ’), 4.20 
(m, 1H, Hα), 3.65 (s, 3H, CH3), 3.37 (dd, J = 11.2,  4.1, 1H, Hδ), 3.26 (m, 1H, Hδ’), 2.11 (m, 1H, Hβ), 1.88 
(m, 1H, Hβ), 1.32 (s, 9H, tBu).  
1H-NMR (400 MHz, DMSO-d6, minor conformer): δ = 3.65 (s, 3H, CH3), 3.40 (dd, J = 11.1, .4, 1H, Hδ), 
1.39 (s, 9H, tBu).  
13C-NMR (100 MHz, DMSO-d6, major conformer): δ = 174.2 (Cq, CO2), 153.8 (Cq, tBu), 79.8 (Cq, tBu), 
68.7 (CH, Cγ), 58.5 (CH, Cα), 55.3 (CH2, Cδ), 52.6 (CH3, CH3), 40.5 (CH2, Cβ), 28.7 (CH3, tBu).  
13C-NMR (100 MHz, DMSO-d6, minor conformer): δ = 173.7 (Cq, CO2), 154.6 (Cq, tBu), 69.4 (CH, Cγ), 
58.5 (CH, Cα), 55.3 (CH2, Cδ), 52.7 (CH3, CH3).  
MS (ESI, pos.) m/z = 146.1 [M + 2Na]2+, 268.0 [M + Na]+, 513.1 [2M + Na]+, (245.13 g/mol calculated 
for C11H19NO5).   
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Synthesis of Boc-(4S)Azp-OMe 
 
40 g Boc-(4R)Hyp-OMe (0.163 mol, 1 equiv) were dissolved in CH2Cl2 (310 mL). 28 mL NEt3 (0.196 mol, 
1.2 equiv) was added and stirred for 15 min. Then the solution was cooled to 0 °C and 15 mL 
methanesulfonyl chloride (0.196 mol, 1.2 equiv) were added dropwise. The reaction mixture was 
stirred at room temperature for 2 h. Then it was washed with saturated aqueous NaHCO3, dried over 
MgSO4 and the solvent was removed under reduced pressure. The product was redissolved in DMF 
(160 mL) and 53.0 g NaN3 (0.815 mol, 5 equiv) were added. The reaction mixture was stirred at 80 °C 
for 18 h. The solvent was removed under reduced pressure to yield 43.2 g of the desired product as a 
yellow oil (0.160 mol, 98%). 
 
TLC (SiO2, pentane/ EtOAc 1:1, ninhydrin): Rf = 0.6  
1H and 13C NMR show a double set of peaks due to cis and trans conformers around the tertiary 
carbamate in a ratio of 1:1.3.  
1H NMR (400 MHz, CDCl3, major conformer): δ = 4.26 (dd, J = 8.8, 4.2, 1H, Hα), 4.11 (m, 1H, Hγ), 3.69 
(s, 3H, CH3), 3.63 (m, 1H, Hδ), 3.41 (m, 1H, Hδ’), 2.41 (m, 1H, Hβ), 2.10 (m, 1H, Hβ’), 1.35 (s, 9H, tBu).  
1H NMR (400 MHz, CDCl3, minor conformer, separated signals): δ = 4.36 (dd, J = 8.9, 3.6, 1H, Hα), 1.40 
(s, 9H, tBu). 
13C NMR (100 MHz, CDCl3, major conformer): δ = 172.6, 154.3, 80.8, 59.6, 58.0, 52.6, 51.2, 36.3, 28.5.  
13C NMR (100 MHz, CDCl3, minor conformer, separated signals): δ = 172.3, 153.8, 58.6, 57.7, 52.7, 
51.6, 35.4, 28.7.  
MS (ESI, pos.) m/z (%) = 293.0 [M + Na]+, (270.13 g/mol calculated for C11H18N4O4).  
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Synthesis of Boc-(4S)Azp-OH 
 
25 g Boc-(4S)Azp-OMe (0.092 mol, 1.0 equiv) were dissolved in THF (48 mL) and MeOH (48 mL). An 
aqueous NaOH solution (7.4 g, 0.185 mol, 2.0 equiv in 8 mL H2O) was added to the reaction mixture 
and then stirred at room temperature for 3.5 h. Then the pH was adjusted to 3 by adding 1 M HCl 
solution. The mixture was extracted with EtOAc and the combined organic layers were dried over 
MgSO4. Then the solvent was removed under reduced pressure to give 23.8 g of the product as a 
white powder (0.092 mol, quant). 
 
TLC (SiO2, CH2Cl2/ MeOH 9:1, 254 nm): Rf = 0.51  
1H and 13C NMR show a double set of peaks due to cis and trans conformers around the tertiary 
carbamate in a ratio of 1:1.  
1H NMR (400 MHz, CDCl3, major conformer): δ = 10.66 (s, 1H, COOH), 4.40 (m, 1H, Hα), 4.13 (m, 1H, 
Hγ), 3.69 (m, 1H, Hδ), 3.45 (m, 1H, Hδ), 2.46 (m, 1H, Hβ), 2.36 (m, 1H, Hβ), 1.42 (s, 9H, tBu).  
1H NMR (400 MHz, CDCl3, minor conformer): δ = 10.66 (s, 1H, COOH), 4.30 (m, 1H, Hα), 4.13 (m, 1H, 
Hγ), 3.59 (m, 1H, Hδ), 3.38 (m, 1H, Hδ), 2.36 (m, 1H, Hβ), 2.18 (m, 1H, Hβ), 1.36 (s, 9H, tBu).  
13C NMR (100 MHz, CDCl3, major conformer): δ = 177.5, 155.8, 82.2, 59.6, 57.9, 52.1, 36.3, 28.7.   
13C NMR (100 MHz, CDCl3, minor conformer): δ = 175.3, 154.1, 81.5, 59.6, 58.7, 51.3, 34.6, 28.6.  
MS (ESI, pos.) m/z (%) = 255.7 [M]+, 511.2 [2M]+, (256.12  g/mol calculated for C10H16N4O4).  
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Synthesis of H-(4S)Azp-OH*HCl 
 
24 g Boc-(4S)Azp-OH (0.092 mol, 1 equiv) were dissolved in 4 M HCl in dioxone (300 mL). The 
reaction mixture was stirred at room temperature for 5 h. Then the solvent was removed under 
reduced pressure. The remaining solid was dissolved in a minimum of a 1:1 (v/v) mixture of CH2Cl2 
and MeOH and then precipitated in Et2O. The precipitate was filtered and dried under reduced 
pressure to yield 15.7 g of the desired product as a white powder ( 0.082 mol, 89%). 
 
TLC (SiO2, CH3CN/H2O 4:1, ninhydrin): Rf = 0.24  
1H NMR  (400 MHz, D2O): δ = 4.57 (m, 2H; Hα, Hγ), 3.49 (m, 2H; Hδ, Hδ), 2.60 (ddd, J = 15.3, 10.1, 
5.3 Hz, 1H, Hβ), 2.45 (m, 1H, Hβ).  
13C NMR (100 MHz, CDCl3): δ = 170.8, 60.7, 59.5, 52.0, 35.3.  
MS (ESI, pos.) m/z (%) = 156.9 [M]+, (156,06 g/mol calculated for C5H8N4O2).  
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Synthesis of Fmoc-(4S)Azp-OH 
 
16 g H-(4S)Azp-OH*HCl (0.082 mol, 1 equiv) were dissolved in dioxane (40 mL) and in an aqueous 
NaHCO3 solution (17 g, 0.205 mol, 2.5 equiv in 160 mL H2O). Then a solution of 25 g Fmoc chloride 
(0.098 mol, 1.2 equiv) in dioxane (40 mL) was added. The reaction mixture was stirred at room 
temperature for 3 h. The organic solvent was removed and saturated NaHCO3 solution (250 mL) was 
added to change the pH to be around 8. The aqueous solution was washed with Et2O and then 
acidified with 1 M HCl to reach a pH of around 2, when a white solid precipitated. The mixture was 
extracted with EtOAc and the combined organic phases were dried over MgSO4. The solvent was 
removed under reduced pressure to yield 27.5 gof the desired product as a white powder (0.073 mol, 
89%). 
 
TLC (SiO2, CH2Cl2/ MeOH 9:1, ninhydrin): Rf = 0.42  
Analytical HPLC: Rt = 12.8 min, 70% to 10% B in 27 min, Reprosil gold, 1 mL/min, 254 nm.  
1H and 13C NMR show a double set of peaks due to cis and trans conformers around the tertiary 
carbamate in a ratio of 1:1.  
1H NMR (400 MHz, CDCl3/CD3OD, conformer a): δ = 7.55 (d, J = 7.8 Hz, 2H, Fmoc), 7.38 (m, 2H, Fmoc), 
7.18 (m, 2H, Fmoc), 7.10 (m, 2H, Fmoc), 3.97 – 4.28 (m, 5H, Fmoc, Hα, Hγ), 3.57 (dd, J = 11.8, 5.9 Hz, 
1H, Hδ), 3.35 (dd, J = 12.7, 3.0 Hz, 1H, Hδ), 2.29 (m, 1H, Hβ), 2.09 (m, 1H, Hβ).  
1H NMR (400 MHz, CDCl3/CD3OD, conformer b): δ = 7.53 (d, J = 7.8 Hz, 2H, Fmoc), 7.38 (m, 2H, Fmoc), 
7.18 (m, 2H, Fmoc), (m, 2H, Fmoc), 3.97 – 4.28 (m, 5H, Fmoc, Hα, Hγ), 3.49 (dd, J = 11.8, 5.9 Hz, 1H, 
Hδ), 3.32 (dd, J = 12.7, 3.0 Hz, 1H, Hδ), 2.29 (m, 1H, Hβ), 2.09 (m, 1H, Hβ). 
13C NMR (100 MHz, DMSO:d6, both conformers): δ = 172.6, 172.0, 153.6, 153.6, 143.8, 143.6, 140.6, 
140.6, 127.4, 127.1, 125.0, 120.0, 66.8, 66.5, 58.8, 58.1, 57.4, 57.2, 51.4, 50.8, 46.7, 46.5, 35.5, 35.4.  
MS (ESI, pos.) m/z (%) = 379.3 [M + H]+, 401.2 [M + Na]+, (378.13 g/mol calculated for C20H18N4O4).  
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5.2.2. Synthesis of Fmoc-Pro-(4S)Azp-Pro-OH 
Synthesis of H-(4S)Azp-OMe*HCl 
 
31.1 g Boc-(4S)Azp-OMe (0.115 mol, 1 equiv) were dissolved in a 4 M HCl solution in dioxane 
(372 mL). The reaction mixture was stirred at room temperature for 1 h. Then the solvent was 
removed under reduced pressure. The remaining solid was dissolved in a minimum of a mixture of 
CH2Cl2 and MeOH in a ratio of 1:1 (v/v). Et2O was added to precipitate a white solid. The supernatant 
solution was removed and the precipitation was repeated to yield 21.91 g of the desired product 
(0.106 mol, 92%). 
 
TLC (CH3CN/ H2O 4:1, ninhydrin): Rf = 0.5 
1H NMR (400 MHz, CD3OD): δ = 4.64 - 4.57 (m, 2H, Hα, Hγ), 3.89 (s, 3H, OCH3), 3.51 (dd, J = 12.5 Hz, 
5.0 Hz, 1H, Hδ), 3.45 (dm, J = 12.5 Hz, 1H, Hδ), 2.56 (ddd, J = 14.4 Hz, 9.8 Hz, 5.6 Hz, 1.7 Hz, 1H, Hβ), 
2.43 (dm, J = 14.4 Hz, 1H, Hβ). 
13C NMR (100 MHz, CD3OD): δ = 170.0, 60.6, 59.7, 54.3, 52.2, 35.3. 
MS (ESI, pos.) m/z (%) = 229.7 [M + Na]+, (206.06 g/mol calculated for C6H11ClN4O2).  
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Synthesis of Boc-Pro-(4S)Azp-OMe 
 
21.9 g H-(4S)Azp-OMe*HCl (0.106 mol, 1 equiv) and 29.7 g Boc-Pro-OH (0.138 mol, 1.3 equiv) were 
dissolved in CH2Cl2 (933 mL). 24 mL 
iPr2NEt (0.138 mol, 1.3 equiv) and 30.5 g EDC (0.159 mol, 
1.5 equiv) were added and the solution was stirred at room temperature for 18 h. The solution was 
washed with 1 M HCl solution and dried over Na2SO4. Removal of the solvent under reduced pressure 
yielded 14.5 g of the desired product as a white solid (0.040 mol, 37%). 
TLC (CH2Cl2/ MeOH 95:5, ninhydrin): Rf = 0.4 
1H NMR shows a double set of peaks due to cis and trans conformers around the tertiary carbamate 
in a ratio of 2:5.  
1H NMR (500 MHz, CDCl3, major conformer): δ = 4.71 (dd, J = 8.9 Hz, 4.3 Hz, 1H, Azp-Hα), 4.43 (dd, 
J = 8.3 Hz, 3.5 Hz, 1H, Pro-Hα), 4.27 (m, 1H, Azp-Hγ), 4.10 (dd, J = 10.6 Hz, 6.1 Hz, 1H, Azp-Hδ), 3.73 (s, 
3H, OCH3), 3.62 – 3.50 (m, 2H, Pro-Hδ, Azp-Hδ), 3.42 – 3.36 (m, 1H, Pro-Hδ), 2.46 (ddd, J = 13.6 Hz, 
9.0 Hz, 6.0 Hz, 1H, Azp-Hβ), 2.24-2.01 (m, 4H, Pro-Hβ, Azp-Hβ, Pro-Hγ, Pro-Hβ); 1.86 (m, 1H, Pro-Hγ), 
1.43 (s, 9H, tBu) 
1H NMR (500 MHz, CDCl3, minor conformer): δ = 4.68 (dd, J = 8.9 Hz, 4.3 Hz, 1H, Azp-Hα), 4.33 (dd, 
J = 8.5 Hz, 3.8 Hz, 1H, Pro-Hα), 4.27 (m, 1H, Azp-Hγ), 3.91 (dd, J = 10.6 Hz, 6.1 Hz, 1H, Azp-Hδ), 3.74 (s, 
3H, OCH3), 3.62 - 3.50 (m, 2H, Pro-Hδ, Azp-Hδ), 3.46 (m, 1H, Pro-Hδ), 2.43 (m, 1H, Azp-Hβ), 2.24 – 2.01 
(m, 4H, Pro-Hβ, Azp-Hβ, Pro-Hγ, Pro-Hβ), 1.86 (m, 1H, Pro-Hγ), 1.38 (s, 9H, tBu). 
13C NMR (126 MHz, CDCl3, major conformer): δ = 171.5, 154.8, 79.8, 59.8, 57.7, 57.4, 52.5, 51.4, 47.0, 
34.1, 29.4, 28.6, 24.3. 
13C NMR (126 MHz, CDCl3, minor conformer): δ = 171.8, 171.2, 153.7, 79.8, 59.7, 58.0, 57.7, 57.4, 
52.7, 51.3, 46.8, 34.2, 30.3, 28.5, 23.6. 
MS (ESI, pos.) m/z (%) = 390.1 [M + Na]+, (367.19 g/mol calculated for C16H25N5O5).   
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Synthesis of Boc-Pro-(4S)Azp-OH 
 
14.5 g Boc-Pro-(4S)Azp-OMe (0.041 mol, 1 equiv) were dissolved in THF (21 mL) and MeOH (21 mL). 
An aqueous NaOH solution (3.3 g, 0.082 mol, 2 equiv in 2.8 mL H2O) was added. A white precipitate 
formed, therefore another 20 mL MeOH were added. The reaction mixture was stirred at room 
temperature for 2.5 h. Then the solution was washed with 1 M HCl and dried over Na2SO4. The 
solvent was removed under reduced pressure to yield 12.9 g of the desired product as a white solid 
(0.037 mol, 89%). 
 
TLC (CH3CN/ H2O 4:1, ninhydrin): Rf = 0.5 
1H NMR shows a double set of peaks due to cis and trans conformers around the tertiary carbamate 
in a ratio of 2:7.  
1H NMR (250 MHz, CDCl3/CD3OD, major conformer): δ = 4.73 (dd, J = 9.1 Hz, 3.3 Hz, 1H, Azp-Hα), 4.44 
(dd, J = 7.8 Hz, 3.6 Hz, 1H, Pro-Hα), 4.39 – 4.27 (m, 1H, Azp-Hγ), 4.06 (dd, J = 10.6 Hz, 5.8 Hz, Azp-Hδ), 
3.64 – 3.36 (m, 3H, Pro-Hδ, Azp—Hδ), 2.53 – 1.78 (m, 6H, Hβ, Pro-Hγ), 1.45 (s, 9H, tBu). 
1H NMR (250 MHz, CDCl3/CD3OD, minor conformer): δ = 3.85 (dd, J = 10.5 HZ, 5.8 Hz, 1H, Azp-Hδ), 
1.39 (s, 9H, tBu). 
13C NMR (100MHz, CDCl3): δ = 174.5, 172.0, 154.7, 80.2, 59.5, 58.7, 57.6, 52.4, 46.9, 32.3, 29.5, 28.4, 
24.3. 
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Synthesis of Boc-Pro-(4S)Azp-Pro-OMe 
 
12.9 g Boc-Pro-(4S)Azp-OH (0.037 mol, 1 equiv) and 7.4 g H-Pro-OMe*HCl (0.044 mol, 1.2 equiv) 
were dissolved in CH2Cl2 (112 mL) and 7.7 mL 
iPr2NEt (0.044 mol, 1.2 equiv) were added. Then 10.6 g 
EDC (0.056 mol, 1.5 equiv) were put into the reaction mixture. The reaction was stirred at room 
temperature for 18 h. The solution was washed with 1 M HCl solution and dried over Na2SO4. Then 
the solvent was removed under reduced pressure to yield 14.9 g of the desired product as a white 
solid (0.032 mol, 86%). 
 
TLC (CH2Cl2/ MeOH 9:1, ninhydrin): Rf = 0.5 
1H NMR shows a double set of peaks due to cis and trans conformers around the tertiary carbamate 
in a ratio of 1:3.  
1H NMR (500 MHz, CDCl3, major conformer): δ = 4.74 (t, J = 7.9 Hz, 1H, Azp-Hα), 4.55 (dd, J = 8.7 Hz, 
3.9 Hz, 1H, ProC-Hα), 4.45 (dd, J = 8.2 Hz, 3.2 Hz, 1H, Pro
N-Hα), 4.22 – 4.14 (m, 2H, Azp-Hγ, Azp-Hδ), 
3.79 (m, 1H, ProC-Hδ), 3.71 (s, 3H, OCH3), 3.61 – 3.33 (m, 4H, Pro
C-Hδ, Pro
N-Hδ, Azp-Hδ, Pro-Hδ), 2.66 –
 2.57 (m, 1H, Azp-Hβ), 2.25 – 1.93 (m, 8H, Pro
C-Hβ, Pro
N-Hβ, Pro
C-Hγ, Pro
N-Hγ, Azp-Hβ, Pro
N-Hγ, Pro
C-Hβ), 
1.86 – 1.78 (m, 1H, ProN-Hγ), 1.43 (s, 9H, tBu) 
1H NMR (500 MHz, CDCl3, minor conformer): δ = 4.67 (t, J = 7.9 Hz, 1H, Azp-Hα), 4.56 (dd, J = 8.7 Hz, 
4.1 Hz, 1H, ProC-Hα), 4.36 (dd, J = 8.1 Hz, 3.5 Hz, 1H, Pro
N-Hα), 4.14 – 4.00 (m, 2H, Azp-Hγ, Azp-Hδ), 
3.84 – 3.75 (m, 1H, ProC-Hδ), 3.71 (s, 3H, OCH3), 3.61 – 3.33 (m, 4H, Pro
C-Hδ, Pro
N-Hδ, Azp-Hδ, Pro-Hδ), 
2.66 – 2.57 (m, 1H, Azp-Hβ), 2.25 – 1.93 (m, 8H, Pro
C-Hβ, Pro
N-Hβ, Pro
C-Hγ, Pro
N-Hγ, Azp-Hβ, Pro
N-Hγ, 
ProC-Hβ), 1.86 – 1.78 (m, 1H, Pro
N-Hγ), 1.43 (s, 9H, tBu) 
13C NMR (126 MHz, CDCl3, major conformer): δ = 172.5, 170.9, 169.5, 154.6, 79.5, 58.9, 58.7, 57.7, 
56.5, 52.2, 51.0, 46.9, 33.0, 28.9, 28.8, 28.6, 24.8, 24.2. 
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13C NMR (126 MHz, CDCl3, minor conformer): δ = 172.5, 171.4, 169.2, 153.6, 79.4, 58.9, 58.7, 57.7, 
56.4, 52.2, 51.0, 46.7, 33.1, 29.9, 28.4, 24.8, 23.5. 
MS (ESI, pos.) m/z (%) = 487.1 [M + Na]+, (464.24 g/mol calculated for C21H32N6O6).   
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Synthesis of Boc-Pro-(4S)Azp-Pro-OH 
 
14.9 g (0.032 mol, 1 equiv) Boc-Pro-(4S)Azp-Pro-OMe were dissolved in 330 mL THF and 165 mL 
MeOH. An aqueous NaOH solution (3.1 g, 2.4 equiv in 6 mL H2O) was added and the reaction mixture 
was stirred at room temperature for 2.5 h. Then the solution was extracted with CH2Cl2 and 1 M HCl 
solution. The combined organic phases were dried over Na2SO4 and the solvent was removed under 
reduced pressure. The product was obtained as a white powder (11.3 g, 0.025 mol, 78%). 
 
TLC (CH3CN/ H2O 4:1, ninhydrin): Rf = 0.5 
1H NMR shows a double set of peaks due to cis and trans conformers around the tertiary carbamate 
in a ratio of 1:3.  
1H NMR (250 MHz, CDCl3, major conformer): δ = 4.73 (t, J = 7.9 Hz, 1H), 4.64 (m, 1H), 4.49 – 4.32 (m, 
1H), 4.25 – 4.02 (m, 2H), 3.82 -3.31 (m, 5H), 2.66 – 2.52 (m, 1H), 2.39 – 2.23 (m, 1H), 2.19 – 1.76 (m, 
8H), 1.44 (s, 9H, tBu) 
1H NMR (500 MHz, CDCl3, minor conformer, separated signals): δ = 1.40 (s, 9H, tBu) 
13C NMR (100 MHz, CDCl3): δ = 173.0, 171.8, 171.2, 79.8, 59.7, 58.9, 57.7, 56.6, 51.0, 47.3, 46.9, 33.3, 
29.0, 28.5, 27.5, 25.0, 24.3. 
MS (ESI, pos.) m/z (%) = 473.1 [M + Na]+, (450.22 g/mol calculated for C20H30N6O6).  
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Synthesis of H-Pro-(4S)Azp-Pro-OH*HCl 
 
11.3 g Boc-Pro-(4S)Azp-Pro-OH (0.025 mol, 1 equiv) were dissolved in a 4 M solution of HCl in 
dioxane (65 mL) and stirred at room temperature for 2 h. The solvent was removed and the 
remaining solid was dissolved in a minimum of CH2Cl2 and MeOH. By addition of Et2O, the product 
precipitated as a white solid. It was filtrated and dried under reduced pressure to yield 9.0 g of H-Pro-
(4S)Azp-Pro-OH*HCl (0.023 mol, 93%). 
 
TLC (CH3CN/ H2O 4:1, ninhydrin): Rf = 0.1. 
1H NMR (250 MHz, CD3OD): δ = 4.80 (dd, J = 8.1 Hz, 8.1 Hz, 1H), 4.65 – 4.55 (m, 1H), 4.46 – 4.20 (m, 
2H), 4.09 (dd, J = 10.1Hz, 6.9 Hz, 1H), 3.90 – 3.56 (m, 2H), 3.42 – 3.3 (m, 3H), 2.88 – 2.75 (m, 1H), 
2.55 – 1.81 (m, 9H). 
13C NMR (100 MHz, CDCl3): δ = 175.0, 170.9, 168.2, 60.6, 60.5, 60.0, 58.7, 52.4, 48.1, 47.6, 34.1, 30.1, 
29.3, 25.9, 25.1. 
MS (ESI, pos.) m/z (%) = 350.3 [M + H]+, (386.15g/mol calculated for C15H22N6O4).  
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Synthesis of Fmoc-Pro-(4S)Azp-Pro-OH 
 
9.0 g H-Pro-(4S)Azp-Pro-OH*HCl (0.023 mol, 1 equiv) were dissolved in dioxane (41 mL). An aqueous 
NaHCO3 solution (4.9 g, 0.058 mol, 2.5 equiv in 81 mL H2O) was added. Then 7.2 g Fmoc-Cl 
(0.028 mol, 1.2 equiv)in dioxane (48 mL) were added and the reaction mixture was stirred at room 
temperature for 18 h. The pH was brought to around pH 10 with a saturated aqueous NaHCO3 
solution. The solution was extracted with Et2O and the aqueous layer was brought to acidic pH with 
2 M HCl solution. The aqueous layer was extracted with ethyl acetate. The solution was dried over 
Na2SO4. The solvent was removed under reduced pressure to yield 12.2 g of the desired product as a 
white solid (0.021 mol, 91%).  
TLC (CH3CN/ H2O 4:1, ninhydrin): Rf = 0.3. 
1H NMR shows a double set of peaks due to cis and trans conformers around the tertiary carbamate 
in a ratio of 1:2.3.  
1H-NMR (500 MHz, CDCl3, major conformer): δ= 7.76 (m, 2H, Fmoc), 7.63 - 7.53 (m, 2H, Fmoc), 7.43 -
 7.37 (m, 2H, Fmoc), 7.34 - 7.28 (m, 2H, Fmoc), 4.74 (t, J = 7.9 Hz, 1H, Azp-Hα), 4.62 (dd, J = 8.6 Hz, 3.2 
Hz, 1H, ProC-Hα), 4.52 (dd, J = 8.2 Hz, J = 3.6 Hz,1H, Pro
N-Hα), 4.35 - 4.30 (m, 2H, Fmoc), 4.26 - 4.20 (m, 
3H, Fmoc, Azp-Hγ, Azp-Hδ), 3.76 (dd, 1H, Pro
C-Hδ), 3.69 (m, 1H, Pro
N-Hδ), 3.58 - 3.45 (m, 3H, Pro
N-Hδ, 
ProC-Hδ, Azp-Hδ), 2.59 (m, 1H, Azp-Hβ), 2.30 - 1.70 (m, 9H, Pro
C-Hβ, Pro
N-Hβ, Pro
N-Hβ, Pro
N-Hγ, Pro
C-Hβ, 
ProC-Hγ, Azp-Hβ, Pro
C-Hγ, Pro
N-Hγ).  
1H-NMR (500 MHz, CDCl3, minor conformer): δ= 7.76 (m, 2H, Fmoc), 7.63 - 7.53 (m, 2H, Fmoc), 7.43 -
 7.37 (m, 2H, Fmoc), 7.34 - 7.28 (m, 2H, Fmoc), 4.59 – 5.54 (m, 2H, Fmoc, ProC-Hα), 4.35 (m, 1H, Azp-
Hα), 4.15 (t, J = 5.0 Hz, 1H, Fmoc), 4.00 (dd, J = 8.5 Hz, J = 3.2 Hz, 1H, Pro
N-Hα), 3.92 (q, 1H, Azp-Hγ), 
3.70 (m, 1H, ProC-Hδ), 3.58 – 3.45 (m, 2H, Pro
N-Hδ, Pro
C-Hδ), 3.45 – 3.36 (m, 2H, Pro
N-Hδ, Azp-Hδ), 3.21 
(dd, J = 9.8 Hz, 8.0 Hz, 1H, Azp-Hδ), 2.45 (m, 1H, Azp-Hβ), 2.30 - 1.70 (m, 9H, Pro
C-Hβ, Pro
N-Hβ, Pro
N-Hβ, 
ProN-Hγ, Pro
C-Hβ, Pro
C-Hγ, Azp-Hβ, Pro
C-Hγ, ProN-Hγ).  
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13C NMR (126 MHz, CDCl3, major conformer): δ = 173.5, 171.2, 171.0, 155.1, 144.1, 143.9, 141.3, 
127.7, 127.1, 125.2, 125.1, 120.0, 67.6, 59.5, 58.8, 58.1, 56.7, 51.2, 47.7, 47.2, 27.1, 46.8, 34.1, 29.0, 
27.8,25.0, 24.7.  
13C NMR (126 MHz, CDCl3, minor conformer): δ = 173.5, 171.2, 171.0, 155.1, 144.6, 143.7, 141.4, 
141.1, 127.8, 127.5, 127.2, 126.8, 124.9, 124.8, 119.7, 65.6, 59.4, 58.7, 57.5, 56.4, 50.4, 47.7, 47.2, 
47.1, 46.8, 33.2, 29.6, 27.8, 25.0, 23.3.  
MS (ESI, pos.) m/z (%) = 595.0 [M + Na]+, (572.24 g/mol calculated for C30H32N6O6).  
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5.3. Solid Phase Peptide Synthesis (SPPS) 
5.3.1. General Procedure for Manual Amino Acid Coupling  
The manual coupling of amino acids on solid support followed the next steps. First the resin needed 
to be swollen in CH2Cl2 (8 mL/g resin) for 30 min. Then a pre-reaction was carried out using 
iPr2NEt 
(9 equiv), HCTU (0.5 M, 3 equiv) and amino acid (0.5 M, 3 equiv) in DMF (5 mL / g resin) by shaking at 
room temperature for 3 min. The mixture was then added to the resin and agitated at room 
temperature for 1 h. After the reaction the solution was removed and the resin was washed with 
DMF (3 x 2 mL/ g resin) and CH2Cl2 (3 x 2 mL/ g resin). To test the completeness of the coupling a 
color test on bead was carried out. To prepare the next coupling step, the N-terminal Fmoc group 
needed to be removed by addition of 20% (v/v) piperidine solution in DMF (2 mL/ g resin) and 
agitation for 10 min. This procedure was repeated for 20 min. Then the resin was washed with DMF 
(3 x 2 mL/ g resin) and CH2Cl2 (3 x 2 mL/ g resin). The reactions were repeated until the peptide was 
complete.  
5.3.2. General Procedure for the Quantitative Fmoc-test 
With the quantitative Fmoc-test, the loading of the resin is determined. 500 µL of a 30% (v/v) 
piperidine solution in DMF were added to 3 mg of dry resin. The mixture was agitated for 30 min. The 
solution was diluted 1:10 and then the UV absorption was measured at a wavelength of 301 nm. The 
respective loading can be calculated according to formula (2). 
 
.         
    
 
  
                    
                 
   (2) 
         ε301 nm = 7.8 mL·mmol
−1·cm−1. 
5.3.3. General Procedure for Automated Peptide Synthesis 
For automated peptide synthesis, a Syro I Peptide Synthesizer (Biotage, Upsala, Sweden) was used. 
The resin was swollen in DMF and then iPr2NEt (9 equiv as a 3 M solution in N-methylpyrrolidone), 
HCTU (3 equiv, 0.5 M in DMF) and Fmoc-amino acid (3 equiv, 0.5 M) in DMF (5 mL / g resin) was 
added to the resin. The reaction mixture was allowed to react in intervals of 1 min agitation and 
5 min break in between for 1 h, followed by a washing step with DMF (5 x). The coupling step was 
followed by Fmoc deprotection. This was carried out by addition of 40% (v/v) piperidine in DMF and 
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reaction for 5 min. This step was repeated with 20% (v/v) piperidine in DMF for 10 min. Then the 
resin was washed with DMF (5 x). The reactions were repeated until the peptide was finished.  
5.3.4. General Procedure for Color Tests on Resin 
For the monitoring of coupling and deprotection of the amino acids on resin, different color tests 
were applied. 
5.3.4.1. Kaiser Test for Primary Amines[223] 
A few beads were put into a vial and three drops of solution 1 (5 g ninhydrin in 100 mL ethanol), 
solution 2 (80 g phenol in 20 mL ethanol) and solution 3 (2 mL 0.001 M aqueous KCN in 98 mL 
pyridine) were added. The reaction mixture was heated to 100 °C for 5 min. If the test was negative, 
meaning no primary amine was present the beads showed no coloration or a slight yellow color. In 
case of a positive test, meaning a free amino function was present, the beads showed a blue color. If 
secondary amines were present, the beads were colored brownish or red but the test is less reliable 
for secondary amines. If the heating was carried out for longer time, there was the danger that side 
chains were deprotected (Boc group) or that the Fmoc group was removed by the pyridine. 
5.3.4.2. Acetaldehyde / Chloranil test for Secondary Amines[224] 
A few beads were put into a vial and three drops of solution 1 (2% acetaldehyde in DMF) and solution 
2 (2% chloranil in DMF) were added. The mixture was allowed to react at room temperature for 
5 min. The beads were analyzed under a microscope. In case of a positive test, when secondary 
amine groups were present, the beads showed a blue coloration. In case of a negative test the beads 
have no coloration or a slightly yellow color. The solution 1 and 2 should be stored at -20 °C. Instead 
of 2% acetaldehyde solution in DMF also pure acetone can be used instead. 
5.3.4.3. TNBS Test for Secondary Amines[225] 
A few beads were placed into a vial and three drops of solution 1 (10% DIPEA in DMF) and solution 2 
(1 M aqueous TNBS) were added. The mixture was allowed to react for 5 min. The beads were 
analyzed under a microscope. In case of a positive test, when secondary amine groups were present, 
the beads showed an orange to red coloration. In case of a negative test the beads were colorless.  
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5.3.5. General Procedure for N-terminal Acetylation 
The resin was swollen for 30 min in CH2Cl2 at room temperature. Then Ac2O (20 equiv) and NEt3 
(20 equiv) in CH2Cl2 were added. The reaction mixture was shaken at room temperature for 1 h and 
then washed with CH2Cl2 (3 x 2 mL/ g resin). To test whether the acetylation was complete a color 
test was applied. 
5.3.6. Staudinger Reduction on Solid Support 
The resin with the peptide, containing an azido functionality was swollen for 30 min in THF. Water 
(65 equiv per N3 group) and PMe3 (1 M in THF, 5 equiv per N3 group) were added to the resin. The 
reaction mixture was shaken at room temperature for 2 h. The resin was washed with THF (3 x 2 mL/ 
g resin), DMF (3 x 2 mL/ g resin) and CH2Cl2 (3 x 2 mL/ g resin). 
5.3.7. Guanidinylation on Solid Support 
The resin was swollen in CH2Cl2 for 30 min. N,N’-di-Boc-N’’-trifluormethane sulfonylguanidine 
(2.2 eqiuv per NH2 group) was dissolved in MeOH : CH2Cl2 (v/v, 1:1) and added to the resin. The 
mixture was shaken for 10 min and then NEt3 (2.8 equiv per NH2 group) was added. The reaction was 
agitated at room temperature for 2 d. After the reaction the resin was washed with DMF (3 x 2 mL/ g 
resin) and CH2Cl2 (3 x 2 mL/ g resin). 
5.3.8. General Procedure for Cleavage of the Peptides from the Resin and 
Simultaneous Side-Chain Deprotection 
The resin was swollen for 30 min in CH2Cl2. A solution of 87.5% TFA, 5% CH2Cl2, 5% H2O and 2.5% TIS 
was added to the resin and the mixture was agitated for 1 h. The cleavage mixture was removed and 
a solution of TFA : CH2Cl2 (v/v, 1:1) was added to the resin and shaken for 10 min. The combined 
filtrates were concentrated under reduced pressure and the remaining peptide was precipitated with 
Et2O. The solid was washed three times with Et2O and then dried. 
5.3.9. General Procedure for Ion Exchange of Peptides 
Ion exchange was done using VariPureTM IPE tubes from Varian. The prepacked column was first 
washed with MeOH and then with the respective elution solvent, typically nanopure H2O : ACN (v/v, 
1:1). The peptide as a TFA salt was dissolved in the elution solution and applied on the column. The 
fractions were analyzed by TLC and visualized with ninhydrin. Peptide containing fractions were 
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combined and lyophilized. The new counterion HCO3
- was herewith removed as CO2 to give the 
desalted peptide as a white solid. The absence of TFA was shown by 19F – NMR spectroscopy.  
5.3.10. General Procedure for Peptide synthesis 
The peptides were synthesized as described above on ChemMatrix® Rink amide resin with a loading 
of 0.64 or 0.52 mmol/ g or on 2-chlrorotrityl chloride resin with a loading of 1.1 mmol/g. Fmoc-
(4S)Azp-OH, Fmoc-Pro-(4S)Azp-Pro-OH and the respective Fmoc- amino acids were used on the Syro I 
Peptide Synthesizer or in manual performed coupling steps. This was followed by acetylation of the 
N-terminus as described under 5.3.4.. The Staudinger reduction of the azido groups was carried out 
using the previously described procedures. The next step was the coupling of acids bearing the 
desired functional groups. In case of the peptides bearing guanidinium functionalities the coupling of 
an amine was followed by a guanidinylation on solid support. The peptides were cleaved from the 
solid support and the peptides were purified by preparative RP-HPLC on a Reprosil Gold 100 C18, 150 
x 10 mm, 5 µm column with a flow of 6 mL/min at 50°C. The pure peptide was desalted according to 
the procedure given above.  
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5.4. Peptides Prepared by Solid Phase Synthesis 
5.4.1. Synthesis of Peptide Bearing Imidazole Moieties 
5.4.1.1. Synthesis of Peptide 17a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, 4-Imidazoleacetic acid hydrochloride was coupled to the amine on the 
oligoproline backbone. The peptide was cleaved from the resin, purified via HPLC and desalted over 
an ion-exchange column. 
 
HPLC: tR = 1.7 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR):  m/z: = 910.4293 (M + Na+), calculated for C42H57N13NaO9: m/z = 910.4294 
   m/z = 888.4473(M + H+), calculated for C42H58N13O9: m/z = 888.4475 
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5.4.1.2. Synthesis of Peptide 17b 
  
Peptide 17b was synthesized, as described for peptide 17a.  
 
HPLC: tR = 2.0 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1738.8314 (M + Na+), calculated for C82H109N25NaO17: m/z = 1738.8325 
   m/z = 1716.8495 (M + H+), calculated for C82H110N25O17: m/z = 1716.8506 
5.4.1.3. Synthesis of Peptide 17c 
 
Peptide 17c was synthesized, as described for peptide 17a.  
HPLC: tR = 7.0 min; Reprosil gold 120 C18 (5 μm); gradient 98% to 40% B over 20 min at 50°C (PDA 
@214 nm), flow 1.0 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 2567.2357 (M + Na+), calculated for C122H161N37NaO25: m/z = 2567.2357  
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5.4.2. Synthesis of Peptides Bearing Guanidine Moieties 
5.4.2.1. Synthesis of Peptide 22a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, Fmoc-GABA was coupled to the amine on the oligoproline backbone. After Fmoc-
deprotection a guanidinylation was performed as described. The peptide was cleaved from the resin, 
purified via HPLC and desalted over an ion-exchange column. 
 
HPLC: tR = 1.8 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 948.5133 (M + Na+), calculated for C42H67N15NaO9: m/z = 948.5138 
   m/z = 926.5312 (M + H+), calculated for C42H68N15O9: m/z = 926.5319 
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5.4.2.2. Synthesis of Peptide 22b 
 
Peptide 22b was synthesized, as described for peptide 22a.  
 
HPLC: tR = 2.1 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1815.0005 (M + Na+), calculated for C82H129N29NaO17: m/z = 1815.0013 
   m/z = 1793.0187 (M + H+), calculated for C82H130N29O17: m/z = 1793.0194 
5.4.2.3. Synthesis of Peptide 22c 
 
Peptide 22c was synthesized, as described for peptide 22a.  
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HPLC: tR = 2.2 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 2659.5104 (M + H+), calculated for C122H192N43O25: m/z = 2659.5069 
5.4.2.4. Synthesis of Peptide 24a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then a guanidinylation was performed as described. The peptide was cleaved from the 
resin, purified via HPLC and desalted over an ion-exchange column. 
 
HPLC: tR = 3.1 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 778.4048 (M + Na+), calculated for C34H53N13NaO7: m/z = 778.4083 
   m/z = 756.4262 (M + H+), calculated for C34H54N13O7: m/z = 756.4264 
5.4.2.5. Synthesis of Peptide 24b 
 
Peptide 24b was synthesized, as described for peptide 24a.  
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HPLC: tR = 3.2 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1474.7905 (M + Na+), calculated for C66H101N25NaO13: m/z = 1474.7903 
   m/z = 1452.8081 (M + H+), calculated for C66H102N25O13: m/z = 1452.8083 
5.4.2.6. Synthesis of Peptide 24c 
 
Peptide 24c was synthesized, as described for peptide 24a.  
 
HPLC: tR = 3.2 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 2171.1718 (M + Na+), calculated for C98H149N37NaO19: m/z = 2171.1723 
   m/z = 2149.1894 (M + H+), calculated for C98H150N37O19: m/z = 2149.1903 
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5.4.3. Synthesis of Peptide Bearing Amino Moieties 
5.4.3.1. Synthesis of Peptide 21a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, Fmoc-GABA was coupled to the amine on the oligoproline backbone.  After Fmoc-
deprotection, the peptide was cleaved from the resin, purified via HPLC and desalted over an ion-
exchange column. 
 
HPLC: tR = 1.6 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 864.4702 (M + Na+), calculated for C40H63N11NaO9: m/z = 864.4702 
   m/z = 842.4881 (M + H+), calculated for C40H64N11O9: m/z = 842.4883 
5.4.3.2. Synthesis of Peptide 21b 
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Peptide 21b was synthesized, as described for peptide 21a.  
 
HPLC: tR = 1.9 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1624.9317 (M + H+), calculated for C78H122N21O17: m/z = 1624.9322 
5.4.3.3. Synthesis of Peptide 21c 
 
Peptide 21c was synthesized, as described for peptide 21a.  
 
HPLC: tR = 2.1 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 2429.3548 (M + Na+), calculated for C116H179N31NaO25: m/z = 
2429.3581 
5.4.3.4. Synthesis of Peptide 23a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
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terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, the peptide was cleaved from the resin, purified via HPLC and desalted over an 
ion-exchange column. 
 
HPLC: tR = 3.0 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 694.3829 (M + Na+), calculated for C32H49N9NaO7: m/z = 694.3647 
   m/z = 672.3829 (M + H+), calculated for C32H50N9O7: m/z = 672.3828 
5.4.3.5. Synthesis of Peptide 23b 
 
Peptide 23b was synthesized, as described for peptide 23a.  
 
HPLC: tR = 3.2 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1306.7032 (M + Na+), calculated for C62H93N17NaO13: m/z = 1306.7031 
   m/z = 1284.7210 (M + H+), calculated for C62H94N17O13: m/z = 1284.7212 
5.4.3.6. Synthesis of Peptide 23c 
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Peptide 23c was synthesized, as described for peptide 23a.  
 
HPLC: tR = 3.3 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1919.0414 (M + Na+), calculated for C92H137N25NaO19: m/z = 1919.0415 
   m/z = 1897.0595 (M + H+), calculated for C92H138N25O19: m/z = 1897.0595 
5.4.3.7. Synthesis of peptide 31 
 
Peptide 23a was acetylated by addition of 20 equiv acetic anhydride and agitation for 10 h, followed 
by repeated precipitation with cold Et2O and drying under high vacuum. 
 
HPLC: tR = 3.3 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 778.3861 (M + Na+), calculated for C36H53N9NaO9: m/z = 778.3858 
   m/z = 756.4040 (M + H+), calculated for C36H54N9O9: m/z = 756.4039 
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5.4.4. Synthesis of Peptides Bearing Carboxylic Acid Moieties 
5.4.4.1. Synthesis of Peptide 18a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, mono-tert-Butyl succinate was coupled to the amine on the oligoproline 
backbone. The peptide was cleaved from the resin and purified via HPLC. 
 
HPLC: tR = 1.9 min; Phenomenex Acris Peptide 1 7u XB-C18 (3 μm); gradient 98% to 40% B over 5 min 
at 50°C (PDA @214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 894.3965 (M + Na+), calculated for C40H57N9NaO13: m/z = 894.3974 
   m/z = 872.4147 (M + H+), calculated for C40H58N9O13: m/z = 872.4154 
5.4.4.2. Synthesis of Peptide 18b 
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Peptide 18b was synthesized, as described for peptide 18a.  
 
HPLC: tR = 2.3 min; Phenomenex Acris Peptide 1 7u XB-C18 (3 μm); gradient 98% to 40% B over 5 min 
at 50°C (PDA @214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1706.7655 (M + Na+), calculated for C78H109N17NaO25: m/z = 1706.7678 
   m/z = 1684.7835 (M + H+), calculated for C78H110N17O25: m/z = 1684.7859 
5.4.4.3. Synthesis of Peptide 18c 
 
Peptide 18b was synthesized, as described for peptide 18a.  
 
HPLC: tR = 2.5 min; Phenomenex Acris Peptide 1 7u XB-C18 (3 μm); gradient 98% to 40% B over 5 min 
at 50°C (PDA @214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 2519.1403 (M + Na+), calculated for C116H161N25NaO37: m/z = 
2519.1377 
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5.4.5. Synthesis of Peptides Bearing Indole Moieties 
5.4.5.1. Synthesis of Peptide 19a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, 3-Indoleacetic acid was coupled to the amine on the oligoproline backbone. The 
peptide was cleaved from the resin, purified via HPLC and desalted over an ion-exchange column. 
 
HPLC: tR = 3.4 min; Phenomenex Acris Peptide 1 7u XB-C18 (3 μm); gradient 98% to 40% B over 5 min 
at 50°C (PDA @214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 986.4874 (M + H+), calculated for C52H63N11O9: m/z = 986.4883 
5.4.5.2. Synthesis of Peptide 19b 
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Peptide 19b was synthesized, as described for peptide 19a.  
 
HPLC: tR = 4.0 min; Phenomenex Acris Peptide 1 7u XB-C18 (3 μm); gradient 98% to 40% B over 5 min 
at 50°C (PDA @214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1934.9131 (M + Na+), calculated for C102H121N21NaO17: m/z = 1934.9142 
   m/z = 1912.9309 (M + H+), calculated for C102H122N21O17: m/z = 1912.9322 
5.4.5.3. Synthesis of Peptide 19c 
 
Peptide 19c was synthesized, as described for peptide 19a.  
 
HPLC: tR = 4.4 min; Phenomenex Acris Peptide 1 7u XB-C18 (3 μm); gradient 98% to 40% B over 5 min 
at 50°C (PDA @214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR):  m/z = 2861.3595 (M + Na+), calculated for C152H179N31NaO25: m/z = 
2861.3581 
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5.4.6. Synthesis of Peptides Bearing Pyrrolidinyl Moieties 
5.4.6.1. Synthesis of Peptide 20a 
 
Ac-[Pro-Azp-Pro]2-NH2 was synthesized according to the general procedures in a 100 µmol scale on 
Rink amide - ChemMatrix resin. The coupling steps were followed by an acetylation of the N-
terminus. The azido groups were reduced under Staudinger conditions according to the procedure 
given above. Then, (2-oxo-1-pyrrolidinyl) acetic acid was coupled to the amine on the oligoproline 
backbone. The peptide was cleaved from the resin, purified via HPLC and desalted over an ion-
exchange column. 
 
HPLC: tR = 2.2 min Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 944.4602 (M + Na+), calculated for C44H63N11NaO11: m/z = 944.4601 
   m/z = 922.4779 (M + H+), calculated for C44H64N11O11: m/z = 922.4781 
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5.4.6.2. Synthesis of Peptide 20b 
 
Peptide 20b was synthesized, as described for peptide 20a.  
 
HPLC: tR = 2.6 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1806.8947 (M + Na+), calculated for C86H121N21NaO21: m/z = 1806.8938 
   m/z = 1784.9119 (M + H+), calculated for C86H122N21O21: m/z = 1784.9119 
5.4.6.3. Synthesis of Peptide 20c 
 
Peptide 20c was synthesized, as described for peptide 20a.  
 
HPLC: tR = 4.6 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 20% B over 5 min at 50°C (PDA 
@214 nm), flow 0.5 mL/min 
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HR-MS (MALDI-FT-ICR): m/z = 2669.3285 (M + Na+), calculated for C128H179N31NaO31: m/z = 2669.3275 
   m/z = 2647.3423 (M + H+), calculated for C128H180N31O31: m/z = 2647.3456 
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5.4.7. Synthesis of Flexible Peptides 
5.4.7.1. Synthesis of Peptide 29a 
 
 
The peptide was synthesized according to the general procedures in a 100 µmol scale on Rink amide - 
ChemMatrix resin, using Fmoc-His-OH and Fmoc-Ahx-OH as building blocks. The coupling steps were 
followed by an acetylation of the N-terminus. The peptide was cleaved from the resin, purified via 
HPLC and desalted over an ion-exchange column. 
 
HPLC: tR = 2.8 min Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 560.3302 (M + H+), calculated for C26H42N9O5: m/z = 560.3303 
5.4.7.2. Synthesis of Peptide 29b 
 
Peptide 29b was synthesized, as described for peptide 29a.  
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HPLC: tR = 2.7 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1060.6160 (M + H+), calculated for C50H78N17O9: m/z = 1060.6163 
5.4.7.3. Synthesis of Peptide 29c 
 
Peptide 29c was synthesized, as described for peptide 29a.  
 
HPLC: tR = 2.7 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1560.9023 (M + H+), calculated for C74H113N25O13: m/z = 1560.9022 
5.4.7.4. Synthesis of Peptide 30a 
 
The peptide was synthesized according to the general procedures in a 100 µmol scale on Rink amide - 
ChemMatrix resin, using Fmoc-Arg-OH and Fmoc-Ahx-OH as building blocks. The coupling steps were 
followed by an acetylation of the N-terminus. The peptide was cleaved from the resin, purified via 
HPLC and desalted over an ion-exchange column. 
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HPLC: tR = 2.5 min Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR):  m/z = 620.3968 (M + Na+), calculated for C26H51N11NaO5: m/z = 620.3967 
    m/z = 598.4148 (M + H+), calculated for C26H51N11O5: m/z = 598.4147 
5.4.7.5. Synthesis of Peptide 30b 
 
Peptide 30b was synthesized, as described for peptide 30a.  
 
HPLC: tR = 2.7 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR):  m/z = 1158.7670 (M + Na+), calculated for C50H97N21NaO9: m/z = 1158.7670 
   m/z = 1136.7851 (M + H+), calculated for C50H98N21O9: m/z = 1136.7851 
5.4.7.6. Synthesis of Peptide 30c 
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Peptide 30c was synthesized, as described for peptide 30a.  
 
HPLC: tR = 2.8 min; Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR):  m/z = 1697.1377 (M + Na+), calculated for C74H143N31NaO13: m/z = 1697.1374 
   m/z = 1675.1557 (M + H+), calculated for C74H144N31O13: m/z = 1675.1554 
5.4.7.7. Synthesis of Peptide 32 
 
The peptide was synthesized according to the general procedures in a 100 µmol scale on Rink amide - 
ChemMatrix resin, using Fmoc-His-OH, Fmoc-Ahx-OH and Fmoc-Asp-OH as building blocks. The 
coupling steps were followed by an acetylation of the N-terminus. The peptide was cleaved from the 
resin, purified via HPLC and desalted over an ion-exchange column. 
 
HPLC: tR = 2.2 min Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR):  m/z = 425.2147 (M + H+), calculated for C18H29N6O6: m/z = 425.2143 
5.4.7.8. Synthesis of Peptide 33 
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The peptide was synthesized according to the general procedures in a 100 µmol scale on Rink amide - 
ChemMatrix resin, using Fmoc-Pro-OH, Fmoc-His-OH and Fmoc-Asp-OH as building blocks. The 
coupling steps were followed by an acetylation of the N-terminus. The peptide was cleaved from the 
resin, purified via HPLC and desalted over an ion-exchange column. 
 
HPLC: tR = 3.2 min Reprosil gold 120 C18 (3 μm); gradient 98% to 40% B over 5 min at 50°C (PDA 
@214 nm), flow 0.7 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 1340.6375 (M + H+), calculated for C62H86N17O17: m/z = 1340.6382 
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5.4.8. Synthesis of Unfunctionalized Oligoprolines 
5.4.8.1. Synthesis of Peptide 25 
 
The peptide was synthesized according to the general procedures in a 100 µmol scale on Rink amide - 
ChemMatrix resin, using Fmoc-Pro-OH as building block. The coupling steps were followed by an 
acetylation of the N-terminus. The peptide was cleaved from the resin, purified via HPLC and 
desalted over an ion-exchange column. 
 
HPLC: tR = 7.8 min Reprosil gold 120 C18 (5 μm); gradient 98% to 40% B over 20 min at 50°C (PDA 
@214 nm), flow 1.0 mL/min 
HR-MS (MALDI-FT-ICR): m/z = 956.4853 (M + Na+), calculated for C47H68N10NaO10: m/z = 956.4852 
    m/z = 934.5036 (M + H+), calculated for C47H69N10O10: m/z = 934.5033 
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5.5. CD spectroscopy 
For CD spectroscopy the peptides were dissolved in ultrapure H2O. Depending on the length, 
different concentrations were adjusted to have about 6 x 10-4 M per amino acid residue. For the 
measurement a quartz cell with a path length of 1 mm was used. The temperature was set to 25°C, 
with a step resolution of 1 nm and for the Chirascan a time constant of 5 s and with the Chirascan 
Plus a time constant of 0.5 s. A background measurement with ultrapure H2O was performed and 
subtracted from the measured spectra. The values given are in molar elipticities (θMRW [10
3 deg cm2 
dmol-1]). The values are calculated according to formula (3). 
     
 
     
     (3) 
 θ = total ellipticity 
 n = number of amino acids 
 c = concentration 
 w = width of cuvette 
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5.6. AgNP generation 
5.6.1. AgNP Generation via Chemical Reduction 
The respective peptide was dissolved in ultrapure H2O and the pH was adjusted using 2 M NaOH 
solution and 2 M HNO3. Aqueous 2 M AgNO3 solution was added to reach a final concentration of 
0.25 M. The mixture was equilibrated for 15 minutes and then the reducing agent was added. The 
generation process was monitored by UV-Vis spectroscopy and the resulting AgNPs were analyzed by 
TEM microscopy.  
5.6.2. AgNP Generation via Radiation with Visible Light  
The respective peptide was dissolved in ultrapure H2O and the pH was adjusted using 2 M NaOH 
solution and 2 M HNO3. Aqueous 2 M AgNO3 solution was added to reach a final concentration of 
0.25 M. The mixture was equilibrated for 15 minutes and then exposed for one hour to the radiation 
source. After this it was kept in the dark. The generation process was monitored by UV-Vis 
spectroscopy and the resulting AgNPs were analyzed by TEM microscopy. 
5.7. AuNP generation 
The respective peptide was dissolved in ultrapure H2O and the pH was adjusted using 2 M NaOH 
solution. Aqueous 2 M HAuCl4 solution was added to reach a final concentration of 0.25 M. The 
mixture was equilibrated for 15 min and then the respective reducing agent was added. The 
generation process was monitored by UV-Vis spectroscopy and the resulting AuNPs were analyzed by 
TEM microscopy.  
5.8. PtNP generation 
The respective peptide was dissolved in ultrapure H2O and the pH was adjusted using 2 M NaOH 
solution. Aqueous 2 M K2PtCl4 solution was added to reach a final concentration of 0.25 M. The 
mixture was equilibrated for 15 min and then the respective reducing agent was added. The resulting 
PtNPs were analyzed by TEM microscopy.  
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6. Appendix 
6.1. Abbreviations 
Å Angström 
Ac Acetyl 
ACN Acetonitrile 
Ac2O Acetic anhydride 
AgNP Silver nanoparticle  
Ahx Aminohexanoic acid 
Amp (4S)-amino-L-proline 
AuNP Gold nanoparticle 
Azp Azidoproline 
Boc tert-Butyyloxycarbonyl 
Boc2O Di-tert-butyl dicarbonate 
°C Celsius degree 
c Concentration 
CD Circular dichroism 
CDCl3 Deuterated chloroform 
CH2Cl2 Dichloromethane 
d day(s) 
d Doublet 
δ Chemical shift [ppm] 
DIPEA N,N´-diisopropylethylamine 
D2O Deuterium oxide 
DMF Dimethylformamide 
DMSO N,N-Dimethylsulfoxide 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimid 
EDX spectroscopy Energy dispersive X-ray spectroscopy 
Equiv Equivalents 
Et Ethyl 
EtOAc Ethylacetate 
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EtOH Ethanol 
Fmoc 9-Fluorenylmethosycarbonyl 
g Gram 
GABA 4-Aminobutanoic acid 
Gup (4S)-guanidinylated L-proline 
h Hour 
H2O Water 
HCl Hydrochloric acid 
HCTU 2-(6-Chloro-1-H-benzotriazole1—y)-1,1,3,3- 
 Tetramethyluroniumhexafluorophosphate 
H-Hyp-OH Hydroxyproline 
J Scalar coupling constant [Hz] 
λ Wavelength [nm] 
m Multiplet 
M Molar 
MALDI Matrix assisted laser desorption or ionization 
MALDI-FT-ICR Matrix assisted laser desorption or ionization Fourier transform ion  
 cyclotron resonance 
Me Methyl 
MeOH Methanol 
MHz Megahertz 
min Minute(s) 
m/z Mass to charge ratio 
NEt3 Triethylamine 
NMR Nuclear magnetic resonance 
tBu tert-Butyl 
PDA Photodiode array 
PMe3 Trimethylphosphine 
ppm Parts per million 
PPI Polyproline type I helix 
PPII Polyproline type II helix 
PtNP Platinum nanoparticle 
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q Quartet 
quint Quintet 
Rt Retention time 
RT Room temperature 
s Singlet 
SERS surface enhanced Raman spectroscopy 
SPPS Solid phase peptide synthesis 
SPR Surface plasmon resonance 
TEM Transmission electron microscopy 
ΘMRW Mean residues weight ellipticity 
TFA 2,2,2-Trifluoroacetic acid 
THF Tetrhydrofurane 
TLC Thin layer chromatography 
TMS tetramethylsilane 
TIS Triisopropylsilane 
TNBS 2,4,6-Trinitrobenzenesulfonic acid 
TOF Time of flight 
Trt Trityl (Triphenylmethyl-) 
UPLC Ultra Performance Liquid Chromatography 
UV-Vis spectroscopy Ultraviolet- visible spectroscopy 
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6.2. CD spectra 
 
Figure 120: CD spectra of flexible peptides Ac-[His-Ahx]n-NH2 (29a n = 2, 29b n = 4, 29c n = 6) and Ac-
[Arg-Ahx]n-NH2 (30a n = 2, 30b n = 4, 30c n = 6). 
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6.3 Conditions for Crystallization 
The attempts for crystallization were carried out using peptide 17b, a 12mer bearing four imidazole 
moieties. The setup was done according to the hanging drop method.[226-227] A solution with a 
concentration of 1 mg/ 50 µL was made of which 1 µL was mixed with 1 µL of the respective 
crystallization mixture listed below. The drop was applied on a cover slip that was laid on the top of a 
vial, containing the same crystallization mixture. The seam of the vial was covered with grease to 
provide for an airtight sealing. The set up was checked regularly for crystal growth. 
Table 2: Crystallization mixtures, used for the attempt to crystallize peptide 17b. 
No Mixture Solvent 
1 2 M NaCl, 0.1 M sodium acetate  H2O 
2 2 M (NH4)2SO4, 0.2 M tartaric acid, 0.1 M sodium acetate H2O 
3 40% EtOH, 0.1 sodium acetate H2O 
4 25% tBuOH, 0.1 M Tris H2O 
5 0.001 M AgNO3, 0.1 M Tris H2O 
6 0.001 M HAuCl4, 0.1 M Tris H2O 
7 0.001 M AgNO3, 0.1 M sodium acetate H2O 
8 0.2 M tartaric acid, 2 M NaCl H2O 
9 0.001 M AgNO3, 1 M NaCl H2O 
10 0.2 M tartaric acid H2O 
11 0.1 M sodium acetate H2O 
12 25% tBuOH, 40% EtOH - 
13 1 M (NH4)2SO4, 0.1 M Tris H2O 
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